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Hypothesized to be ancestors of eukaryotic spliceosomal introns, extant group II 
introns are found in bacteria, archaea, and in the mitochondria and chloroplast genomes 
of some eukaryotes. While some of these catalytic intron RNAs encode an intron-
encoded maturase to assist in their splicing, not all do, eliciting the question of how these 
introns are spliced out. Two such introns are the mitochondrial introns aI5 and bI1 
of Saccharomyces cerevisiae. Previous in vitro studies on the self-splicing activity of 
these introns revealed requirements for non-physiologically high salt concentration and 
temperature for catalytic activity, suggesting a dependence upon proteins in vivo.  With 
most mitochondrial proteins known to be encoded by the nucleus, it seems likely that 
some exist to assist, either directly or indirectly, in the correct splicing of these introns. 
Previous searches for such proteins relied on a combination of two genetic screens: 
looking for a mutant’s inability to grow on the non-fermentable carbon source glycerol-
(Gly
- 
phenotype)-  in the presence of a given intron, and a Gly
+
 phenotype in the intron’s 
absence. In contrast, this study employs Northern hybridization to identify splicing 
defects in a series of mutants constructed by targeted gene deletion, allowing for 
vi 
 
identification of proteins required for splicing that would not have been otherwise 
detectable. In order to identify associated proteins, this method  is complemented by 
Tandem Affinity Purification of Mss116, the DEAD-box RNA chaperone required for 
splicing of all the yeast mitochondrial introns. In addition to Mss116, special attention 
was given to the insertase Oxa1, found to be required for aI5 and bI1splicing 
specifically; and to Mne1, found to be required for splicing group I intron aI5. The 
results point to distinctly different auxiliary protein requirements for group I introns, 
group II introns that encode their own maturases, and group II introns that do not encode 
maturases. My findings are consistent with the possibility that the splicing of aI5 and 
bI1, group II introns that do not encode maturases, is coordinated by multiple proteins 
comprising a splicing complex situated at the surface of the mitochondrial inner 
membrane in close association with the mitoribosomes. 
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Chapter 1: Introduction 
1.1 INTRONS 
1.1.1 Four classes of introns 
Introns are nucleotide sequences found within a gene that must be removed from 
the precursor RNA to allow the proper expression of the gene product. Four distinct 
classes of introns have been identified to date: introns in nuclear protein-coding genes 
that are excised by spliceosomes; introns in nuclear and archaeal transfer RNA genes that 
are spliced by proteins (tRNA splicing enzymes); and two classes of self-splicing introns 
that are removed by RNA catalysis, group I and group II introns. 
Those of the last two classes, the group I and group II introns, are catalytic RNAs 
thought to be vestiges of the RNA World (Gilbert 1986; Lambowitz et al. 1999). Introns 
capable of self-splicing have been identified in organisms from all three domains of life: 
bacteria, archaea and eukaryotes (Lambowitz and Caprara 1999; Simon et al. 2008; 
Tocchini-Valentini et al. 2011). Group I and group II introns can be distinguished based 
on their splicing mechanisms and secondary and tertiary structures, with each group 
displaying distinctively characteristic mechanisms and structures despite having few 
conserved nucleotides. 
1.1.2 Structure of group I and group II introns 
The core secondary structure of group I introns generally consists of nine paired 
segments (P1-P9) that fold into two principal domains: the P4-P6 domain (formed from 
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the stacking of P5, P4, P6 and P6a helices) and the P3-P9 domain (formed from the P8, 
P3, P7 and P9 helices) with additional peripheral segments that differ between intron 
subclasses (Figure 1.1 A) (Saldanha et al. 1993; Cate et al. 1996; Woodson 2005). 
Examples of these introns can be found in bacteria, in the plastids and mitochondria of 
lower eukaryotes and in the rRNA genes of the nucleus of protozoa and certain other 
lower eukaryotes.  
The group II secondary structure consists of six conserved stem-loop domains, 
(termed DI-DVI) that radiate from a central core to bring the 5' and 3' splice junctions 
into close proximity of one another (Fig. 1.1 B) (Marcia et al. 2013). DI is the scaffold 
for the assembly of the catalytic core and is further divided into subdomains. Though not 
essential, domains II and III enhance the catalytic rate. Domain IV is not conserved in 
sequence but may harbor an ORF for a multifunctional intron-encoded-protein (IEP) that 
assists in the intron’s excision and mobility. DV is a central component of the ribozyme 
active site (Lehmann and Schmidt 2003; Pyle and Lambowitz 2006) and together with 
domain I, forms the minimal catalytic core of the intron. Domain VI contains a bulged 
adenosine residue, whose 2-OH is the nucleophile that initiates the splicing reaction. 
Group II introns are further divided into subgroups IIA, IIB and IIC, which have 
distinctive structural features. Noteworthy distinctions are the interactions of the 
exon/intron binding sites that differ among the three main subgroups. The subgroups also 
differ in DV and several tertiary interaction motifs (Lambowitz and Zimmerly 2011). 
Like group I introns, group II introns have been found in bacteria, as well as in the plastid 
and mitochondrial genomes of lower eukaryotes (Lambowitz and Zimmerly 2011).  
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1.1.3 Splicing mechanisms of group I and group II introns 
The splicing of group I introns proceeds via two sequential transesterification 
reactions (Cech 1986). The first of these is initiated by an exogenous guanosine (exoG) 
docking into the G-binding site located in P7 (Figure 1.2 A). The 3'-OH of this exoG is 
positioned to attack the phosphodiester bond at the 5' splice site in P1, leaving a free 3'-
OH at the upstream exon and the exoG covalently attached to the 5' end of the intron. In 
the second transesterification reaction, the 5 exon attacks the 3 splice site so that the 
terminal G of the intron replaces the exoG and occupies the G-binding site. This results in 
ligation of the two adjacent exons and the excised linear intron (Cech 1990). 
Like group I splicing, group II splicing also occurs via two sequential 
transesterification steps; however, the reactions are distinctively different from those of 
group I introns (Figure 1.2 B) (Cech 1993). Group II excision occurs in the absence of 
GTP and instead is initiated when the 2'-OH of a bulged adenosine in domain VI attacks 
the 5' splice site, generating a lariat with an unusual 3-phosphodiester-bond structure. 
This is followed by the second nucleophilic attack: that of the 3'-OH of the upstream 
exon on the 3' splice site, ligating both exons, and releasing the looped intron. This 
mechanism is identical to that used by the spliceosome in the splicing of nuclear pre-
mRNA (Lambowitz and Zimmerly 2011; Lambowitz and Belfort 2015). 
1.2 GROUP II INTRONS AS PROGENITORS OF THE SPLICEOSOME 
 There is general consensus today that group II introns are the ancestors of 
spliceosomal introns (Sharp 1985; Cech 1986; Rogers 1989; Cavalier-Smith 1991; 
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Lambowitz and Belfort 2015). With their similarities in splicing mechanisms, the use of a 
2´-OH group on a branchpoint adenosine, lariat intermediates, and RNA helicases as co-
factors (Lambowitz and Zimmerly 2004; Huang et al. 2005; Cordin et al. 2012), the 
evidence appears strong.   
The parallels extend further: To fold into catalytically-active structures in vivo, 
group II introns often use intron-encoded proteins, termed  maturases (Matsuura et al. 
2001). Spliceosomal introns do not encode maturases nor fold as group II introns do, but 
rely instead on snRNAs provided in trans for their excision (Matera and Wang 2014). 
Similarities between snRNAs and group II intron domains have long been noted, with the 
former being famously described as introns in “five easy pieces” (Sharp 1991). For 
example, group II intron domain V has strong structural similarities to the U6 snRNA 
(Sashital et al. 2004; Seetharaman et al. 2006); and snRNA U5 was found to functionally 
complement the stem loop from a subdomain  of group II intron domain I (Hetzer et al. 
1997). The snRNAs do not act alone, however, but instead coordinate with a large 
number of proteins to form RNA-protein complexes that constitute the spliceosome 
(Matera and Wang 2014). Some group II introns do not have intron-encoded maturases 
and in that respect, more closely resemble spliceosomal introns than introns that do 
encode maturases. Do they, like their spliceosomal descendants, have auxiliary proteins 
that work in trans to assist in their folding? If so, what are they? Could those proteins 
give us clues to the ancestry of the spliceosome?  
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1.3 INTRON INVASION FROM AN ENDOSYMBIONT 
Though the specifics as to how are still being debated, it is now widely accepted that 
mitochondria originated from an endosymbiotic event between an ancestral -
proteobacterium and a proto-eukaryotic host (Wallin 1927; Sagan 1967). The ancestral 
proteobacterium is thought to have contained group II introns, since these have now been 
identified in many extant bacterial genomes (Martinez-Abarca and Toro 2000). Over 
time, it is believed that a large number of the endosymbiont’s genes were transferred to 
the host, so that today, mitochondrial proteins are mostly encoded by the nucleus. 
Importantly, introns are presumed to have been among the genetic material transferred to 
the host (Rogozin et al. 2012) perhaps triggering eukaryogenesis as hypothesized by 
some (Martin and Koonin 2006). Though mitochondria of many higher eukaryotes do not 
contain introns, those of some extant organisms such as yeast still do, and thus make 
good models to study the putative evolutionary relationship between group II introns and 
the spliceosome. 
1.4 THE YEAST MITOCHONDRIAL SYSTEM 
1.4.1 The yeast mitochondrial genome (mtDNA) 
Having once been free-living -proteobacteria, mitochondria have retained much 
of their prokaryotic physiology (Martin and Muller 1998; Gray et al. 1999). Two of the 
ways that mitochondria are thought to have done so is through the persistence of a 
circular genome and their own translational machinery. 
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The Saccharomyces cerevisiae genome, also known as the rho factor 
((Williamson 2002), is often up to 8.6 kb in size, though it may be smaller, largely 
depending on the number of introns present (Fig. 1.3) (Turk et al. 2013). Wild-type yeast 
cells which respire normally and form large or grande colonies, are termed 
+
. Petites   
(
-
), which have deletions of 20-99.9% of the genome, form small colonies and are 
unable to respire (Borst and Grivell 1978). In the event of total loss of the mt genome, the 
cells are referred to as 
0
. As a consequence of losing portions of its genome, the 
mitochondrion almost invariably loses genes, such as tRNA and rRNA genes, needed for 
its translation machinery as well as those required for respiration, making them unable to 
grow on non-fermentable carbon sources such as glycerol (Gly
-
 phenotype).  
1.4.2 Few proteins are encoded in the mt genome 
In addition to several intron-encoded ORFs, there are eight major proteins 
encoded by the extant mtDNA of S. cerevisiae (Williamson 2002; Sickmann et al. 2003). 
These proteins and their associated genes are cytochrome c oxidase subunits I, II and III 
(COX1, COX2 and COX3), cytochrome b (COB), ATP synthase subunits 6, 8 and 9 
(ATP6, ATP8 and ATP9), and small subunit ribosomal protein Var1 (VAR1). Except for 
Var1, these are hydrophobic proteins and key components of the electron transport chain 
located within the inner mt membrane (Sickmann et al. 2003).  
With so few proteins encoded in the mitochondria, most of the estimated 590 to over 
800 mitochondrial proteins are nuclear-encoded, many being essential (Perocchi et al. 
2006; Elstner et al. 2009). Thus, despite having its own genome and translational 
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machinery, the mitochondrion is highly dependent on extra-mitochondrial processes for 
its function and biogenesis.  
1.4.3 Group I and group II introns are found in three yeast mitochondrial genes 
It is within the COX1, COB and 21S rRNA genes that the yeast mitochondrial introns 
are found (Figure 1.4). COX1 harbors up to four group I introns (aI3, aI4, aI5 and aI5) 
and 3 group II introns (aI1, aI2, aI5). COB may have up to four group I introns (bI2, bI3, 
bI4, bI5) and one group II intron, bI1 (Pel and Grivell 1993). In most strains, the group II 
intron aI5 is the last intron found in the COX I gene; while the group II intron bI1 is the 
first of 5 introns in the COB gene (Pel and Grivell 1993). An additional group I intron 
(may be present within the gene encoding the 21S rRNA, so that a yeast strain may 
have up to 13 introns or none at all, (I
0
).  
1.4.4 Maturases, intron-encoded proteins that assist in splicing 
In vitro, some introns are self-splicing (Peebles et al. 1986), but  in vivo, many introns 
are assisted by intron-encoded maturases in order to fold into their catalytically-active 
tertiary structures (Lambowitz and Caprara 1999)Many introns are assisted by intron-
encoded maturases, most of which are specific to the intron from which they are encoded 
(Saldanha et al. 1993). Group II intron maturases are encoded by ORFs within intron 
domain IV, and are thought to act by stabilizing the catalytic RNA structure via long-
range intron-intron and  intron-exon interactions (Matsuura et al. 2001).  
The known maturases of the yeast mitochondria are diagrammed in Fig. 1.4. Within 
COX1, introns aI1 and aI2 encode their own maturases; while aI4 encodes an inactive 
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one. Within COB, introns bI2, bI3 and bI4 encode their own maturases, the latter of 
which, in addition to assisting in its own splicing, also assists with the splicing of aI4 
(Goguel et al. 1989). Two group II introns, aI5 and bI1, do not have ORFs and 
consequently, do not encode maturases. 
1.5 NUCLEAR-ENCODED  INTRON-SPECIFIC SPLICING FACTORS 
In addition to the intron-encoded maturases, several nuclear-encoded proteins 
have been identified that act specifically as splicing factors for one or more yeast mt 
introns (Fig. 1.4) (McGraw and Tzagoloff 1983; Seraphin et al. 1988; Costanzo et al. 
1989; Valencik et al. 1989; Bousquet et al. 1990; Gampel and Cech 1991; Naithani et al. 
2003; Kaspar et al. 2008; Watts et al. 2011).  Many of these were identified in screens for 
nuclear mutations that cause respiratory deficiency only in strains whose mtDNA 
contains introns. To date, other than the general RNA chaperone Mss116 (which is 
required for the splicing of all yeast mt introns ), no splicing factors other than the IEPs 
of aI1 and aI2 have been identified for yeast mt group II introns (Seraphin et al. 1989; 
Huang et al. 2005; Mohr et al. 2006 ) possibly reflecting the differences between group I 
and group II splicing mechanisms. Thus, introns aI5 and bI1 have neither intron-
encoded maturases nor nuclear-encoded splicing factors that have yet been identified.  
1.6 MSS116, A DEAD-BOX PROTEIN THAT FUNCTIONS AS A GENERAL RNA CHAPERONE 
DEAD-box proteins are ubiquitous RNA helicases which function in various 
RNA-mediated processes: transcription, translation, ribosome biogenesis, RNA export, 
and both nuclear and mitochondrial pre-mRNA splicing (de la Cruz et al. 1999; Linder 
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2003; Pan and Russell 2010; Jarmoskaite and Russell 2011; Jarmoskaite and Russell 
2014) 
Named for an eponymous four amino acid residue motif, DEAD-box helicases 
play key roles in remodeling many cellular RNAs from inactive but stable states to their 
active three-dimensional conformations (Jarmoskaite and Russell 2014). They function 
by coupling cycles of ATP binding and hydrolysis to alter their affinity for single-
stranded RNA, effectively separating the strands of short RNA duplexes in a non-
processive manner (Fairman-Williams et al. 2010).  
Spliceosomal introns require several DEAD-box proteins for proper splicing 
(Cordin et al. 2012). Within the yeast mitochondrion, the DEAD-box protein Mss116 
(Fig. 1.5) is required for the splicing of all thirteen mt group I and group II introns 
(Huang et al. 2005).  
The domain structure of Mss116 is shown in Fig. 1.5 (Mohr et al. 2011; Russell et 
al. 2013). Mss116 is expressed in the cytoplasm and targeted to the mitochondrion with 
the N-terminal mitochondrial localization signal (Fig. 1.5, Mt, diagonal lines) which is 
cleaved off to form the mature protein upon mitochondrial import. The N-terminal 
extension (NTE) precedes the helicase core of the protein, which is itself comprised of 
two RecA-like helicase domains, D1 and D2. Distributed within D1 and D2 are thirteen 
conserved motifs, common to all DEAD-box proteins: Q, I, Ia, Ib, Ic, II, III, IV, IVa, 
V,Va,Vb, and VI (Fairman-Williams et al. 2010), some of which function primarily for 
ATP binding (orange bands); others for ssRNA binding (green bands). D1 and D2 are 
joined by a linker that allows the protein to adopt either an open or closed conformation 
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(Cao et al. 2011). Following D2 are the C-terminal extension (CTE) and the C-tail. While 
much is known about Mss116, details of how its different domains and motifs contribute 
to splicing have remained unclear.  
1.7 OVERVIEW AND SIGNIFICANCE OF RESEARCH PROJECT 
1.7.1 Overview 
This study was principally designed to identify nuclear-encoded proteins involved 
in the splicing of mitochondrial group II introns aI5 and bI1 in Saccharomyces 
cerevisiae. Not having intron-encoded maturases, these introns are presumed to have as-
yet-unidentified nuclear-encoded proteins that assist in their splicing. This notion is 
supported by the finding that self-splicing of these introns in vitro is possible only at non-
physiologically high salt concentration and temperature, suggesting a dependence upon 
proteins for splicing in vivo (Peebles et al. 1986; Schmelzer and Schweyen 1986; Jarrell 
et al. 1988). Previous searches unsuccessfully relied on a combination of two screening 
steps: looking for a Gly
-
 phenotype in the presence of a given intron and a Gly
+
 
phenotype in the intron’s absence (Séraphin et al. 1987; Luban 2005).  
Here, I employed Northern hybridization to identify splicing defects in knock-out 
strains, allowing for recognition of proteins that would not have been detectable by 
previously used methods.  One important limitation to the screen is its inability to test 
essential proteins or proteins not yet identified as being mitochondrial. To circumvent 
this problem, the screen was complemented by pull-down assays in which RNA 
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chaperone Mss116, known to be required for the splicing of all the yeast mt introns, was 
tagged and its associated proteins were identified. 
It has been long recognized that yeast mitochondrial intron splicing and 
functionality of the mitoribosomes are linked (Rodeheffer and Shadel 2003). The most 
common view is that without functional mitoribosomes, intron-encoded maturases cannot 
be translated, thereby blocking splicing (Pel and Grivell 1993).  Here, I provide evidence 
that the splicing of introns lacking intron-encoded maturases is also impacted by 
mitoribosomes in vivo (Chapter 3). Interestingly, this splicing block due to lack of 
functional mitoribosomes could sometimes be circumvented by putative second-site 
suppressor mutations. To eliminate secondary effects due to inhibition of translation, 
deletions were made in 
 
strains using a list of candidate proteins determined by mass 
spectroscopy analysis (Chapter 4). Chapters 5 and 6 each focus on two different proteins, 
Oxa1 and Mne1, respectively, which were found to be of interest during the preliminary 
screens.  Oxa1 is an insertase closely associated with the mitoribosome. Its deletion 
caused severe splicing defects in introns aI5 and bI1, though not in introns aI1, aI2, aI4, 
bI4 or bI5. Splicing defects in aI5 and bI1 were also found to be growth medium-
dependent. Together, the data suggest that the splicing of aI5 and bI1 is indirectly 
affected by Oxa1’s insertase function in rapidly dividing cells. Mne1 was found to be a 
splicing factor for the group I intron aI5β, adding to the array of proteins required for the 
splicing of that intron.  In Chapter 7, the splicing capabilities of Mss116 mutants were 
investigated and measurements were made of wild-type Mss116 levels and the minimal 
amount of the protein needed for splicing. Through the use of TAP-tag pull-down 
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analysis, other proteins associated with Mss116 were identified which included primarily 
mitoribosomal proteins and several known splicing factors. Treatment with RNase 
suggests that Mss116’s association with the mitoribosomes is via the rRNAs. 
1.7.2 Significance 
The impact introns have had on evolution cannot be underestimated. One 
hypothesis purports that group II intron invasion from an endosymbiont to the host was 
the key factor for the emergence of the nucleus, and consequently, for eukaryogenesis 
(Koonin 2006; Martin and Koonin 2006). Their catalytic properties and genetic 
information storage capabilities have engendered the notion that life on primordial Earth 
was originally RNA-based, an idea known as the RNA World Hypothesis (Gilbert 1986). 
How these RNAs fold into their catalytic conformations is not yet fully understood. Of 
key interest is the possible evolutionary relatedness based on the similarity in splicing 












Figure 1.1: Secondary structures of group I and group II introns. 
 
(A)  The group I intron secondary structure consists of two main domains P4-P6 and P3-
P9, made up of nine base-paired helices (P1- P9). (B) Group II intron structure consists of 
six domains (Roman numerals I- VI). Domain IV sometimes contains an ORF (dotted 
circle) which is lacking in introns aI5and bI1. The branchpoint adenosine in domain VI 
is indicated by A*. Greek letters indicate the location of sequence motifs involved in 
long-range tertiary interactions. The exon-binding sites, EBS1 and EBS2 base pair to the 
intron binding sites, IBS1 and IBS2 in the 5´ exon; sequences within the 3´ exon base 





Figure 1.2: The splicing mechanisms of group I and group II introns.  
 
(A) A group I intron (blue loop) lies between the 5´ and 3´ exons (fuchsia and black lines, 
respectively). An exogenous guanosine (exoG) initiates the first transesterification 
reaction (teal arrow), leaving exoG covalently attached to the 5´ end of the intron as well 
as a free 5´ exon with an available 3´OH group. The second transesterification reaction is 
initiated by the 3´ OH of the 5´ exon (teal arrow, middle) resulting in the release of the 
excised linear intron and ligation of both exons (bottom). (B) A group II intron (red loop) 
lies between the 5´ and 3´ exons (fuchsia and black lines, respectively) and contains a 
bulged branchpoint adenosine, A, that initiates the first transesterification reaction (teal 
arrow, top), resulting in a lariat with a 2´5´-phosphodiester bonds (red lariat, center). The 
3´OH of the 5´ exon initiates the second transesterification reaction (teal arrow, middle) 






 Figure 1.3: The S. cerevisiae mitochondrial genome 
 
The 8.6-kb genome with 13 introns. The relative positions of the primary transcripts (blue 
arrows), with protein-coding names (upper case, bold), dodecamer termination sequences 
(red lollipops), introns (lower case), and intron-encoded proteins (+ upper case, bold) are 




Figure 1.4: Yeast mt introns, their intron-encoded maturases, and known nuclear-encoded 
splicing factors. 
 
Gene names are indicated to the left of the figure. Exons and introns are indicated by gray 
rectangles and dotted lines, respectively. Group I introns are indicated in blue and group 
II introns are indicated in red. Intron-encoded proteins (IEPs) are indicated by green 
rectangles with active (MAT) and inactive (mat) intron-encoded maturases indicated 
within. Blue ovals represent known splicing factors for the associated introns, with the 















Figure 1.5: Schematic of wild-type Mss116. 
 
Diagram of Mss116 showing domain architecture and the location of conserved sequence 
motifs. The pre-protein begins with an N-terminal mitochondrial target sequence (Mt), 
which is cleaved during transport into the mitochondrion, followed by an N-terminal 
extension (NTE), and Domain 1 which contains motifs Q, I, Ia, Ib, Ic, II, and III. 
Following Domain 1 is Domain 2 which contains motifs IV, Iva, V, Va, Vb, and VI. 
Domain 2 is followed by a C-terminal extension (CTE) and the C-tail. Motifs colored 
orange interact with ATP and those colored green interact with ssRNA. Motif III (black) 
does not contact either ATP or RNA, but is instead involved in bridging domains 1 and 2. 
Amino acid residues at the boundaries between different regions are numbered below. 




Chapter 2: Methods and Materials 
2.1 S. CEREVISIAE STRAINS USED  
S. cerevisiae strains used in this study are derivatives of wild-type strain 161-U7 
which has the nuclear background MATa ade1 lys1 ura3 and can have up to 12 group I 





 strain harbored all 12 of the group I and group II introns found in the COX1 and 
COB genes and the I
0
 strain had none. The single-intron strains contained either intron 





were isogenic derivatives of the aI5 and bI1 strains. All 
strains were obtained from Dr. Philip Perlman (Howard Hughes Medical Institute). 
To engineer null mutants for each protein of interest, the kanamycin KanMX 
module was amplified by colony PCR (described below) from the commercially available 
BY4741 knock-out strains (Open Biosystems’ Saccharomcyces cerevisiae Genome 
Deletion collection) using pairs of oligonucleotide primers specific for each gene of 
interest (Appendix B). The resulting PCR products were then used to replace the 
corresponding target gene in the experimental strains by a standard yeast transformation 
protocol (Gietz and Schiestl 2007), as described in more detail below. Confirmation of 
the correct gene replacement was performed using two pairs of primers: One pair at the 
5´ end of the kanamycin cassette with the forward primer upstream of the transforming 
PCR product and the reverse primer within the kanamycin cassette. The second pair 
tested the 3´ region using a forward primer within the kanamycin cassette and the reverse 
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primer downstream of the transforming cassette. All the null mutants in the screen are 
then formally orfKANMX, but will be designated in this thesis by the shortened orf
S. cerevisiae strains used for the Mne1study (chapter 6) were W303 (MAT 
ade2-1 his3-1, 15 leu2-3, 112 trp1-1 ura3-1), containing all twelve COX1 and COB 
introns, and the corresponding mne1 mutant (Kispal et al. 1999; Watts et al. 2011). 
2.2 YEAST COLONY PCR  
Amplification of the kanamycin cassette and confirmation of correct gene 
replacement were both performed by colony PCR, a method adapted from the Eckdahl 
lab  website at Davidson-Missouri Western State University (Eckdahl 2014). 
Oligonucleotides were designed to PCR-amplify the appropriate region from the 
appropriate BY4741 knock-out strain including the kanamycin cassette plus upstream and 
downstream flanking regions of at least 50 nt for each gene of interest.  A second set of 
oligonucleotides lying outside of the transformation cassette was designed to confirm 
proper gene replacement. Primers used are listed in the Appendix. 
For colony PCR, a small amount of cells was transferred with a sterile pipette tipfrom 
a plate to the bottom of a PCR tube and placed in -80°C for 15 min before microwaving 
at full power for 1 min. Cells were then placed on ice.  The PCR reaction was prepared as 
follows: 25 µl of Phusion Master mix (NEB), 0.3 µl of mixed 100 µM oligonucleotides, 
and 24.7 µl ddH2O. The starting thermocycler program used was: 98°C for 10s for 
initialization, followed by 30 cycles of 10 s at 98C, 30 s at 55C and 45 s at 72. The 
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final elongation step was 5 min at 72. Denaturing and annealing times and temperatures 
were adjusted as required by the primers used and length of the expected product. 
2.3 YEAST TRANSFORMATION 
Yeast strains were transformed by adapting a method previously described 
(Agatep et al. 1998).  Each yeast strain to be transformed was streaked out onto 2% agar 
YPG plates (Yeast Peptone with 2% glycerol as carbon source) and grown at 30° C for 2-
3 days. Isolated colonies were used to inoculate 50 ml of YPD (Yeast Peptone with 2% 
glucose) and grown at 30° C overnight with shaking. The following morning, the O.D.600 
of the culture was measured and the volume equivalent to 2.5 X 10
8
 cells was diluted in 
50 ml total volume of pre-warmed YPD, giving a starting titer of about 5 X 10
6
 cells/ml 
(O.D.600 = 0.5). A culture was grown 3-5 h to O.D.600 = 2, yielding approximately 2 X 10
7 
cells/ml. (For most strains, an O.D.600 = 0.1 corresponds to approximately 1 X 10
6
 
cells/ml.) The culture was centrifuged in a 50 ml conical tube in a Sorvall JA14 at 3,000 
rpm for 5 min at 25°C. The resulting pellet was resuspended in 25 ml of ddH2O and 
centrifuged a second time at 1,000 rpm for 4 min. The washed pellet was resuspended in 
900 µl of ddH2O and transferred to a 1.5 ml microcentrifuge tube. The cells were then 
pelleted at 13,000 rpm for 1 min in an Eppendorf microcentrifuge 5424 and the resulting 
supernatant removed by pipetting. The cells were resuspended in approximately 700 µl 
0.1 M LiAc to a final volume of 1 ml and incubated at 30°C for 10 min. For each 1X 
transformation reaction, 100 µl of the LiAc cell suspension were aliquotted into a fresh 
microcentrifuge tube. The cells were then pelleted at 13,000 rpm for 1 min in a 
microcentrifuge and the supernatant was discarded. The following reagents were added to 
the pellet in the following order: 240 µl of 50% polyethelene glycol (3350 PEG); 36 µl of 
1M LiAc; 10 µl of 10 mg/ml single-stranded carrier DNA (Sigma-Aldrich); 100 ng of the 
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DNA being transformed; and sufficient ddH2O to bring the total volume to 360 µl. The 
tubes were vortexed vigorously until cells had been resuspended, then incubated at 30°C 
for 30 min. Cells were heat-shocked in a 42°C water bath for 30 min. Cells were pelleted 
at 13,000 rpm in a microcentrifuge for 1 min then resuspended in 1 ml YPD and 
incubated on a rocker overnight at 30°C. Transformants were selected by plating the cells 
onto selective media as required, either YPD/G418 or HC/Ura
-
/Glu (Hartwell Complete 
media lacking uracil with 2% glucose) (Amberg et al. 2005) and grown for 2-3 days.  
2.4 TOTAL RNA ISOLATION 
Cultures were grown in 30 ml YPR (Yeast Peptone with 2% raffinose) or 
HCR/Ura-(Hartwell’s Complete defined medium lacking uracil with 2% raffinose) in 250 
ml Erlenmeyer flasks in a 30°C shaker for 20 h or to O.D.600 = 0.5 – 0.8. Cells were 
centrifuged  in a Sorvall JA14 rotor at 5,000 rpm in 50 ml conical tubes for 4 min at room 
temperature, and the resulting pellets resuspended in 400 µl of AE buffer (50 mM 
NaOAc pH 5.3, 10 mM EDTA),  then transferred to a 1.5 ml microcentrifuge tube. 
Pellets that were not used immediately were stored at -80° in 25% glycerol for later use. 
(Frozen pellets that had been stored in glycerol were centrifuged at 13,000 rpm for 2 min 
to remove glycerol. The pellets were then resuspended in room temperature AE buffer 
and brought to 30 for 15 min prior to continuing with the preparation as described here.) 
Cells were centrifuged at 5,000 rpm for 6 min and the resulting pellet resuspended in 400 
l AE buffer plus 40 l of 10% SDS. This and subsequent centrifugations were 
performed in an Eppendorf microcentrifuge. Tubes were vortexed vigorously for 1 min. 
To remove DNA, 550 l of acid phenol (pre-equilibrated with AE buffer; Ambion/Life 
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Technologies) were added to the tube, which was then vortexed for an additional 3-4 min 
and incubated in a 65C water bath for 4 min. The tube was chilled in a dry ice/ethanol 
bath until phenol crystals appeared (about 5 min) then centrifuged at 12,000 rpm for 6 
min at room temperature to separate the phenol and aqueous phases. The upper aqueous 
phase (400-500 l) was transferred to a fresh microcentrifuge tube leaving some aqueous 
layer behind to minimize the likelihood the sample contained contaminating protein. The 
sample was extracted with equal volume (~500 l) phenol/chloroform/isoamyl alcohol 
(25:24:1) (Ambion/Life Technologies) at room temperature for 5 min, then centrifuged in 
a microcentrifuge at 12,000 rpm for 6 min to separate the phases. The upper aqueous 
phase was again transferred to a fresh microcentrifuge tube, taking the same precautions 
as before. 40 l of 3 M NaOAc, pH 5.3 and 2.5 volumes (1 ml) ice cold 100% ethanol 
were added to the sample to precipitate the RNA. The tubes were left at -80 for at least 1 
h prior to pelleting in an Eppendorf 5415 microcentrifuge at 13,000 rpm at 4C for 20 
min. The supernatant was discarded and the resulting pellet was washed with 1 ml ice 
cold 70% ethanol, then repelleted at 12,000 rpm at 4C for 5-10 min. As much of the 
ethanol as possible was removed by pipetting without disturbing the pellet. The pellet 
was resuspended in a volume of Rnase-free Millipore ddH2O to give RNA concentrations 
between 2.0-2.9 g/l at 260 nm as determined by Nanodrop 1000 (Thermo Scientific).  
2.5 NORTHERN HYBRIDIZATIONS  
For Northern hybridization, cells were grown and RNA isolated as described 
above. Samples containing 1.2 μg of RNA were denatured by incubation with 20% 
 23 
(vol/vol) glyoxal at 65 °C for 15 min and electrophoresed in an RNA-grade 1.5% agarose 
gel with 1× TAE buffer (40 mM Tris–acetate, pH 8 and 1 mM EDTA) at 25 °C. The gels 
were blotted onto a nylon membrane (Hybond-XL; GE Healthcare) overnight, UV 
crosslinked (Stratogene Stratolinker 2400), and hybridized with a 5′-
32
P-end-labeled 
DNA oligonucleotide probe as detailed in Table 2.1. Following overnight hybridization, 
the membrane was scanned with a PhosphorImager (Amersham), visualized with Canvas 
9 software (ACD Systems of America), and measured with GelQuant.NET software 
provided by biochemlabsolutions.com. 
2.6 PREPARATION OF INTERNALLY-LABELED PCR PROBES  
The PCR reaction was prepared as follows: 9.25 µl ddH2O, 2.0 µl ThermoPol 
buffer (Invitrogen), 0.2 µl PCR template (prepared from the wild-type strain), 0.5 µl each 
of 10 mM dATP, dCTP, and dGTP, 0.25 µl 1 mM dTTP, 6.0 µl 
32
P dTTP (Perkin-
Elmer),0.5 µl Taq DNA polymerase (Invitrogen), 0.3 µl 100 µM mixed oligonucleotides 
(seeTable 2.1) for a total reaction volume of 20 µl. The thermocycler program used was: 
94°C for 60s for initialization, followed by 25 cycles of 45 s at 98C, 45 s at 55C and 60 
s at 72. The final elongation step was 7 min at 72. Denaturing and annealing times and 
temperatures were adjusted as required by the primers used and length of the expected 
product. The PCR product was cleaned with a Qiagen PCR Clean-up kit, eluting in 30 µl 
ddH2O, and then incubating the eluate at 95C for 10 min prior to use.
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2.7 ISOLATION OF MITOCHONDRIA 
Overnight starter cultures were grown with shaking (200 rpm) at 30 in 50 ml HC 
/Ura
-
 media using 2% glucose as the carbon source. 1 ml of starter culture was inoculated 
into 1 l of HC/Ura
-
 media with 2% raffinose and grown to an O.D.600 of ~3.0 The cells 
were pelleted in a Beckman Avanti J-20I JLA 8.1 rotor at 3,500 rpm at 6 for 5 min and 
kept on ice until cultures for that day’s experiments reached the appropriate O.D.600. 
Pellets were then resuspended in 100 ml of room temperature TE resuspension buffer (10 
mM Tris, pH 9.5; 1 mM EDTA, pH 7.5) plus 0.5 ml -mercaptoethanol, transferred to 
250 ml centrifuge bottles and centrifuged again at 3,500 rpm in a Beckman Avanti JA14 
rotor for 5 min at 25.  Pellets were then resuspended in 25 ml of citrate buffer (1.2 M 
sorbitol, 26 mM K2HPO4, 20 mM citrate monohydrate, 1.26 mM EDTA, adjusted to pH 
5.8 with NaOH) and centrifuged once more under the same conditions. Each pellet was 
then resuspended in 50 ml of citrate buffer plus 1 ml (5,000 units) lyticase (Sigma) in 
H2O and incubated for 30 min in a 30 water bath. A 50 l aliquot of cells mixed with 10 
l of 10% SDS was tested for cell lysis, indicative of protoplast formation. Protoplasts 
were centrifuged at 3,500 rpm for 5 min at 4, then carefully resuspended in 25 ml 15% 
sucrose plus 20 ml acid-washed glass beads (425-600 m, Sigma) and mixed by hand for 
3 min. The supernatant was transferred to a fresh 250 ml Beckman bottle. The beads were 
washed 2X with 50 ml 15% sucrose with both washes combined with the supernatant in 
the fresh bottle. This was centrifuged in Beckman rotor JA14 at 3,500 rpm for 5 min at 4 
with the resulting supernatant once again being transferred to a fresh 250 ml Beckman 
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bottle. This was then centrifuged in Beckman rotor JA14 at 13,000 rpm for 15 min at 4 
retaining the resulting pellet and discarding the supernatant. The pellet was carefully 
resuspended in the residual 15% sucrose and transferred to a 25 X 89 mm Ultra-ClearTM 
ultracentrifuge tube (Beckman). 12 ml of 65% sucrose (65% sucrose, 10 mM tricine, 0.05 
mM EDTA, pH 7.5) were added a bit at a time with stirring. This was overlaid with 12 
ml 53% sucrose (53% sucrose, 10 mM tricine, 0.05 mM EDTA, pH 7.5), followed by a 
13 ml layer of 44% sucrose (44% sucrose, 10 mM tricine, 0.05 mM EDTA, pH 7.5). The 
tubes were centrifuged in a Beckman Optima LE-80K ultracentrifuge SW28 rotor at 
27,000 rpm for 2 h 10 min at 4. Intact mitochondria migrated to the interface between 
the 44% and 53% sucrose phases and were moved to a 15 ml conical tube. The 
mitochondria were gently mixed with an equal volume (about 5 ml) of HKCTD (0.5 M 
KCl, 0.05 M CaCl2, 0.025 M Tris-HCl pH 7.5). Following a 15 min centrifugation at 
13,000 rpm at 4, the supernatant was discarded and the mitochondrial pellets were stored 
at -80 until use. 
2.8 RIBONUCLEOPROTEIN (RNP) PREPARATION 
RNP preparations and analyses were performed by Dr. Georg Mohr following a 
method previously described (Kennell et al. 1993). Yeast strains were grown to early log 
phase in YPR and mitochondria were isolated as described above. Mitochondria were 
resuspended in HKCTD and lysed with 0.2% Nonidet P40. The lysates were layered over 
1.85 M sucrose cushions containing HKCTD and centrifuged in a Beckman Optima LE 
80K ultracentrifuge using rotor SW28. Following a 17 h spin at 50, 000 rpm at 4°, the 
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clear, gelatinous pellet was washed three times with Rnase-free ddH2O, then resuspended 
in 10 mM Tris-HCl pH 7.5 and 1 mM DTT and transferred to a microcentrifuge tube and 
placed on ice. Resuspended RNP particles were stored at -80° until use. 
2.9 CONSTRUCTION OF OXA1 MUTANTS 




 strain by colony PCR 
using oligonucleotides (Table 2.1) that were designed to allow directional cloning into 
the BamHI and SacI sites of the multi-cloning site (MCS) in yeast CEN plasmid pRS416 
(Agilent Technologies).  This vector contains an ampicillin cassette for selection of E. 
coli, and a URA3 marker for auxotrophic selection of yeast in Ura
-
 media. Deletions of 
the Loop 1 and the C-terminal domains in Oxa1 were engineered by PCR stitching (Table 
2.1) and cloned into pRS416 at the same restriction sites. Following sequence 
confirmation, plasmids were transformed by standard protocol as described above into 
oxa1 mutants of the single-intron strains 161-U7/aI5 and 161-U7/bI1 and the oxa1  
isogenic intronless strain (I
0
) used as control.  
2.10 TOTAL PROTEIN ISOLATION  
For Western blots, whole-cell proteins were isolated by trichloroacetic acid 
(TCA) precipitation (Yaffe and Schatz 1984). Briefly, 3 O.D.600 units of culture were 
collected and pelleted at 1,000 x g in an Eppendorf 5424 tabletop microcentrifuge for 5 
min. The pellet was resuspended in 1 ml of H2O and 160 l of freshly-prepared SB buffer 
(1.85 M NaOH, 7.4% -mercaptoethanol) and moved to a 1.7 ml microcentrifuge tube. 
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After 10 min on ice, 160 l of 50% trichloroacetic acid was added to the slurry and the 
tube was returned to sit on ice for another 10 min. Following a 2 min 
microcentrifugation, the supernatant was discarded. The pellet was washed (not 
resuspended) with 0.5 ml 1 M Tris-base (pH not adjusted), then centrifuged at top speed 
for 15 s and the supernatant discarded. The protein pellets were dissolved in 150 μl of 
SDS-PAGE sample buffer (50 mM Tris-HCl, pH 6.8; 2% SDS; 10% glycerol; 1% 
mercaptoethanol; 12.5 mM EDTA). 
2.11 WESTERN BLOT ANALYSIS 
Samples (~60 μg of protein measured as O.D.280 by Nanodrop) were run in a pre-
cast 4–20% polyacrylamide gradient gel (NuPAGE BioRad) with 0.1% SDS in the 
running buffer and transferred to a Sequi-Blot
™
 polyvinylidene fluoride membrane  
(PVDF) membrane (BioRad) using a BioRad Criterion blotter apparatus.   The membrane 
was cut and the top portion probed with a guinea pig anti-Mss116 antibody (1:5,000 
dilution) (gift of the Perlman lab; (Huang 2004)) while the lower portion was probed with 
mouse anti-porin antibody (Abcam) to confirm equal loading when needed. Each 
membrane was developed using an ECL Plus Western Blotting kit (GE Healthcare), and 
imaged using a Cell Biosciences (Santa Clara, CA) HD2 imager or Kodak Biomax XAR 
film. Afterward, the membranes were stripped of antibodies with Restore™ Plus Western 
Blot Stripping Buffer (ThermoScientific, Waltham, MA) and stained with AuroDye Forte 
(GE Healthcare) or  Colloidal Gold Total Protein Stain (Bio-Rad), following the 
manufacturers’ directions, to additionally confirm equal loading of protein samples. 
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2.12 FRACTIONATION OF MITOCHONDRIAL INNER MEMBRANE  
This method was adapted from one described by the Martinou lab (Da Cruz et al. 
2003). Mitochondria were isolated as described above from 5 l cultures of isogenic 
aI5strains withwild-type and oxa1 nuclear backgrounds grown in YPR at 30° C with 
shaking to O.D.600 = 3.0. Mitochondrial pellets were resuspended in 0.2 mM 
phenylmethanesulfonylfluoride (PMSF) and ddH2O to a concentration of 5 mg/ml and 
stirred on ice for 20 min. The suspension was homogenized 20 times with a Dounce 
homogenizer and centrifuged at 15,000 rpm for 10 min at 4°. The resulting mitoplasts 
were treated with 0.1 M Na2CO3, pH 11.5 at a final concentration of 0.5 mg/ml for 20 
min on ice. Each mixture was transferred to a thick walled 25 X 89 mm Beckman Ultra-
Clear™ polycarbonate tube. The mitochondrial inner membrane proteins were pelleted at 
24,000 rpm at 4° for 30 min in a Beckman Optima LE 80K ultracentrifuge using rotor 
SW28. The pelleted proteins were resuspended in 2X sample buffer (0.1% digitonin, 20% 
glycerol, 120 mM Tris-HCl, pH 6.8) and run approximately 1 cm on a 4-12% Bis-Tris 
NuPAGE gel. Following staining with fresh Coomassie blue, the large protein band was 
cut from the gel and submitted to the University of Texas at Austin Protein Facility for 
in-gel digest, then run on the Dionex LC and Orbitrap Elite for LC-MS/MS with a 30 
min run time. The SEQUEST HT analysis references both the SwissProt protein database 
and the yeast database for protein identification. 
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2.13 MODULATING MSS116 EXPRESSION 
For experiments to determine Mss116 abundance, MSS116 was digested from 
plasmid pHRH197 (Huang et al. 2005) using restriction enzymes HindIII and SacI and 
cloned behind a calibrated set of  Translation Elongation Factor (TEF) promoters in 
plasmid p416-TEF-yECitrine that had been engineered to vary in strength (Alper, et al. 
PNAS, 2005) by replacing the original citrine reporter gene with MSS116. 
Mutations in the MSS116 promoter were constructed in plasmid pHRH197 
(Huang et al. 2005). For the deletion of the region flanked by the two ClaI sites (-
704/356), pHRH197 was digested with ClaI and 29runk29ted by standard methods.  This 
plasmid, pRZW212, was then used as the template for the remaining deletion constructs. 
To delete various portions of the MSS116 promoter, stitch PCR was used with 
oligonucleotides listed in Table 2.1 and cloned into plasmid pRZW212.  Sequence-
verified plasmids amplified in E. coli (DH5) with selection on LB/Amp
R
 plates. 




mss116Δ strain using the yeast transformation 
protocol described above. For subsequent Western blots, cultures were grown at 30°C in 
30 ml HC/Ura
-
 media, with 2% raffinose as carbon source to O.D.600 = 1.5. 
2.14 CONSTRUCTION AND EXPRESSION OF TAP-TAGGED WILD-TYPE MSS116  
Tandem Affinity Purification (TAP)-tagged Mss116 proteins were expressed from 
plasmid HRH197, a derivative of the centromeric shuttle vector pRS416 (Agilent 
Technologies) that contains an amp
R
 marker for E. coli (DH5) selection and a URA3 
marker for yeast selection on media lacking uracil. The TAP tag was PCR-amplified from 
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a commercially available strain (GE Healthcare) using oligonucleotides that allow for in-
frame, directional cloning into plasmid HRH197, harboring the full length MSS116 gene 









 and bI1 
-
 strains, all of which had nuclear background mss116, 
then selected on HC/Ura
-
 agar plates with 2% glucose. 
2.15 TANDEM AFFINITY PURIFICATION 
TAP-tagged Mss116 proteins were isolated from mitochondria prepared as 
described above. All the TAP purification steps were carried out at 4° unless otherwise 
indicated. All rotations were performed on a Labquake rotisserie (Thermo Scientific). 
The 200 µl mt pellet was defrosted at 30°C or room temperature, moved to a 
microcentrifuge tube and centrifuged at 12,000 rpm for 5 min. The pellet was 
immediately resuspended in 3 ml ice-cold solubilization buffer (SB) (20 mM Hepes-
KOH, pH 7.4; 250 mM sucrose; 200 mM KCl; 1 mM EDTA; 1 mM spermidine; 7 mM 
mercaptoethanol; 0.2 mM PMSF).  75 µl of 20% NP40 (Sigma) was added slowly, 
drop by drop to 0.5%, followed by incubation on ice for 15 min. The lysate was split in 
half, with approximately 1.5 ml in each microcentrifuge tube. These were centrifuged at 
20,000 rpm for 10 min, and the clear supernatant moved to a non-stick 1.5 ml Phenix 
tube (Phenix Research) containing 50 µl pre-washed Protein A Sepharose 4B FF beads. 
Following a1 h incubation at slow rotation, the supernatant was separated from the beads 
on a touch spin microfuge and transferred to a fresh non-stick Phenix tube with 25 µl pre-
washed IgG Sepharose 6FF beads. (IgG/Sepharose beads were prepared by washing with 
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NP40 buffer (no inhibitors) to remove ethanol and resuspended in 1:1 slurry with NP40 
buffer.) Following a 3 h rotation, the supernatant was discarded. Beads were washed 5 
times with 1.5 ml SB + 0.1% NP40, lacking EDTA (wash buffer). The beads from both 
tubes were combined into a 0.6 ml non-stick Phenix microcentrifuge tube, and 
resuspended in 500 µl wash buffer containing 10 µl AcTEV protease (expressed in E. 
coli and purified by Lilian Lamech). Following a 6 h incubation with rotation, the eluate 
was separated from the beads using a touch spin microfuge. The eluate was transferred to 
a fresh 0.5 ml tube containing 25 µl Calmodulin Sepharose 4B beads pre-washed with 
wash buffer containing 2 mM CaCl2 and allowed to incubate for 3 h with rotation. The 
beads were washed 5 times with wash buffer and 2 mM CaCl2, followed by 2 washes 
with CaCl2-free buffer. The protein was eluted from the beads by boiling in 30 µl of 
NuPAGE LDS loading buffer (Life Technologies). 15 µl were used for visualizing the 
polypeptides separated by electrophoresis in a 4-12% Bis-Tris NuPAGE gel (Life 
Technologies) and stained with fresh Coomassie blue. The remaining 15 µl were loaded 
onto a separate gel and run approximately 1 cm, and stained with fresh Coomassie blue. 
The large protein band was sliced from the gel and submitted to the University of Texas, 
Austin, Protein Facility for LC-MS/MS analysis as described above. 
2.16 PROTEIN ANALYSIS 
 The software used to validate MS/MS peptide and protein identifications was 
Scaffold (version 4.4.1.1, Proteome Software, Inc, Portland OR). Protein identifications 
were considered valid if they were comprised of at least two identified peptides at a 
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greater than 97% probability. Proteins were annotated with terms from 
gene_association.goa_uniprot (downloaded Jul 14, 2014) (Ashburner et al. 2000). 
2.17 OLIGONUCLEOTIDES USED IN THIS STUDY 
The oligonucleotides used to PCR amplify the kanamycin cassette from the 
commercial strains as described in section 2.2 are listed in Appendix B. In the table 





















E1(s)     AGTGGTATGGCAGGAACAGC 
E2 (as)     CATTAATACAGCATGACCAACTAC 
E3 (s)     GTAATGCCTGCTTTAATTGGAGG 
E3 (as)     CCTCCAATTAAAGCAGGCATTAC 
E4 (as1)     CTACACTAGGTCCTGAATGTGC 
E4 (as2)     GCTCGTATAAGATTGGGTCACC 
E5a 8377 (as)    GGAATTGCAATAATCATTAGTGCAG 
E5b (as)     GTGGAATGCTACATCTAATGAG 
E5g 11505 (as)    ATGTCCCACCACGTAGT 
E6 (as) terminal exon probe   GAATAATGATAATAGTGCAATGAATGAACC 
  
COX1 introns 
aI1 851 (as)    GTTTCTAATGTTGTACCTGGAG 
aI2 270 (as)    GAATAAACAGAGATATGTTTATC 
aI3 (as)     GCTAAATAAGGTCCCAACTTATC 
aI3 (s1)     GGGTTGAAGATATAGTC 
aI3 (s2)     AGAGACTACACGTGTTGCACC 
aI4 7432 (as)    CCATCACCATCAATTAATCCAGC 
aI5a (as)    TCTATTTGATCTTGGATAAATATC 
aI5b TTT (as1)    TAATTATAAGAGTTTCCCCGT 
aI5b (as2)    CATTCACGTTTAGTCTCTAC 
Snab aI5g (as)    GGTTTATTCTGTTTTATC   
  
COB exons 
E1(s)     GATTCACCACAACCATCATCAATTAATT 
E3 (as)     CCCACCTCATAATCAAGATACAATATC 
E4 (as)     GCAAAGAATCTCTGGATTAGAGGGTT 
E5 (as)     GGATTACCAGGAATATAGTTATCAGG 
E6 (s)     GTACCTGAATGATACTTATTACCATTCTATGC 
E6 (as) terminal exon probe   AATGTAGCGATTTGTCCCATTAAGAC 
COB introns 
bI1 (s)     GTGAGACAAGTATAAGTATATTATT 
bI1 170 (as1)    TACGCTATCCATATGAATCTTACC 
bI1 714 (as2)    CCACTCAGAACTGTACGTACTACTTTCA 
bI2 (as)     CCTTTTCTTTTTTCAGCATGACCATCTCC 
bI3 (as)     GAGTATTAAATGGTTTAATAGGACG 
bI4 (as)     ATAGTACCATCAGCATCAAAGAACC 
bI5 (as)     CCTTATGGGAGTTCCCACAAAGCGG 
21srRNA  non-coding exon 
21s rRNA 3-640 (as)   GCAACATCAACCTGTTCGATCG 
21s rRNA intron (omega) 
21s rRNA 746 (as)    TCTCATTTACCTCCATCATCT 
COX2 (as)    AGGTAATGATACTGCTTCGATC 
RF1 (s)     CTGAAGGTTCATTTGATCTATCTCC 
RF1 (as)     AGAGCTGCTGGTCTATAACCAG 
 




OXA1 deletion mutants  
 
BamHI wtOxa1 (s-1)    ATTGGATCCTCAGTCAGTCAGACGTGTTCCGTTCTTATGTTCG 
DeltaLoop1 (as-2)   GCCATCTGTTAACAGTATCAGAGGACTTGACATAGAGGGGAA 
DeltaLoop1 (s-3)                TCTGATACTGTTAACAGATGGCTGGCCGCACC 
Myc (s-5)       TTCTGAAGAAGATCTGTGAATAAAGGCTCTATATCTCTCTGT  
Myc (as-6)      TTCACAGATCTTCTTCAGAAATAAGTTTTTGTTCTTTTTTGTTATTAATGAAGT 
Myc 34runk (s)       AAACAAATGGGAACAAAAACTTATTTCTGAAGAAGATCTGTGAATAAAGGCTCTA 




Mss116 promoter mutants 
 
ClaI KasI                                                                                 CGG TAT CGA TTT TGC TGG CGC CGG AG 
KasI MscI                                                                                    CGC TGG CGC CGG ATG ATG GCC ACT A 
ClaI MscI                                                                                     CGG TAT CGA TTT TTG ATG GCC ACT AT 
Mss116 promoter deletion stitch PCR primers 
BsrGI del 5’ R-10                        TGC TGT ACA GGA GTT AAA CCG GGA AAT TCC ATC CTG 
ClaI del 5 F-9                               GGT ATC GAT ATG TTG ACC TCT ATA TTG ATA AAA GGT CGC ACA 
 
TAP tagged Mss116 
Mss116 1536 Xba1F ATAAAATCTGAGGTTCTAGAGGC 
Mss116 3’TAPstopR2 CCGCGGCTAATTCGCGTCTA 
 
Mss116 3’TAPstopF TAGACGCGAATTAGCCGCGG 
Mss116 R4  GAGCTCCTTCCATCCGTTTAAA 
 









Chapter 3:  Screen for nuclear-encoded splicing factors for yeast 
mitochondrial introns aI5 and bI1 
3.1 BACKGROUND 
3.1.1 Screen, Phase I and Phase II 
As discussed in the Introduction, earlier work had identified some auxiliary, 
nuclear-encoded splicing factors specific for several yeast mt introns, though none have 
yet been found for any group II intron (Fig.1.3).  Many of these nuclear-encoded splicing 
factors were identified by comparing a knock-out strain harboring introns that was unable 
to grow on glycerol to an isogenic strain without introns that maintained that ability 
(Seraphin et al. 1989; Barros et al. 2006; Turk and Caprara 2010). This type of screen 
was based on the fact that yeast with dysfunctional mitochondria cannot carry out 
oxidative phosphorylation, but get energy from fermentation instead. Consequently, 
dysfunctional strains cannot grow on non-fermentable carbon sources like glycerol, 
lactate, or ethanol. This method, however, fails to uncover dual-functioning proteins 
whose primary role may be required for respiration.  
 To better detect other candidate splicing factors, a more sensitive screen was 
devised and used here: Using the commercially-available knock-out collection of strain 
BY4741 (GE Healthcare Healthcare Open Biosystems), known mitochondria-localized 
proteins were tested for a glycerol growth defect. This haploid strain harbors all known 
introns within the COX1 and COB genes. Those 466 strains that had a mild-to-severe 




) comprised Phase I of 
the study and was conducted by Tarah Nyberg in lab of Dr. Philip Perlman. The 
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(see Appendix) comprised the candidate pool of this, Phase II of the screen for my 
dissertation research. During Phase I of the screen, the nuclear deletions in BY4741 were 
tested by Northern hybridization for the effect each deletion had on the various COX1 
and COB introns. Ten splicing factors were identified, of which five had been previously 
unknown (Nyberg 2006). One candidate, Mne1, was observed to be defective for splicing 
of the group I intron, aI5. This protein was further examined in this study and the results 
will be discussed in Chapter 6. Among the ten identified candidate factors, only Mss116, 
a previously identified general RNA chaperone, was found to be required for splicing 
aI5 and bI1, the two yeast mt group II introns that do not encode maturases (Nyberg 
2006). 
In Phase II of the screen, I focused on these two introns whose lack of intron-
encoded maturases makes their study of particular interest. To do this, I used single-
intron strains that contained only the introns aI5 or bI1. Using Northern hybridization 
analysis, I tested the effect of the deletion of nuclear-encoded mitochondrial proteins on 
the splicing of these group II introns.  
3.1.2 The processing of the COX1, COB and COX2 transcripts 
The 6.6-kb primary transcript for the COX1 gene is a polycistronic message that 
includes ATP8 and ATP6 (Osinga et al. 1984) (Fig.3.1A). The 161-U7 strain used here 
does not have the ENS gene sometimes found downstream of ATP6 in some yeast strains. 
In the single intron aI5 strain, the COX1 precursor is 3.1 kb which, after endonucleolytic 
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cleavage between COX1 and ATP8, releases the individual mRNAs (Simon and Faye 
1984). Following the excision of the 886-nt intron, the 2.2-kb mature mRNA results. In 
the Northern hybridizations that follow, these various RNA species were visualized by 
using a 
32
P-labeled DNA oligonucleotide complementary to the terminal exon of COX1 
(small arrow below COX1 in the figure). 
The COB 8.4-kb primary transcript is bicistronic, also containing the upstream 
tRNA(Glu) gene (Fig. 3.1B). The primary tRNA(Glu)/COB transcript undergoes several 
processing events, including removal of the 71-nt tRNA(Glu) transcript and production of 
the mature 5' end of the COB mRNA (Mittelmeier 1993; Chen and Dieckmann 1994), 
generating the 3.0- and 2.9-kb precursors (Pre-1 and Pre-2). The mature 2.2-kb mRNA is 
generated with the excision of the 0.8-kb bI1 intron. In the Northern hybridization 
analyses that follow, these various COB RNA species were visualized by using a 
32
P-
labeled DNA oligonucleotide complementary to the terminal exon of COB (small arrow 
below COB in the figure). 
  The 0.9-kb mature COX2 mRNA originates from the processing of a biscistronic 
2.5-kb primary transcript also containing an uncharacterized, maturase-like ORF, RF1, 
(Fig. 3.1C). The 5´ end of RF1 overlaps the 3´end of COX2 and is indicated in the figure 
by a stippled rectangle. COX2 is processed 75 nt downstream of its stop codon (first 
dodecamer lollipop), well into RF1, truncating that putative protein (Bordonne et al. 
1988). In the Northern hybridization analyses that follow, the two COX2 RNA species 
were visualized by using a 
32
P-labeled DNA oligonucleotide complementary to the 3´ 
region of COX2 just upstream of the RF1 overlap (small arrow below COX2 in the 
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figure). The RF1 RNAs were probed using a 
32
P-labeled DNA oligonucleotide 
complementary to its 3´ end (small arrow below RF1 in the figure). 
3.2. RESULTS 
3.2.1. Deletion of many ribosomal proteins causes processing and splicing defects 
Among the first genes in the screen to be deleted were those encoding 
mitoribosomal proteins. I deleted these genes in both the 161-U7/aI5 and 161-U7/bI1 
strains. Mitoribosomal proteins are nuclear-encoded, translated in the cytosol and 
subsequently imported into the mitochondrion for assembly into the mature 
mitoribosome. During the course of evolution, there has been a considerable amount of 
change to the mitoribosome when compared to its bacterial predecessor, presumably in 
adapting to expressing the largely hydrophobic proteins of the electron transport chain in 
the mt inner membrane (Smits et al. 2007; Amunts et al. 2014).  
Loss of mitoribosomal proteins from both the large and small subunits were found 
to cause splicing defects of varying degrees. Of the 18 mitoribosomal proteins tested, 14 
(77%) caused splicing defects, in the splicing of both aI5 and bI1, as observed in the 
Northern hybridization analyses in Figs. 3.2 and 3.3, respectively. The degree of the 
defect was measured using GelQuant.net software (BioChem Lab Solutions) with two 
values were calculated for each: The percentage of splicing as a ratio of the signal of the 
mRNA band to that of the mRNA and precursor signals combined (upper value); and the 
ratio of the mRNA to the combined signals of mRNA, precursor and primary transcripts 
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(lower value). Unless otherwise stated, the values referred to below are those of the first 
category.  
3.2.1.1 Effect of the deletion of mitoribosomal proteins on COX1 processing and 
aI5splicing  
In the Northern blot in Fig. 3.2 (and others to follow), the 6.6-kb unprocessed 
COX1 primary transcript is visible as the uppermost band in many of the deletion strains, 
though the band is not evident in wild type. Immediately beneath this band, the faint band 
of the polycistronic transcript following excision of the aI5 intron is visible in most of 
the deletion mutants. The next main band down is the COX1 precursor at about 3.1 kb, 
which, with the excision of the 0.89-kb aI5 intron, generates the lowest band on the 
membranes, the 2.2-kb mature mRNA. Note that in the wild-type aI5 strain, a small 
fraction of precursor remains visible, yet the ratio of mature mRNA to precursor is high.  
In contrast to the typical asplicing observed in the wild-type strain, deletion of 
most of the mitoribosomal proteins tested caused splicing defects resulting in reduced 
levels of  mature mRNA. In the wild-type, single-intron aI5 strain, there often remains a 
small amount of precursor RNA containing unspliced intron; however, the ratio of mature 
to unspliced precursor RNA is high at 88% (Fig.3.2, lane 1).  In contrast, deletion of most 
of the tested mitoribosomal proteins resulted in lower ratios (mean value = 60%) of 
mature to precursor RNA (Fig. 3.2, lanes 2-15.) 
The unprocessed COX1 primary transcript is not evident in the wild-type strain 
(Fig. 3.2, lane 1), but is clearly apparent to varying degrees in all of the mitoribosomal 
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protein deletion strains exhibiting a splicing defect. This suggests a direct or indirect role 
for either the individual ribosomal proteins or the ribosome as a whole for primary COX1 
transcript processing. The presence of the faint secondary band beneath the primary 
transcript and the significant amount of visible precursor, indicate that splicing of aI5 
can occur prior to the complete endonucleolytic processing of the primary transcript.  
The strongest splicing defect among this set of proteins were observed with the 
deletion of mitoribosomal protein Mrp10 which exhibited 36% splicing (Fig. 3.2, lane 
5). Mrp10 is a small subunit protein with a conserved CHCH domain [coiled coil 1]-
[helix 1]-[coiled coil 2]-[helix 2] that, unlike other CHCH proteins, is not confined to the 
inner membrane space (Jin et al. 1997). Though the Mrp10 protein is well-conserved 
among eukaryotes and is found to be essential for yeast mt translation,  a BLAST search 
revealed no known bacterial homologs (Smits et al. 2007), suggesting this protein may 
have evolved to be mitochondria-specific.  
Though the deletion of Mrpl13 did not cause as severe a splicing defect as did 
Mrp10, it nonetheless produced a significant defect at 40% splicing (lane 8). Mrpl13 is an 
organelle-specific protein found within the mitoribosomal tunnel exit (Gruschke et al. 
2010). Interestingly, this protein is not strictly essential for mitochondrial translation 
(Grohmann et al. 1994), suggesting that this protein may have a secondary role, one that 
may be associated with splicing.  
The mitoribosomal proteins whose deletion caused the weakest splicing defects 
were Img2 (80%), Mrp1 (72%), and Mrp17 (68%) (lanes 3,4, and 6, respectively). 
However, these strains also had among the weakest COX2 signals (discussed below). 
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Deletions of other mt ribosomal protein genes resulted in intermediate splicing 
defects ranging between 41%- 56%. Compared to the 88% splicing displayed by the 
wild-type strain, these data suggest some mitoribosomal proteins play a role in aI5 
splicing. 
3.2.1.2 Effect of the deletion of mitoribosomal proteins on bI1splicing  
In the Northern hybridization analysis in Fig. 3.3, the 8.4-kb primary transcript is 
not evident in either the wild-type or derivatives of that strain with deletions of 
mitoribosomal proteins. This suggests that processing of the primary COB transcript, 
unlike that of COX1, is not dependent on any of the tested mitoribosomal proteins. The 
3.0-kb precursor (Pre-1) can be observed as the faint uppermost band in many of the 
mutants, although the 2.9-kb precursor (Pre-2) is more readily apparent. With the 
excision of the 0.8-kb bI1 intron, the mature COB transcript is 2.2 kb, similar in size to 
the COX1 mRNA, and is observed as the lowest, most prominent band in the wild-type 
strain (lane 1).  
Among the mitoribosomal proteins tested, the strongest bI1 defects were also 
those that exhibited the strongest defects in aI5 splicing—Mrpl10 and Mrpl13, with 54% 
and 57% splicing, respectively (lanes 5 and 8). Deletion of Mrp1 produced a defect 
similar to that of Mrpl13 with 58% splicing (lane 4). MRP1 has been shown to exhibit 
genetic interactions with PET122, which encodes a COX3-specific translational activator 
(Haffter et al. 1991). 
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Deletion of the genes of two mitoribosomal proteins, IMG2 and, MRPL11, 
exhibited the highest ratios of bI1 splicing ability at 84% and 90%, respectively (Fig. 3.3, 
lanes 3 and 7). However, these two also exhibited severely reduced levels of RNA as 
observed by the weak COB and COX2 hybridization signals. 
In general, deletion of mitoribosomal proteins had a similar effect on bI1 splicing 
as on that on athough less severeThe ratio of spliced to unspliced precursor is 99% 
in wild-type bI1 splicing, while the mean value exhibited by the tested deletion strains 
was 66% splicing, slightly better splicing than the observed 60% mean value for aI5 
with the same deletions.  
3.2.1.3 Deletions of many mitoribosomal proteins cause a more severe COX2 
processing defect in aI5-containing strains than in bI1-containing strains. 
The intronless COX2 mRNA is routinely used as a loading control in yeast 
mitochondrial studies. With the Phase II proteins having been chosen based in part on 
their deletion triggering cells to become petite, I exercised care to grow the cells for short 
periods of time. Nonetheless, many times, the Northern hybridizations detected only low 
levels of mtRNA, despite normalization of total whole cell RNA. Thus, it was 
particularly important to test for COX2 levels, especially in cases such as those where 
hybridization signals were weak.  Unexpectedly, the deletion of the genes of several 
mitoribosomal proteins also caused a processing defect in COX2, as seen in the lower 
panels of 3.2 and 3.3. To compensate for this effect, I used the total amount of COX2, 
both primary and mature, relative to that of wild-type for loading control values (% total: 
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WT, bottom panels in Fig 3.2 and Fig. 3.3). The weak COX1 signals exhibited by img2 
and mrp1 in lanes 3 and 4 of Fig. 3.2, and img2 and mrpl11 in lanes 3 and 7 of Fig. 
3.3 are likely a result of the cells becoming 

with the loss of the portion of the mt 
genome that includes COX2 This result was expected for img2; its protein is known to 
be required for mt genome maintenance (Coppee et al. 1996). The signal is almost 
completely lacking in both its primary and mature form. Interestingly, deletion of most of 
the mitoribosomal proteins that cause a COX1 processing defect also cause a similar 
processing defect in COX2.  
In Fig. 3.4, a comparison of both COX2 Northern hybridizations strains aI5 (A) 
and bI1 (B) indicate that deletions in the aI5 strains are associated with more severe 
COX2 processing defects than in bI1 strains. Two values of COX2 processing were 
measured: the percent processing taken as the ratio of mRNA to primary transcript + 
mRNA (upper value); and this percent processing normalized to wild-type processing 
(lower value). The mean percentage of COX2 processing for the aI5 null mutants was 
54% wild type, compared to 79% wild type for the bI1 null strains, an indication that 
COX2 processing may be more dependent on proper COX1 splicing than on COB. 
The difference, however, may also be, at least in part, a function of the processing 
efficiencies observed for the wild type of each strain (Fig. 3.4A and B, lanes 1). As seen 
in the first lanes of each blot, the wild-type aI5 strain exhibited a 77% processing 
efficiency compared to the 91% splicing in the wild-type bI1 strain.  Since the Cox2 
protein is part of the cytochrome c oxidase multisubunit holoenzyme, it is possible that 
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COX2 processing and subsequent translation has a greater dependence on correct COX1 
splicing than on that of COB.  
3.2.1.4 Deletion of some mitoribosomal proteins does not cause splicing defects 
Intriguingly, four of the ribosomal proteins tested did not demonstrate a splice 
defect: Mrpl38, Sws2, Mrpl36 and Mrpl8. Results of the mrpl38 and sws2 strains are 
shown in the Northern hybridization analyses in Fig. 3.5, with the hybridization for 
COX1 in the upper panel in (A), and that for COB in the upper panel in (B).  Mrpl38 is a 
universally conserved protein whose bacterial homolog, L14, has been mapped to a 
central location between the peptidyl transferase and GTPase regions of the large 
ribosomal subunit (Davies et al. 1996). Sws2/Ynl081C is a putative ribosomal protein of 
the small subunit with similarities to the bacterial S13 which has been found to function 
as a control element for translocation of the mRNA-tRNA complex (Cukras et al. 2003). 
Interestingly, the loss of neither Mrpl38 nor Sws2 caused a COX2 processing 
defect (lower panels of Fig. 3.5A and B), suggesting that there may exist a correlation 
between proper splicing of the COX1 and COB mRNAs and COX2 processing.  
Deletion of the MRPL8 gene resulted in loss of mtRNA and consequently no 
Northern hybridization was possible. Mrpl8, homologous to bacterial ribosomal protein 
L17, is located near the mitoribosomal tunnel exit (Amunts et al. 2014). 
3.2.2 Deletions of several tRNA synthetases cause a splicing defect 
In addition to their role in protein synthesis in which amino acids are attached 
specifically to cognate tRNAs, the diverse group of aminoacyl tRNA-synthetases has 
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been co-opted to perform alternate activities in the cell including assisting in splicing of 
group I introns in the mitochondria (Martinis et al. 1999). To date, at least two such dual-
functioning fungal mitochondrial splicing cofactor synthetases have been identified: 
leucyl-tRNA synthetase (LeuRS or Nam2) from S. cerevisiae and S. douglasii (Herbert et 
al. 1988; Labouesse 1990; Sarkar et al. 2012) and the tyrosyl-tRNA synthetase (TyrRS or 
Cyt18) from Neurospora crassa (Akins and Lambowitz 1987; Paukstelis and Lambowitz 
2008). Both of these synthetases are group I splicing factors. 
Here, several mitochondrial tRNA synthetases were tested for the effect of their 
deletion on aI5and bI1 splicing (Fig. 3.6): Mst1 (mt threonyl-tRNA synthetase), Msm1 
(mt methionyl-tRNA synthetase), Msd1 (mt aspartyl-tRNA synthetase), Mse1 (mt 
glutamyl-tRNA synthetase), and Dia1 (probable mt seryl-tRNA synthetase). All exhibited 
a degree of defective splicing in aI5 (Fig. 3.6A, lanes 6, 10, 13, 16, 9), while in most 
cases, the deletions also caused a processing defect of the 6.6-kb COX1 primary 
transcript. There is a conspicuous difference in the msm1and msd1 strains in that the 
COX1 primary transcript containing the aI5 intron is reduced (lanes 10 and 13) as 
compared to mst , mse and dia4 (lanes 6,16, and 19). To confirm the presence of the 
aI5intron in the COX1 primary transcript, the membranes in Fig. 3.6A were stripped 
and re-probed with a 
32
P-labeled DNA oligonucleotide complementary to the aI5 intron 
(Fig. 3.6B). The presence of the 6.6-kb primary transcript corresponds to the primary 
transcript that includes unspliced aI5 intron in A. With the exception of the msd1 




indicating that the loss of these synthetases also impacts processing in strains lacking 
introns. 
Deletion of these tRNA synthetases also caused splicing defects in bI1 (Fig. 3.6C, 
lanes 7, 11, 14, 17, 20). Additionally, the dia4/aI5 strain lost its COB RNA (lane 19). 
3.2.3  Deletions of two translation elongation factors cause splicing defects 
Within the yeast mitochondrion, there are three identified elongation factors, 
Mef1, Mef2 and Tuf1, of which I tested the latter two. Both Tuf1 and Mef2 are required 
for respiratory growth, protein synthesis and are essential for mitochondrial genome 
maintenance. Tuf1 is a G-protein that, when bound to GTP, binds to and delivers an 
aminoacylated-tRNA to the A-site of the ribosome. If the codon-anticodon pairing is 
correct, the ribosome acts as a GTPase activator and the GTP is hydrolyzed, releasing the 
inactive GDP-bound form of the protein.(Myers et al. 1985; Chiron et al. 2005). The 
Northern hybridization analyses in Fig. 3.7A show that tuf1 causes a strong defect in 
aI5 splicing (lane 6) and a weaker bI1 splicing defect (Fig. 3.7B, lane 7). Remnants of 
the COX1 primary transcript are also visible in all tuf1 strains. 
Though Mef2 is defined as an elongation factor in the Saccharomyces Genome 
Database (SGD; yeastgenome.org, April 2015), there is some evidence to indicate that it 
is not involved in the GTP-dependent ribosomal translocation step during translation 
elongation (Welcsh et al. 1994). It has, however, been found to have involvement in 
ribosome recycling (Callegari et al. 2011). The negative effect of the deletion of Mef2 on 
the splicing of aI5 and bI1 is observed in Fig. 3.7A, lane 10 and Fig. 3.7B, lane 11, 
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respectively. Though the deletion of this protein also caused a processing defect of the 
COX1 primary transcript in most of the strains, the I
0
 shows wild-type processing (Fig. 
3.7A, lane 9), suggesting the presence of introns affects processing in mef2 strains. 
3.2.4 Deletions of proteins that act on mt 21S rRNA or 15S rRNA cause splicing 
defects 
Pet56/Mrm1 is a ribose methyltransferase that modifies a functionally critical, 
conserved nucleotide in mitochondrial 21S rRNA, the mitochondrially-encoded 
ribosomal RNA of the large mitoribosomal subunit (Sirum-Connolly and Mason 1993). 
In the Northern hybridization analyses in Fig. 3.8, the loss of Pet56 is seen to cause a 
strong defect in the splicing of aI5 (A, lane 6) and a weak defect in splicing bI1 (B, lane 
7). 
According to the SGD, YOR199w and YOR200w are dubious ORFs that overlap 
PET56 at its 5´end. As such, the result of their deletions would be expected to be similar 
to the defective splicing observed for pet56 That is indeed the case for aI5splicing, as 
observed in Fig. 3.8A, lanes 10 and14; though not as evident for bI1 splicing (Fig. 3.8B, 
lanes 11 and 15). This difference suggests that the putative interactions of Pet56/Mrm1 
with the aI5 and bI1 introns occur at different domains of the protein, as would be 
expected.  
There is a pronounced processing defect of the COX1 primary transcript in the 
LSU strains (Fig. 3.8A, lanes 8, 12, and 16) that is especially evident in the yor199w 
strain (lane 12). This effect suggests that processing of the COX1 primary transcript is 
defective without the critical modification to the 21S rRNA normally provided by Pet56. 
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 Ccm1/Rrg2/Dmr1 is a pentatricopeptide repeat (PPR) protein, required for the 
maintenance of the 15S rRNA, the mitochondrially-encoded ribosomal RNA of the small 
subunit (Lipinski et al. 2010; Puchta et al. 2010). Deletion of this gene caused a weak 
aI5splicing defect, though the total RNA was also apparently reduced as seen by the 
comparatively weaker 2.2-kb RNA band (Fig. 3.8A, lane 18). The COX1 processing 
defect was observed to be more severe in the bI1 and LSU strains (top panel, lanes 19 and 
20) than in others (lanes 17 and 18). Previous work had reported this protein to be 
required only for excision of group I introns aI4 in COX1 and bI4 in COB. (Moreno et al. 
2009; Lipinski et al. 2011), but not for aI5or bI1as was observed here. This is likely 
due to their use of a different methodology (RT-PCR) or perhaps due to strain 
differences. 
3.2.5 Deletions of some translational activators cause splicing defects 
There are fifteen known translational activators critical for the expression of 
mitochondrial proteins within S. cerevisiae, with each of the eight mitochondrially-
encoded genes having at least one translational activator (Herrmann et al. 2013).  Of the 
fifteen identified translational activators, eleven were tested in Phase I of the screen. 
Deletion of each was found to cause either instability of the transcript or a splicing defect, 
though none specifically in aI5 or bI1(Nyberg 2006). Here I have tested the remaining 
four: Aep1, Atp22, Sov1 and Pet309, all of which contain RNA-binding PPR motifs 
(Lipinski et al. 2011) (Fig. 3.9). 
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Peripherally associated with the mt inner membrane, Aep1 is a translational 
activator for ATP9 (Payne et al. 1993), a gene encoding a component of the ATP 
synthase complex. The deletion of AEP1 caused splicing defects in both aI5and bI1, 
though the effect on aI5 was strong, while that on bI1 was weak (Fig. 3.9A, lane 6 and 
Fig. 3.9B, lane 7, respectively). 
Atp22 is the translational activator for ATP6 and ATP8 (Herrmann et al. 2013), 
genes that also encode proteins for the ATP synthase complex. It is unknown whether 
this protein is an integral inner membrane protein or only peripherally associated with the 
inner mt membrane. The strong effect of its deletion on aI5 splicing is seen in lane 9 of 
Fig. 3.9A, as compared to the weak defect observed for bI1 splicing in lane 10 of Fig. 
3.9B.  Unidentified bands that run more slowly than the COB mRNA are evident in all 
four strains (lanes 8-11).  
Sov1 is described by the SGD (April 2015) as a protein of unknown function, but 
is categorized as a translational activator for VAR1 by others (Sanchirico 1998; Herrmann 
et al. 2013). Taken as such, it is being grouped here with other translational activators. 
Var1 is the only mitochondrially-encoded ribosomal protein in yeast and is part of the 
mitoribosomal small subunit. The strong aI5splicing defect caused by sov1is seen in 
lane 13 of Fig. 3.9A. The relatively weak bI1 splicing defect is seen in lane 14 of Fig. 
3.9B.  
Pet309 is the membrane-bound translational activator for COX1 known to affect 
the stability of COX1 primary transcripts (Manthey and McEwen 1995; Manthey et al. 
1998). Due to a severe reduction in COX1 RNA with deletion of this gene, testing its 
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effect on splicing required the use of three times the total RNA (3.6 µg) as compared to 
the other translational activators. The strong effect pet309 has on aI5 splicing is seen in 
lane 17 of Fig. 3.9A. (Other unidentified RNA species that run more slowly than the 
mRNA are observed here as in atp22 and may be the result of non-specific cross-
hybridization.) Lane 18 of Fig. 3.9B shows that pet309 causes no splicing defect in bI1. 
Because the COB Northerns for atp22 and pet309hybridized with an exon 
probe appear to have a very weak or non-existent bI1 splicing defects, all five membranes 
were stripped and re-probed for the bI1 intron using a
 32
P-internally-labeled probe 
complementary to the intron itself (see Table 2.1). The results of those hybridizations are 
seen in Fig. 3.9C. With aep1 and sov1 and to a far lesser degree, with atp22, there 
remains a small amount of bI1-containing 2.9-kb precursor (lanes 7, 14, and 10, 
respectively), in contrast to none in the pet309strain (lane 18). All four, however, show 
the excised 0.77 kb intron that is only faintly visible in wild-type. This band is reduced in 
pet309 (lane 18) relative to that of the other three (lanes 7, 10, and 14), despite having 
three times the total RNA, and therefore comparable to wild-type levels of excised bI1 
(lane 3). 
In conclusion, splicing of aI5 was strongly impacted by the deletion of each of 
the tested translational activators, raising the possibility of an interconnected network 
among these proteins as discussed below. In contrast, bI1 splicing was only weakly 
affected, and then only by Aep1 and Sov1. 
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3.2.6 Novel functions observed for Pet 309 and Atp22 
Pet309 (and to a lesser degree, Atp22) appeared to be specific for aI5 splicing. 
To test for specificity and the possible effect of their deletion on other introns, the genes 
for these translational activators, plus that for Pet54, were knocked out of strains 
harboring introns other than aI5 and bI1. These three strains, HRH421, HRH 524, and 
HRH422, obtained from the lab of Dr. Philip Perlman, are all in a 161-U7 background. 
Pet54,  a translational activator for COX3 (Herrmann et al. 2013) required for normal 
levels of COX1 synthesis in an intronless strain (Shingu-Vazquez et al. 2010), and a 
known splicing factor for the group I intron aI5 (Costanzo et al. 1989), was used as a 
control. 
Strain HRH421 contains only group II intron aI1 and strain HRH524 has only 
group II intron aI2. Both of these introns encode their own active maturases. (see Fig. 
1.3). Strain HRH422 has three group I introns: aI4, bI4 and bI5. Intron aI4 encodes an 
inactive maturase but is aided instead by the active maturase encoded by bI4 that assists 
in the splicing of aI4 as well as itself (Rho and Martinis 2000). Splicing of both of these 
introns is aided by Nam2, a mt leucyl-tRNA synthetase (Labouesse 1990) and 
Ccm1(Moreno et al. 2009). Intron bI5 does not code for a maturase; its splicing is 
facilitated by Cbp2 (Gampel and Cech 1991). All of the mt introns are also aided in their 
splicing by the general RNA chaperone, Mss116. 
The results of deleting the genes for Pet309, Atp22 and Pet54 in these strains are 
shown in the Northern hybridization analyses in Fig. 3.10A. All were performed with 3.6 
µg total RNA. Lanes 1-7 are in strain HRH421 harboring only intron aI1. As seen in the 
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top panel, none exhibit defective splicing. However, the deletion of PET309 destabilizes 
the transcript with only the single, maturase-containing intron, contradicting a previous 
report regarding the role of Pet309 in which the stability of a COX1 transcript in pet309 
strains was inversely related to the number of introns contained (Manthey and McEwen 
1995). Lanes 8-13 are in the strain harboring only intron aI2. The deletion of PET309 
(lanes 9-10) is observed to destabilize the transcript, again with only a single, maturase-
containing intron. With the deletion of ATP22 and PET54 in lanes 11-13, some minor 
bands of the sizes of the primary and precursor transcripts can be observed. Lanes 14-20 
are in the strain harboring the group I intron aI4. Faint bands are visible in the 
pet309strain in the atp22straina clear splicing defect is evident for this intron, 
while no defect is evident in the pet54strainTo assess loading, particularly for the 
pet309strains all the membranes were stripped and re-probed with a 
32
P-labeled DNA 
oligonucleotide complementary to COX2. The results are shown in Fig. 3.10B and 
confirm that loading is approximately equal.  
The instability of the COX1 transcripts containing introns aI1or aI2 when deleted 
for the PET309 gene is in sharp contrast to the stability of the transcript containing only 
aI5, shown in Fig. 3.10C.  In contrast to the results of Manthey and McEwen, here the 
data show that it is not the number of introns that are important to COX1 stability— 
strains with aI1, aI2, or aI5 each have only one intron— but rather whether those introns 
encode their own maturases.  Those with intron-encoded maturases like aI1 and aI2 are 
dependent upon the translational activator role of Pet309, while aI5 is not. The separate 
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functions of translation and stabilization of transcript are thought to function in two 
separate domains of Pet309 (Tavares-Carreón et al. 2008). While the translation function 
is not required for the maturase-lacking aI5 intron, the loss of Pet309 results in a strong 
splicing defect. Thus, in addition to roles in translation and transcript stability, Pet309 
may also be acting as a splicing factor specific for aI5. 
Figure 3.11 shows the effect of pet309atp22and pet54on the splicing of 
COB group I introns bI4 and bI5. The blots were hybridized with the various 
32
P-labeled 
probes as indicated beneath each. Pet309 and Pet54 do not appear to be playing a role 
either in splicing of these introns or in transcript stability (Fig. 3.11A, lanes 2-3, 6-7, 9-
10, 13-14, 16-17, and 20-21). Atp22, however, does seem to be required for COB 
stability (lanes 4-5, 11-12, and 18-19). The loss of this protein causes a striking 
destabilization of the COB transcript not previously reported, suggesting that Atp22 may 
also be a translational activator for COB. As discussed earlier, bI4 encodes a maturase 
that it shares with aI4. With the destabilization of the COB transcript, it is likely that the 
aI4 splicing defects observed in Fig. 3.10A, lanes 17 and 18, are a result of not having 
this bI4 maturase. 
To assess loading, the blots were stripped and re-probed with a 
32
P-DNA 
oligonucleotide complementary to COX2 (Fig. 3.11B). As noted with the hybridizations 
in Fig. 3.10, deletions of these proteins do not exhibit the COX2 processing defect 
observed with the deletions of some mitoribosomal proteins. 
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3.2.7 Deletions of miscellaneous other proteins that cause splice defects 
There were several other proteins tested that do not share a single category, yet 
their loss caused a splicing defect. These are shown together in Fig. 3.12. 
Sls1 is a mitochondrial membrane protein thought to coordinate expression of 
mitochondrially-encoded genes. It  may facilitate delivery of mRNA to membrane-bound 
translation machinery, also interacting with Nam1, the mt transcription factor (Bryan et 
al. 2002). Lane 5 of fig. 3.12A shows the stringent aI5 splicing defect caused by 
sls1A bI1 defect is also evident (Fig. 3.12B, lane 7), though the defect is not as severe 
as that observed for aI5. There is no observable COX1 processing defect. 
Rrg1 is a protein of unknown function according to the SGD, though it has been 
described as essential for mt genome maintenance (Merz and Westermann 2009). 
Deletion of its gene caused splicing defects in both aI5 and bI1 (Fig. 3.12A, lane 9 and 
B, lane 10). Some COX1 processing defect is evident. 
Atp5 is subunit 5 of the stator stalk of mitochondrial F1F0 ATP synthase 
(Devenish et al. 2000). Deletion of this protein also caused splicing defects in both aI5 
and bI1 (Fig. 3.12A, lanes 12-13 and B, lanes 14-15, respectively).  
Oxa1 is a highly-conserved mitochondrial inner membrane insertase that interacts 
with the mitoribosomes. It mediates the insertion of both mitochondrial- and nuclear-
encoded proteins from the matrix into the inner membrane by behaving as a pore-forming 
translocase regulated in a membrane potential and substrate-dependent manner (Krüger et 
al. 2012). Deletion of this protein caused strong splicing defects in both aI5 and bI1 
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(Fig. 3.12A, lanes 18-19 and B, lanes 20-21, respectively). Note: the atp5and oxa1 
Northern hybridizations were performed by Kathryn Turner. 
3.2.8 Pet309 may be part of a large complex involved in splicing 
Of all the proteins tested, only Pet309 appeared to be specific for aI5splicing 
and as such warranted further testing. This COX1 translational activator had previously 
been found to be part of 900-kDa complex that also included COB translational activators 
Cbp1 and Cbs2 (Krause et al. 2004).This complex has been proposed to link transcription 
to translation and thus may also affect splicing. 
To identify other proteins that may associate with Pet309 and potential 
components of this putative complex, a commercially available BY4741 strain (GE 
Healthcare) in which a Tandem Affinity Purification (TAP) tag had been appended to the 
3´ end of the chromosomal copy of Pet309 was used. An untagged isogenic strain was 
used as negative control. Purified mitochondria from 3 l cultures grown in YPR to an 
O.D.600 ≈ 3.0 were subjected to the TAP protocol described in Methods. Samples were 
run on a 4-12% bis-tris polyacrylamide gel (Life Technologies) and stained with 
Coomassie Brilliant Blue (Fig. 3.13). Isolated gel fragments from an identical gel run 
approximately 1 cm were submitted to the University of Texas at Austin Protein Facility 
for mass spectrometry analysis.  
Although the tagged Pet309 sample contained many more proteins than the 
untagged sample, thereby suggesting enrichment of a complex, Pet 309 is not among 
them. It had been previously noted that disruption of mitochondria either by sonication or 
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by the use of detergents resulted in the fragmentation of Pet309 when tagged with HA 
(Krause et al. 2004), and may explain the inability to detect the naturally low-abundant 
protein here. Among the proteins identified in the tagged sample, however, was the RNA 
chaperone Mss116. Interestingly, Pet309 was among the proteins associated with RNA 
chaperone Mss116 in an aI5
-
 strain tested in Chapter 7, where it will be discussed 
further. 
Overexpression of Pet309 is likely not a suitable alternative strategy as previous 
work in overexpressing translational activators has resulted in the formation of 
aggregates (Weber and Dieckmann 1990). 
3.2.9 Tested proteins that had no effect on splicing 
The following are those proteins whose gene deletions did not cause a splicing 
defect in either aI5 or bI1. Following each name is a brief description taken from the 
SGD. The Northern hybridizations indicated in parentheses can be found in the Appendix 
unless otherwise noted.  
Abf2: Mitochondrial DNA-binding protein; involved in mitochondrial DNA replication  
Adh3: Glucose-repressible alcohol dehydrogenase II  
Aep3: Peripheral mitochondrial inner membrane protein; may facilitate use of in 
mitochondrial translation initiation 
Dcs1: Non-essential hydrolase involved in mRNA decapping  
Glo3: ADP-ribosylation factor GTPase activating protein (ARF GAP); involved in ER-
Golgi transport  
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Gon1/Gem1: Outer mitochondrial membrane GTPase. No effect on bI1 splicing; lost 
COX1 RNA  
Grx5: Protein involved in the synthesis and assembly of Fe-S centers.  
Inh1: Protein that inhibits ATP hydrolysis by the F1F0-ATP synthase  
Kap123: Karyopherin beta; mediates nuclear import of ribosomal proteins prior to 
assembly into ribosomes and import of histones H3 and H4; localizes to the 
nuclear pore, nucleus, and cytoplasm 
Lcb5: Minor sphingoid long-chain base kinase  
Mrpl36: a mitoribosomal protein of the large subunit  
Mrpl38: a mitoribosomal protein of the large subunit  
Mtg1: Putative GTPase peripheral to the mitochondrial inner membrane; essential for 
respiratory competence, likely functions in assembly of the large mitoribosomal 
subunit 
Mtg2: Putative GTPase; member of the Obg family  
Nam1: Mt protein that interacts with an N-terminal region of mtRNA polymerase Rpo41 
and couples RNA processing and translation to transcription  
Nrp1: Putative RNA binding protein of unknown function  
Pim1: ATP-dependent Lon protease; involved in degradation of misfolded proteins in 
mitochondria  
Pkh2: Serine/threonine protein kinaseinvolved in sphingolipid-mediated signaling 
pathway that controls endocytosis  
Qr17/Ydl104c: Protein involved in threonylcarbamoyl adenosine biosynthesis  
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Ssq1: Mitochondrial hsp70-type molecular chaperone  
Sws2: a putative mitoribosomal protein of the small subunit  
Ydr042: Putative protein of unknown function  
Yhm1: Mitochondrial GTP/GDP transporter  
Ynl170w: Dubious open reading frame; unlikely to encode a functional protein  
Yta12: Mitochondrial inner membrane m-AAA protease component; mediates 
degradation of misfolded or unassembled proteins  
3.2.10 Deletions of some proteins result in loss of mtRNA 
 Despite short incubation times, the deletion of several genes and the proteins they 
encode (listed below) caused severe loss of mtRNA resulting in poor hybridizations.  
Following each name is a brief description taken from the SGD.  
Caf17: Involved in incorporating iron-sulfur clusters into proteins  
Dem1/Exo5: Mitochondrial 5'-3' exonuclease and sliding exonuclease; required for 
mitochondrial genome maintenance  
Gem1: Outer mt membrane GTPase, may coordinate mtDNA replication and growth, 
specific for COX1  
Isa2: Protein required for maturation of mt Fe-S proteins  
Mrpl8: mitoribosomal protein of the large subunit  
Met7: required for methionine synthesis and for maintenance of mitochondrial DNA  
Msu1/Dss1: 3'-5' exoribonuclease; component of the mitochondrial degradosome along 
with the ATP-dependent RNA helicase Suv3 (loss appears specific for COB) 
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Mtf1: mtRNA polymerase specificity factor, similar to bacterial sigma factor  
Oct1: Mt intermediate peptidase; cleaves destabilizing N-terminal residues of a subset of 
proteins upon import  
Rim 1: ssDNA-binding protein essential for mt genome maintenance  
Rpo41: mt RNA polymerase; RNA lost in all strains but aI5 
 The results of all the deletions tested in this part of the study are summarized in 
Table 3.1. 
3.2.11 An as-yet-unidentified mt genomic splicing factor? 
Most of the proteins that caused a splicing defect were associated with either the 
mitoribosome or with translation, posing the question as to whether there may be an as-
yet-unidentified splicing factor within the mt genome. One protein that appeared to be a 
good candidate was the putative protein, Rf1, discussed in section 3.1.2 and diagrammed 
in Fig. 3.1C. Rf1 has been annotated in the SGD as an uncharacterized maturase-like 
protein, since it is reported to have two very small introns (39 and 30 nt) and a variant 
LAGLIDADG motif (Foury et al. 1998). The LAGLIDADG motif has been found in at 
least one group II intron splicing factor, the pentatricopeptide repeat gene OTP51 (de 
Longevialle et al. 2008). Endonucleases with this motif have also been found to be 
encoded by free-standing ORFs not associated with introns (Lambowitz and Caprara 
1999).  
 To test the possibility that the RF1 transcript may not be properly processed from 
the COX2/RF1 transcript (and thereby precluding the possibility of its translation), the 
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membranes used in Fig. 3.4 were stripped once again and re-probed for RF1 with a 
32
P-
labeled oligonucleotide complementary to the 3´ end of the gene (see Fig. 3.1C). Since 
the COX2 processing defect was more pronounced in the aI5 strain, that membrane is 
shown. The RF1 signal is seen only in the primary transcript, but there is no visible band 
where the 1.5 kb mRNA was expected in either the null or the wild-type strains. A more 
sensitive 
32
P-internally-labeled PCR product was then used as a probe with similar results 
(Fig. 3.14C). 
 A recent study of the yeast mt transcriptome found that levels of the RF1 RNA 
were extremely low (Turk et al. 2013). Thus, any future studies should perhaps try using 
much more RNA for Northern hybridizations, or perhaps use RT-PCR (reverse 
transcription-PCR) to test this intriguing putative protein. Future work to test any 
possible role of Rf1 in aI5 and bI1 splicing might also involve the re-coding of the 
transcript to allow for centromeric, allotropic expression and subsequent mitochondrial 
import in splicing-defective strains. Similar methods were successfully employed for 
COX2 (Cruz-Torres et al. 2012) and for the cytosolic expression of the bI4 maturase 
(Banroques et al. 1986).  
3.3 DISCUSSION 
Results of this portion of the study showed that with few exceptions, those genes 
whose deletion caused a splicing defect in aI5 and bI1 were associated primarily with 
the mitoribosome or with mitochondrial translation. Previous studies in the 
Saccharomyces cerevisiae mitochondrial system have revealed a functional coupling of 
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transcription and translation at the inner mitochondrial membrane where the assembly of 
the oxidative phosphorylation machinery is initiated (Naithani et al. 2003; Rodeheffer 
and Shadel 2003; Krause et al. 2004; Shadel 2004). Of course, excision of introns must 
occur subsequent to transcription and prior to translation to ensure proper expression.  
Introns that encode their own maturases are clearly dependent upon functional 
mitoribosomes. Here, I show that two introns that do not encode maturases, aI5 and bI1, 
also appear to be dependent upon functional mitoribosomes as well as upon proteins 
involved in mt translation. 
While it is theoretically possible that an as-yet-unidentified splicing factor is 
encoded within the mt genome and is dependent upon the mitoribosomes for its 
translation and subsequent functionality, no evidence of that was found here.  
Translational activators interact with the 5´ ends of newly transcribed RNAs 
guiding them to the mitoribosomes and are thus perfectly positioned to monitor splicing 
prior to translation. In 2003, Naithani et al. reported interactions between the translational 
activators for COX1, COX2 and COX3. Later, translational activators for COB and COX1 
mRNAs, Cbp1 and Pet309 respectively, were shown to be associated in a high-molecular 
weight complex thought to link transcription to translation (Krause et al. 2004). The 
results presented here expand on this model, showing that Pet309 and translational 
activators for other mRNAs, Aep1, Sov1, and Atp22, strongly impact the splicing of aI5, 
possibly reflecting that a higher order of organization among these proteins is involved in 
aI5splicing. Two of these translational activators, Aep1 and Sov1, also impact bI1 
splicing, albeit weakly. Finally, Atp22, a translational activator for the ATP8/ATP6 
 62 
mRNA was found to be important to the stability of COB mRNA when harboring introns 







Figure 3.1: Processing pathways of COX1, COB, and COX2 mRNAs 
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Figure 3.1 (continued): Processing pathways of COX1, COB, and COX2 mRNAs 
 
(A) Processing and splicing of the COX1/ATP8/ATP6 primary transcript. The transcriptional start 
site of the COX1 gene is indicated by a bent arrow, COX1 exons are in black, and the aI5 intron 
is in gray. A 6.6-kb primary transcript (Pri) is cleaved downstream of COX1 to generate a 3.1-kb 
COX1 precursor (Pre) from which the aI5 intron is spliced to yield a mature 2.2-kb mRNA.  (B) 
Processing and splicing of the primary tRNAE-COB transcript. The position of the transcriptional 
start site upstream of tRNAE is indicated by a bent arrow. COB exons are in black, and the bI1 
intron is in gray. An 8.4-kb primary transcript (Pri) is cleaved just downstream of the tRNAE gene 
generating an initial 3.0-kb precursor (Pre-1) transcript. A second cleavage reaction upstream of 
the COB gene then generates a second 2.9-kb precursor (Pre-2) from which the bI1 intron is 
spliced to yield a 2.2-kb mature mRNA. (C) Processing of the COX2/RF transcript. The 
transcriptional start site for the 2.5-kb COX2-RF1 primary transcript is 54 bp upstream from the 
protein-coding gene. Endonucleolytic cleavage occurs just after the conserved dodecamer 
sequence, AAUAAUAUUCUU (lollipop), 75-nt downstream from the COX2 stop codon. The 5´-
coding region of RF1 overlaps the 3´ region of COX2 (stippled). Cleavage of COX2 at its 
dodecamer sequence truncates the RF1 transcript. Small arrows under the genes indicate the 






















Figure 3.2: Northern hybridization analysis of aI5 splicing in the single intron wild-type 161-















Figure 3.2 (continued): Northern hybridization analysis of aI5 splicing in the single intron wild-
type 161-U7/aI5 and derivatives of that strain with deletions in mitoribosomal protein genes. 
 
The blots show Northern hybridizations of wild-type strain 161-U7/aI5 and derivatives of that 
strain in which the indicated mitoribosomal protein gene has been deleted. Strains were grown in 
YPR to an O.D.600 of about 0.8. Total cellular RNA was isolated, run in a 1.5% RNA-grade 
agarose gel, blotted onto a nylon membrane, and hybridized with a 32P-labeled DNA 
oligonucleotide complementary to the COX1 terminal exon (the small arrow below COX1 in Fig. 
3.1 A). The deleted mitoribosomal protein gene is indicated above each lane with the letter in 
parentheses indicating whether the protein is from the large (L) or small (S) ribosomal subunit. 
The YNL184C gene encodes an uncharacterized protein that overlaps mitoribosomal protein 
Mrpl19 (Hu et al. 2007). The primary and precursor transcripts are denoted as Pri and Pre, 
respectively. The percentage of spliced mRNA relative to mRNA + precursor RNA (upper value) 
or mRNA + precursor RNA + primary transcript (lower value) is indicated under each lane in the 
blot. After hybridization with the COX1 exon probe, the blots were stripped and rehybridized 
with a probe complementary to the intronless COX2 mRNA to assess loading (measured as the 
total of Pri + mRNA and normalized to the wild-type strain).  Deletion of the mitoribosomal 

























Figure 3.3: Northern hybridization analysis of bI1 splicing in the single intron wild-type 161-




Figure 3.3 (continued): Northern hybridization analysis of bI1 splicing in the single intron wild-
type 161-U7/bI1 and derivatives of that strain with deletions in mitoribosomal protein genes.  
 
The blots show Northern hybridizations of wild-type strain 161-U7/bI1 and derivatives of that 
strain in which the indicated mitoribosomal protein gene has been deleted. Northern 
hybridizations were carried out as described in Fig. 3.2 but hybridized with a 32P-labeled DNA 









Figure 3.4: COX2 processing defects caused by deletion of mitoribosomal protein genes are more 







Figure 3.4 (continued):  COX2 processing defects caused by deletion of mitoribosomal protein 
genes are more severe in the aI5-containing strain than the bI1-containing strain.  
 
A comparison of the COX2 Northern hybridizations from Figs. 3.2 and 3.3 for strains 161-
U7/aI5 (top) and 161-U7/bI1 (bottom) indicate that deletions of the mitoribosomal protein genes 
in the aI5-containing-strains result in greater COX2 processing defects than in the bI1-containing 
strains. COX2 processing was measured in two ways: as the percentage of mRNA relative to 
primary transcript + mRNA (upper value); and percent wild-type processing (lower value). The 
mean processing efficiency for COX2 RNAs was 54% wild type in the aI5 null mutants and 79% 



































Figure 3.5: Northern hybridization analysis for strains with deletions of mitoribosomal protein 
genes that had no effect on aI5 or bI1 splicing or on COX2 processing. 
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Figure 3.5 (continued):  Northern hybridization analysis for strains with deletions of 
mitoribosomal protein genes that had no effect on aI5 or bI1 splicing or on COX2 processing. 
 
(A) The blots show Northern hybridizations of wild-type strain 161-U7 whose mtDNA contains 
either no introns (I0) or single intron aI5 or bI1 and derivatives of those strains in which 
mitoribosomal protein genes MRPL38 and SWS2 were deleted. Northern hybridizations were 
carried out as in Fig. 3.1 and probed with a 32P-labeled DNA oligonucleotide complementary to 
the COX1 terminal exon (top panel). After hybridization with the COX1 exon probe, the blots 
were stripped and rehybridized with a probe complementary to the COX2 mRNA (lower panel). 
(B) Strains are as in A, but hybridized with a 32P-labeled DNA oligonucleotide complementary to 
the COB terminal exon. After hybridization with the COB exon probe, the blots were stripped and 


































Figure 3.6: Northern hybridization analysis showing that deletions of mt aaRS genes cause aI5 







Figure 3.6 (continued):  Northern hybridization analysis showing that deletions of mt aaRS genes 
cause aI5 and bI1 splicing defects.  
  
(A) The blots show Northern hybridizations of wild-type strain 161-U7 whose mtDNA contains 
either no introns, (I0) or single introns aI5, bI1 or LSU and derivatives of each strain in which 
genes MST1, MSM1, MSD1, MSE1 and DIA4 have been deleted. Northern hybridizations were 
carried out as in Fig. 3.2 and probed for the COX1 terminal exon.(B) Following hybridization 
with the COX1 exon probe, the blots were stripped and rehybridized with a 32P-labeled 
oligonucleotide complementary to the aI5 intron. (C) Strains are as in A, but hybridized with a 
32P-labeled DNA oligonucleotide complementary to the COB terminal exon. Primary (Pri),  








Figure 3.7: Northern hybridization analysis showing that deletions of mt elongation factor genes 
cause aI5 and bI1 splicing defects.  
 
(A) Northern hybridizations of wild-type strain 161-U7 whose mtDNA contains either no introns, 
(I0) or single introns aI5, bI1, or LSU and derivatives of each strain in which genes TUF1 and 
MEF2 have been deleted. Northern hybridizations were carried out as in Fig. 3.2 and probed for 
the COX1 terminal exon. (B) Strains are as in A, but hybridized with a 32P-labeled DNA 
oligonucleotide complementary to the COB terminal exon. Primary (Pri), Precursor (Pre), and 









Figure 3.8: Northern hybridization analysis showing the effects on aI5 and bI1 splicing with 
deletions of proteins that bind directly to the mt 21S rRNA or 15S rRNA. 
 
(A) The blots show Northern hybridizations of wild-type strain 161-U7 whose mtDNA contains 
either no introns, (I0) or the single introns aI5, bI1, or LSU and derivatives of each strain in 
which genes PET56, YOR199w, YOR200w, and  CCM/DMR1 have been deleted. Northern 
hybridizations were carried out as in Fig. 3.2 and probed with a 32P-labeled DNA oligonucleotide 
complementary to the COX1 terminal exon. (B) Strains are as in A, but hybridized with a 32P-
labeled oligonucleotide complementary to the COB terminal exon. Primary (Pri), Precursor (Pre), 







Figure 3.9: Northern hybridization analysis showing the effect on aI5 and bI1 splicing with 










Figure 3.9 (continued):  Northern hybridization analysis showing the effect on aI5 and bI1 
splicing with deletion of four mt translational activator/PPR proteins. 
 
(A) The blots show Northern hybridizations of wild-type strain 161-U7 whose mtDNA contains 
either no introns, (I0) or the single introns aI5, bI1, or LSU and derivatives of each strain in 
which genes for translational activator/PPR proteins AEP1, ATP22, SOV1, and  PET309 have 
been deleted. Northern hybridizations were carried out as in Fig. 3.2 except that the amount of 
total RNA for pet309 was tripled compared to other samples. Membranes were probed with a 
32P-labeled DNA oligonucleotide complementary to the COX1 terminal exon. (B) Strains are as in 
A, but hybridized with a 32P-labeled DNA oligonucleotide complementary to the COB terminal 
exon. (C) After hybridization with the COB exon probe, the blots were stripped and rehybridized 
with a probe complementary to the bI1 intron. Primary (Pri), Precursor (Pre), mature mRNA 






Figure 3.10: Northern hybridization analysis showing the effect of the deletion of three 





Figure 3.10 (continued):  Northern hybridization analysis showing the effect of the deletion of 
three translational activators on the splicing of COX1 introns aI1, aI2, aI4 and aI5.  
 
(A) The blots show Northern hybridizations of a wild-type 161-U7-derived strain whose mtDNA 
contains only introns aI1, aI2, or aI4 and mutants of each strain in which genes for PET309, 
ATP22, and PET54 have been deleted. Northern hybridizations were carried out as in Fig. 3.2 
except all mutants contain triple the amount of total RNA. Blots were probed for the COX1 
terminal exon. (B) Following hybridization, the blots were stripped and rehybridized with a probe 
complementary to the COX2 mRNA. (C) Northern hybridizations of wild-type 161-U7-derived 
strains whose mtDNA contains either no introns (I0) or the single intron aI5, bI1 or LSU and 
mutants of each strain in which the gene for PET309 has been deleted. Northern hybridizations 
were carried out as in Fig. 3.2 except all mutants contain triple the amount of total RNA. Blot was 
probed with a 32P-labeled DNA oligonucleotide complementary to the COX1 terminal exon. 






























































































































Figure 3.11 (continued): Northern hybridization analysis showing the effect of deletion of three 
translational activators on the splicing of group I introns bI4 and bI5. 
 
The blots show Northern hybridization analysis of wild-type 161-U7-derived strains whose 
mtDNA contains either intron bI4 or bI5 and mutants of each strain in which genes for PET309, 
ATP22, and PET54 have been deleted. Northern hybridizations were carried out as in Fig. 3.2 
except all mutants contain triple the amount of total RNA. Blots were probed for COB exons 4 
and 5 (indicated below top panel), after which they were stripped and rehybridized with a probe 
complementary to the COX2 mRNA (lower panels). Blots were re-stripped and re-probed for 
COB exon 6 and introns bI4, and bI5. Each blot was probed with a 32P-labeled DNA 
oligonucleotide complementary to the exon or intron indicated. The mature mRNAs (mRNA) are 



















































































































Figure 3.12 (continued):  Northern hybridization analysis showing the effect of deletion of 
miscellaneous proteins on aI5 and bI1 splicing. 
 
(A) The blots show Northern hybridizations of wild-type strain 161-U7 whose mtDNA contains 
either no introns, (I0) or single introns aI5, bI1, or LSU and mutants of each strain in which 
genes SLS1, YLR091w, MTG1, ATP5, and  OXA1 have been deleted. Northern hybridizations 
were carried out as in Fig. 3.2 and probed for the COX1 terminal exon. (B) Strains are as in A, but 
hybridized with a 32P-labeled DNA oligonucleotide complementary to the COB terminal exon. 
Primary (Pri), Precursor (Pre), and mature mRNA (mRNA) are indicated to the right of the 






































Figure 3.13: SDS-PAGE analysis resulting from TAP-tagged and untagged Pet309 pull-down 
assay. 
 
Commercially available yeast strains BY4741 in which the chromosomal copy of PET309 is 
untagged (WT) or TAP-tagged at the C-terminus (GE Healthcare) were grown to O.D.600 ≈ 3.0 in 
3 l of YPR. Mitochondria were isolated and subjected to the Tandem Affinity Purification 
protocol as described in Methods. Aliquots from the tagged and untagged samples were separated 
in a 4-12% Bis-Tris polyacrylamide gel (Life Technologies) and stained with Coomassie Brilliant 







Figure 3.14: Northern hybridization analysis showing the effect of deletions of mitoribosomal 
protein genes on processing of the RF1 transcript. 
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Figure 3.14(continued): Northern hybridization analysis showing the effect of deletion of 
mitoribosomal protein genes on processing of the RF1 transcript. 
 
(A) The COX2 blot is the same one used in Fig. 3.2, which had been probed for the 3´ end of 
COX2 RNA. The 2.5-kb primary transcript and 0.9-kb processed COX2 transcript are indicated to 
the right of the figure. (B) The blot was stripped and re-probed for RF1 with a 32P-labeled DNA 
oligonucleotide complementary to the 3´ end of RF1 RNA (small arrow beneath RF1 in Fig. 3.1). 
(C) The blot was re-stripped and probed with a 32P-internally-labeled PCR product 
complementary to the 3´ end of RF1 RNA. The expected position of the processed 1.5-kb RF1 













































1 YCR046C IMG1 + + Mt rp (L) 
2 YCR071C IMG2 + + Mt rp  (L) 
3 YDR347W MRP1 + + Mt rp  (S) 
4 YDL045W-A MRP10 + + Mt rp  (S) 
5 YKL003C MRP17 + + Mt rp  (S) 
11 YDL202W MRPL11 + + Mt rp  (L) 
12 YKR006C MRPL13 + + Mt rp  (L) 
14 YBL038W MRPL16 + + Mt rp  (L) 
19 YBR282W MRPL27 + + Mt rp  (L) 
23 YBR122C MRPL36 -- -- Mt rp  (L) 
25 YKL170W MRPL38 -- -- Mt rp  (L) 
30 YPR100W MRPL51 + + Mt rp  (L) 
31 YHR147C MRPL6 + + Mt rp  (L) 
32 YDR237W MRPL7 + + Mt rp  (L) 
33 YJL063C MRPL8 0 0 Mt rp  (L) 
38 YMR158W MRPS8 + + Mt rp  (S) 
40 YEL050C RML2 + + Mt rp (L) 
48 YNL081C SWS2 -- -- MT rp (S) putative  
49 YDR042C YDR042C -- -- Uncharacterized ORF 
54 YNL184C (MRPL19) + + Uncharacterized ORF 
57 YHR011W DIA4 + + Probable mitochondrial seryl-tRNA synthetase 
58 YPL104W MSD1 + + Mitochondrial aspartyl-tRNA synthetase 
59 YOL033W MSE1 + + Mitochondrial glutamyl-tRNA synthetase 
62 YGR171C MSM1 + + Mitochondrial methionyl-tRNA synthetase 
64 YKL194C MST1 + + Mitochondrial threonyl-tRNA synthetase 
65 YMR287C MSU1 + 0 
3'-5' exoribonuclease; component of the mitochondrial degradosome  
along with the ATP-dependent RNA helicase Suv3p 
70 YOR201C PET56 + + 
Ribose methyltransferase; modifies a functionally critical, conserved 
 nucleotide in mitochondrial 21S rRNA 
74 YBR163W DEM1 0 0 
Mitochondrial 5'-3' exonuclease and sliding exonuclease; required  
for mitochondrial genome maintenance 
75 YOR199W YOR199W + + Dubious ORF 
76 YOR200W YOR200W + + Dubious ORF 
77 YFL036W RPO41 0 0 Mitochondrial RNA polymerase  
 
Table 3.1:  Summary of the results of deletions in the single intron + strains.  
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78 YDL044C NAM1 -- -- 
Mitochondrial matrix protein that interacts with an N-terminal region 
 of mitochondrial RNA polymerase (Rpo41p) and couples RNA 
processing and translation to transcription 
79 YLR27W DCS1 -- -- Hydrolase involved in mRNA decapping 
80 YLR139C SLS1 + + 
Coordinates expression of mitochondrially-encoded genes; may facilitate 
 delivery of mRNA to membrane-bound translation machinery 
81 YPL005W AEP3 -- -- 
May facilitate use of unformylated tRNA-Met in mitochondrial  
translation initiation 
82 YMR228W MTF1 0 0 Mitochondrial RNA polymerase specificity factor 
83 YMR064W AEP1 + + 
Required for expression of the mitochondrial OLI1 gene encoding 
 subunit 9 of F1-F0 ATP synthase 
85 YJL102W MEF2 + + Mitochondrial elongation factor involved in translational elongation 
87 YMR097C MTG1 -- -- Putative GTPase 
89 YLR067C PET309 + -- Specific translational activator for the COX1 mRNA 
90 YMR066W SOV1 + + Mitochondrial protein of unknown function 
91 YOR187W TUF1 + + Mitochondrial translation elongation factor 
92 YKL134C OCT1 0 0 Mitochondrial intermediate peptidase 
94 YHR168W MTG2 -- -- Putative GTPase; member of the Obg family 
95 YER154W OXA1 + + 
Mitochondrial inner membrane insertase; mediates the insertion of both 
 mitochondrial- and nuclear-encoded proteins 
98 YBL022C PIM1 -- -- 
ATP-dependent Lon protease; involved in degradation of misfolded 
 proteins in mitochondria 
99 YDL104C QR17 -- -- Essential for t6A modification of mitochondrial tRNAs 
100 YLR369W SSQ1 -- -- Mitochondrial hsp70-type molecular chaperone 
101 YMR089C YTA12 -- -- 
m-AAA protease that mediates degradation of misfolded or 
 unassembled proteins and is also required for correct assembly of 
mitochondrial enzyme complexes 
102 YMR072W ABF2 -- -- 
Mitochondrial DNA-binding protein; involved in mitochondrial DNA 
 replication and recombination 




RIM1 0 0 
Single-stranded DNA-binding protein essential for mitochondrial 
genome maintenance; involved in mitochondrial DNA replication 
114 YDL198C YHM1 -- -- 
Mitochondrial GTP/GDP transporter; essential for mitochondrial 
genome maintenance 
115 YMR083W ADH3 -- -- 
Mitochondrial alcohol dehydrogenase isozyme III; involved in the 
shuttling of mitochondrial NADH to the cytosol under anaerobic 
conditions 
117 YDR298C ATP5 + + Subunit 5 of the stator stalk of mitochondrial F1F0 ATP synthase 
121 YDR350C ATP22 + -- Specific translational activator for the mitochondrial ATP6 mRNA 
122 YPL059W GRX5 -- -- 
Hydroperoxide and superoxide-radical responsive glutathione-dependent  
oxidoreductase; mitochondrial matrix protein involved in the 
synthesis/assembly of iron-sulfur centers 
124 YDL181W INH1 -- -- Inhibits ATP hydrolysis by the F1F0-ATP synthase 
125 YPR067W ISA2 0 0 Required for maturation of mitochondrial [4Fe-4S] proteins 
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128 YLR091W YLR091W + + Unknown 
132 YJR122W CAF17 0 0 
Involved in the incorporation of iron-sulfur clusters into mitochondrial 
 aconitase-type proteins 





Mitochondrial 15S rRNA-binding protein; required for intron removal  
of COB and COX1 pre-mRNAs  
143 YPR116W YPR116W + + Uncharacterized; required for mitochondrial genome maintenance 
148 YER122C GLO3 -- -- ADP-ribosylation factor GTPase activating protein 
151 YER110C KAP123 -- -- 
Karyopherin beta; mediates nuclear import of ribosomal proteins prior to 
assembly into ribosomes and import of histones H3 and H4; localizes to 
the nuclear pore, nucleus, and cytoplasm 
152 YLR260W LCB5 -- -- Minor sphingoid long-chain base kinase 





Outer mitochondrial membrane GTPase, subunit of the ERMES 
complex; potential regulatory subunit of the ERMES complex that links 
the ER to mitochondria 
162 YDL167C NRP1 -- -- Uncharacterized; predicted to be involved in ribosome biogenesis 
163 YNL170W YNL170W -- -- Dubious ORF 














Table 3.1:  Summary of the results of deletions in the single intron + strains.  
Phase II identification numbers as given in Phase I of the study (Nyberg, 2006) are given next to each 
systematic name and gene name. Splicing defects for aI5 or bI1are indicated by +, wild-type splicing is 
indicated by--. Loss of RNA is indicated by 0. Description or function of the encoded protein is taken 
from the Saccharomyces Gene Database. Mitoribosomal proteins (Mt rp) are from large (L) or small 
subunit (S). 
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Chapter 4: Screen for nuclear-encoded splicing factors using yeast 
petite strains 
4.1 BACKGROUND 
4.1.1 Rationale: reducing the mitoribosomal background 
Of the 72 candidate genes that were deleted in the initial Phase II screen described 
in the previous chapter, 54% displayed splicing defects in either aI5 or both aI5 and 
bI1—many more than were originally anticipated. As many of these proteins are 
associated with the mitoribosome or function in translation, it was possible that the 
splicing defects observed for deletions made in wild-type yeast strains could be 
secondary effects of disruption of mitoribosomes or inhibition of translation. We 
therefore shifted to using petite (
-
) strains that lack functional mitoribosomes and are 
unable to carry out mitochondrial protein synthesis. By using such strains, the expectation 




The petite phenotype is generally caused by the loss or mutation of nuclear- or 
mitochondrial-encoded genes involved in oxidative phosphorylation (Sherman 1965). 
The defective respiratory chain that results from such mutations prevents the cell from 
being able to grow on media containing only non-fermentable carbon sources, such as 
glycerol or ethanol. Though incapable of respiration, such cells are still capable of 
fermentation using carbon sources such as glucose or raffinose, resulting in the formation 
of small (petite) anaerobic colonies. Loss of portions of the mt genome also results in the 
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cell’s inability to assemble functional mitoribosomes. It was the latter condition which 
made the use of petite strains valuable in this portion of the study, enabling the 
investigation of the splicing effects of other mt genes in a background free of functional 
mitoribosomes or mitochondrial protein synthesis. 
4.2 RESULTS 
4.2.1 Candidate protein determination by mass spectrophotometry  
  To identify additional candidates for testing, ribonucleoprotein (RNP) complexes 
from isolated mitochondria (see Methods) from each of the experimental strains were 
analyzed by mass spectrometry. The RNPs were prepared and the mass spectroscopy 
results were analyzed by Dr. Georg Mohr, a senior scientist in our lab. The strains tested 
















Each of the single-intron strains was tested by PCR and Northern hybridization to 
confirm its status as bearing only the intron of interest (not shown).  
The spectral counts obtained from the mass spectroscopy data represented a 
general measure of abundance for each protein with higher numbers indicating more 
abundant proteins.  However, the counts are also sensitive to the length of the proteins 
and the number of possible peptides that can be detected by MS/MS. The tabulated 
counts were determined by averaging three injections of each RNP. Abundant proteins 
showed less than 25% variation between injections, while less abundant proteins varied 
by several fold and were not considered. The spectral counts for each protein were 
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normalized to the total number of counts for each RNP to allow for comparison across 
strains. A second value, a Z-score, was also calculated for each protein, which indicated 
the number of standard deviations the spectral count was above or below the mean. 
Proteins with Z-scores greater than 3 were considered significant since Z-scores greater 
than 2.58 are generally equivalent to a 99% confidence level, p-value = 0.01 (Lu et al. 
2007).  
Preliminary comparisons of known splicing factors were found in greater 




strain as compared to the I
0
 strain and established the soundness of 





(as was the general splicing factor, Mss116) comprised the list of candidates to be tested 
for this portion of the study.  
Of the eight proteins known to be encoded in the mt genome, four were detected 
in more than three RNPs: Atp6, Cox1, Cox2, and Var1. Interestingly, Rf1, also known as 
Q0255, or Orf1, was also detected. This is the maturase-like protein discussed previously 
in section 3.2.11.  
Several translational activators were also among the enriched proteins in the 
-
 
strains:  Sov1 (translational activator for VAR1, enriched in bI1
-
), Atp22 (translational 




), Pet54 (translational 
activator for COX3, moderately enriched in bI1 
-
), and Pet309 (translational activator for 
COX1, moderately enriched in bI1 
-
). All but Pet54 are pentatricopeptide repeat (PPR) 
proteins.  
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Several other proteins were highly enriched in the 
-
 strains but had previously 
been tested and their deletions caused either a weak or no splice defect in 
+
 strains, or 
caused the cells to lose mtRNA: Rim1 (Appendix, Blot 39) , Rpo41 (Appendix, Blots 12 
and 15), and Rmd9 (Phase I), and so were not tested further. The final candidate proteins 
and their functions, if known, are listed in Table 4.1, most of which had also been 
identified for analysis in Phase I and Phase II of the study. 
4.2.2 Growth of petite strains 
By necessity, 
- 
knock-out strains were grown for a longer period than were the 
+
 
strains in the initial part of the study (see Methods for details). When allowed to grow 
only to an O.D.600 of about 0.8-1.0 as were the initial 

strains, there were no clear 
differences in splicing observed between 
-
 knock-outs and 
- 
with wild-type nuclear 
backgrounds. By growing for 20 hours, however, differences in splicing patterns became 
apparent, though in several cases, the cells were not able to retain their mtDNA.  
4.2.3 Deletions in 
-
 strains produce various effects 
The Northern hybridization analyses in Fig. 4.1 show the effect on the splicing of 
aI5 (A) and bI1 (B) with the deletions of several of the potential splicing candidates that 
had been determined by mass spectrometry. Some null mutants in the aI5 strains 
exhibited variant colony phenotypes and are identified by the isolate number alongside 
the strain name which will be discussed in more detail below.  
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 The wild-type 
+
 strain and 
-
 strains are in lanes 1 and 2, respectively. The 
-
 
strain with a wild-type nuclear background exhibits a splicing defect for both aI5 (A) 
and bI1 (B), suggesting that the mitoribosome oe mitochondria protein synthesis may 
play a role in splicing these introns, albeit an indirect one. Additionally, the 
- 
strain 
appears be deficient in processing the primary COX1 transcript (Pri).  
4.2.3.1 Some deletions in - cause splice defects in aI5 and loss of COB mtRNA 
 Several of the deletion strains exhibited a splicing defect in aI5, but lost the COB 
transcript in the bI1 strains: aim10, fmp38, mrp10, and atp22 in Fig. 4.1A and B, 
lanes 3, 5, 7, and 11.  AIM10 encodes a putative prolyl-tRNA synthetase that when 
deleted, displays an elevated frequency of mitochondrial genome loss (Sentandreu et al. 
1997) as observed here for COB. FMP38/GEP3/MTG3 encodes an inner membrane 
protein required for mitochondrial ribosome small subunit biogenesis through the 
maturation of 15S rRNA (Paul et al. 2012). MRP10 encodes a mitoribosomal protein 
from the small subunit whose deletion was observed to also cause aI5 and bI1 splicing 
defects in the 
+ 
strains (upper panels in Figs. 3.2, and 3.3, lanes 5). ATP22 encodes a 
specific translational activator for ATP6/8 mRNA, encoding a subunit of the F1F0 
synthase. Deletion of ATP22 was observed earlier to destabilize the COB transcript in the 
presence of introns bI4 and bI5 in a 
+ 
strain (Fig. 3.11, lanes 4,5, 11, 12, 18, and 19) and 
to a lesser degree when only bI1 was present (Fig. 3.9B, lane 10). 
 Though strains pet123 and rsm22 did not entirely lose the COB transcript, they 
exhibited severe reductions in the COB RNA, suggesting it might be lost with longer 
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culturing (Fig. 4.1B, lanes 14 and 15, respectively). Both of these strains also exhibited 
aI5 splicing defect (Fig. 4.1A, lanes 14 and 15). PET123 encodes a mitoribosomal 
protein of the small subunit that exhibits genetic interactions with PET122 which, in turn, 
encodes a COX3 mRNA-specific translational activator (Haffter et al. 1991). RSM22 also 
encodes a mitoribosomal protein of the small subunit that is predicted to be an S-
adenosylmethionine-dependent RNA methyltransferase (Petrossian and Clarke 2009). 
 In summary, COB RNA was lost or greatly reduced with the loss of proteins of 
the small mitoribosomal subunit; a protein involved in small subunit biogenesis; the 
translational activator for ATP6/8; and a putative tRNA synthetase. These deletions also 
exacerbated the aI5 splicing defect of the 
-
 wild-type strain. 
4.2.3.2 Some deletions in - cause splice defects in both aI5 and bI1 
Some strains exhibited splicing defects beyond the baseline defect of the wild-
type 
-
 strains. Strains pet130, pet54, and mrh4 exhibited exacerbated splicing 
defects in both aI5(Fig. 4.1A) and bI1 (Fig. 4.1B)(lanes 8, 12, and 17, respectively).  
Little is currently known about Pet130, other than it is required for respiratory growth 
(Petrossian and Clarke 2009). The observation that splicing of both aI5 and bI1 is 
affected in the pet130 strain may, in part, explain that requirement. PET54 encodes one 
of three translational activators for the COX3 mRNA and acts as a splicing factor for the 
group I intron, aI5, facilitating exon ligation (Costanzo et al. 1989; Kaspar et al. 2008).  
Mrh4 (lanes 17) is a mt ATP-dependent RNA helicase of the DEAD-box family that is 
required for assembly of the large subunit of the mitoribosomes. It binds to the large 
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subunit 21S rRNA and localizes to the matrix face of the mitochondrial inner membrane, 
associating with the large subunit precursor and with mature mitoribosomes (De Silva et 
al. 2013). Its deletion caused a severe splicing defect in bI1. 
Thus, loss of a COX3 translational activator and a DEAD-box RNA helicase 
associated with the large mitoribosomal subunit caused splicing defects for both aI5 and 
bI1. 
4.2.3.3 Some deletions in - cause splice defects in aI5 but not in bI1 
Deletions of three genes, MRP17, PET309, and MRPS12 appear to cause splicing 
defects specific for aI5 beyond that of the wild-type 
- 
strain, though not for bI1 (lanes 9, 
13, and 16, respectively). Mrp17 is a mitoribosomal protein of the small subunit that 
exhibits genetic interactions with PET122, which encodes a COX3-specific translational 
activator (Haffter and Fox 1992). Pet309 is a translational activator for the COX1 mRNA 
which localizes to the mitochondrial inner membrane (Manthey et al. 1998; Zamudio-
Ochoa et al. 2014). As observed in the 
+
 strain earlier, this protein appears to be specific 
for aI5Figs3.10 and 3.11. In this 
-
 background, its role in translation activation is 
likely minimized and emphasizes its possible role as a splicing factor specific for aI5. 
Mrps12 is a mt protein with similarities to the E. coli S12 ribosomal protein (Gan et al. 
2002) which has been identified as an subunit interface protein that assists rRNA in 
translocation (Cukras et al. 2003).  
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4.2.3.4 Some deletions in - exhibit wild-type splicing phenotype in aI5 strains 
 Unexpectedly, three of the strains, aep1, sov1, and aep3 (Fig. 4.1A, lanes 4, 
6, and 10) all exhibited a wild-type splicing phenotype for aI5. The colony color 
phenotype for these strains was not the same white color as the 
-
 parent strain, but 
cream, in contrast to the red color of the 
+
 strains. For each of these deletions, bI1 
splicing and color phenotype were similar to the 
-
 parent strain. All three proteins, Aep1, 
Sov1, and Aep3,  contain PPR motifs (Lipinski et al. 2011). Additionally, Aep1 and Sov1 
are translational activators for the ATP9 and VAR1 mRNAs, respectively (Herrmann et al. 
2013) and Aep3 reportedly functions as an accessory initiation factor in mitochondrial 
protein synthesis (Lee et al. 2009). 
 The 161-U7 wild-type red phenotype is known to be caused by oxidation of a by-
product of the adenine pathway (Jones and Fink 1982). In respiratory-deficient strains, 
this by-product is not oxidized, so that the colony phenotype remains white. Addition of 
excess adenine to the media bypasses the adenine pathway, preventing both the formation 
of the by-product and the red color.  To test whether this pathway was influencing 
splicing, these strains were re-cultured with the addition of excess adenine (0.15 mg/ml). 
While the strains reverted to the white color phenotype, the excess adenine had no effect 
on splicing which remained as wild-type (not shown). 
4.2.4 Testing other translational activators and PPR proteins  
Since the strains displaying a wild-type splicing phenotype were either 
translational activators, PPR proteins, or both, I decided to test isolates of others that met 
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these criteria. The pet54 and pet309 strains in Fig. 4.1A were white colonies that 
exhibited splicing defects (lanes12 and 13), however, other knock-outs of these genes 
displayed the cream-colored phenotype, as did other isolates of aep3, and sov1; 
therefore these were also tested for their splicing abilities. The atp22 and pet111 
strains all exhibited white phenotypes. Since protein products of these genes are both 
translational activators as well as PPR proteins, these mutants were included in the 
subsequent tests. A cbp1 strain was generated to be included, since Cbp1 is likewise a 
translational activator that contains PPR motifs (Lipinski et al. 2011; Herrmann et al. 
2013) although Phase I of the screen had shown no splicing defect with the deletion of 
this protein.  









strains of each blot are in 
lanes 1 and 2, respectively. Lanes 3 and 4 show the difference in splicing abilities in two 
isolates of pet54, with the first exhibiting a more severe splicing defect than the wild 
type 
-
 strain, while the second exhibits a wild-type splicing ability comparable to 
+
. In 
lanes 5 and 6 are the two isolates of cbp1. Both exhibit a wild-type splicing phenotype. 
In lanes 7 and 8 are two atp22 isolates; both of which exhibit a stronger splicing defect 
than the wild type 
-
 strain. None of the deletions in the bI1
-
 strains (B) exhibit any 
significant difference in splicing ability as compared to the wild type 
-
. Both blots were 
stripped and re-probed with 
32
P-labeled DNA oligonucleotides complementary to their 
respective introns. There appears to be residual intron in the primary transcripts (Pri) in 
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all the aI5 
-
 strains not observed in the 
+
. The amount of precursor (Pre) is inversely 
proportional to the amount of excised intron (aI5). 
Because no differences had been observed in the bI1
- 
strains, the next set of 
Northern hybridizations were only tested in the aI5strains (Fig. 4.3). The wild type 
- 
strain is in lane 1. In lanes 2 and 3 are aep3 isolates, with the first exhibiting a near 
wild-type splicing phenotype, while the second is similar to the 
-
 parent strain, albeit 
with an apparent increased amount of unspliced and unprocessed primary transcript (Pri). 
In lanes 4 and 5 are two isolates of pet309, with the first displaying a very strong 
splicing defect, while the second displays near-wild-type splicing. In lane 6 is a strain 
deleted for OXA1, which encodes an insertase associated with the mitoribosomes and is 
neither a translational activator nor a PPR protein. This control strain exhibits a severe 
splicing defect. In Fig. 4.3, lane 7 is another pet54 strain that again exhibits a wild-type 
splicing phenotype in contrast to the ones in Figs. 4.1A, lane 12 and 4.2A, lane 3. In Fig. 
4.3,  lanes 8 and 9 are two pet111 isolates, both exhibiting a more severe splicing defect 
than observed in the 
- 
parent strain. In lane 10 another sov1 isolate, that exhibits a 
strong splicing defect, in contrast to the one seen in Fig. 4.1, lane 6. 
4.2.5 Re-confirming gene replacement in 
- 
mutants that exhibit wild-type splicing 
 Though each of the mutants used in these Northern hybridizations had been 
previously tested by PCR to check for gene replacement by a kanamycin antibiotic 
resistance cassette, here I re-tested those that gave mixed phenotypes: pet309, aep1, 
sov1, and aep3, also testing for the presence/absence of the gene of interest. Figure 
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4.4A diagrams the relative positions of the primers used to test for the presence of the 
gene (G) and to test for the presence of kanamycin cassette (K). In Fig. 4.4B, PCR 
products of the expected sizes are seen in the mutants only for those reactions amplifying 
the kanamycin cassette (K) (lanes 1, 3, 6, 8, 11, 13, 15, 18, 20, and 22). The gene (G) is 
only amplified in the control wild-type strain (WT, lanes 5, 10, 17, 24). In Fig. 4.4C, total 
RNA from each of the strains was tested by PCR for the presence of contaminating DNA, 
though none is found. These results confirm the replacement of the indicated gene with 
the kanamycin cassette. 
4.2.6 
-
 mutants are not 
+
 contaminants 
 To test for the possibility that these may be 
+
 knock-out contaminants, the blots 
from Fig. 4.1A and B were stripped and re-probed with a 
32
P-labeled DNA 
oligonucleotide complementary to the COX2 mRNA. Figure 4.5 shows the results for the 
aI5strains, with the original blot in panel A. The signal for the COX2 mRNA is only 
visible for the 
+
 strain in lane 1 of panel B, indicating that the remaining strains lack the 
COX2 portion of the mt genome and therefore are petite. Similar findings are seen for the 
bI1 strains in Fig. 4.6 with the original blot shown in panel A. The signal for the COX2 
mRNA is only visible for the 
+
 strain in lane 1 of panel B. This indicates that those 
strains exhibiting wild-type splicing are indeed 
-
 
4.2.7 Phenotype colors are stable 
The finding that deletions in aI5
-
 strains can sometimes lead to near-wild-type 
splicing suggests there may be alternate pathways to aI5 splicing. Could alternate 
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pathways develop over time in splice-defective strains? To test this notion, the strains in 
Fig. 4.4 were streaked onto YPD/G416 agar plates and YPR/G418 agar plates and 
incubated at 30° C for 3 to 5 days. Several of the colonies were re-streaked onto fresh 
plates and incubated again at 30° C for another 3 to 5 days.  This procedure was repeated 
two more times to look for a color change from white to cream indicating a change in 
splicing ability, but none was ever observed; the color phenotypes remained stable. This 
suggested that instead of multiple splicing pathways, there may be second-site suppressor 
mutations that rescued the splicing of aI5 in the absence of both functional 
mitoribosomes and some translational activators or PPR proteins. This problem will 
remain for future studies.  
4.3 DISCUSSION 
 
The results of this portion of the study showed that mitoribosomal proteins and 
proteins involved in mt translation impacted the splicing of aI5 and bI1 in strains lacking 
functional mitoribosomes or mitochondrial protein synthesis. This suggests that several 
of these proteins may be involved in functions other than translation, and/or perhaps that 
they are part of a larger complex involved in the splicing of these two introns. 
The deletion of genes PET130, PET54 and MRH4 caused splicing defects in both 
aI5 and bI1, with the deletion of DEAD-box protein MRH4 having a severe impact on 
bI1 splicing. Deletion of other genes resulted in defective aI5 splicing and loss or 
reduction of the COB RNA: AIM10, FMP38, MRP10, ATP22, PET123, and RSM22, 
suggesting that these proteins may participate in coordinating COX1 splicing and COB 
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stability.  In Chapter 3, deletion of ATP22, translational activator for ATP6, was seen to 
cause the instability of COB. Pet123 genetically interacts with PET122 which encodes a 
translational activator for COX3 (Haffter et al. 1991). Loss of Cbp1, a translational 
activator known to be required for COB stability, exhibited a wild-type splicing 
phenotype in the 
-
 strain (this study) as well in the 
+
(Nyberg 2006).  
The deletion of three genes, PET309, MRP17, and MRPS12 caused splicing 
defects for aI5, but not for bI1. A similar effect was observed when PET309 was deleted 
in 
+
 strains (Fig. 3.9) where its deletion was specific for aI5. Mrp17 and Mrps12 are 
both mitoribosomal proteins of the small subunit, the former known to exhibit genetic 
interactions with COX3 translational activator Pet122 (Haffter and Fox 1992) which in 
turn, has been shown to interact with Pet309 (Naithani et al. 2003). 
Along with Pet309, translational activators for other mRNAs, Aep1, Sov1, and 
Atp22, were shown in Chapter 3 to impact the splicing of aI5, suggesting these proteins 
may coordinate to regulate aI5 splicing. In this part of the study, three of these 
translational activators were found to sometimes exhibit near wild-type splicing when 
deleted in aI5 
-
 strains, possibly due to second-site suppressor mutations. Loss of the 
fourth, Atp22, the translational activator for the ATP6 mRNA, consistently caused an 




 strains. Pet54, the translational activator for the 
COX3 mRNA, did not impact aI5 splicing in the 
+
 strain, but its deletion sometimes 
caused a splicing defect in the 
-
 strain, and sometimes exhibited a wild-type splicing 
phenotype. Similarly, in Phase I of the study, Nyberg observed no splicing defect in aI5 
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with the deletion of PET111 (although a strong defect was observed for aI5. Here, its 
deletion exhibited wild-type splicing in the 
-
 strain. Loss of a translational activator for 
COB, Cbp1, did not impact splicing of either aI5or bI1 when tested in Phase I of the 




These results further support the idea that a higher order of organization exists 
among these proteins to regulate aI5 splicing, possibly also including many of the 
ribosomal proteins. Alternatively, most of these translational activators have been 
identified as PPR proteins, well known for their interactions with RNA, so that it is also 
possible that the proteins are interacting with each others’ mRNAs or with the rRNAs. 
Pet54, though not identified as a PPR protein, is recognized as a splicing factor for aI5 
in addition to its role as translational activator for COX3, confirming the protein’s ability 
to also interact with RNA. This protein is also required for the maintenance of normal 
levels of COX1 synthesis in an intronless strain (Shingu-Vazquez et al. 2010). 
It is unclear why deletions of several of the translational activator and/or PPR 
proteins would sometimes have a near-wild-type splicing phenotype. One possible 
explanation may be that these translational activators, in normal, wild-type backgrounds, 
would bind their respective mRNAs and/or mitoribosomal proteins or rRNAs, which in 
effect, sequesters these proteins thereby releasing a block on aI5 splicing. Deletion of 
these proteins, along with the mitoribosomal proteins or rRNAs mimics this condition, 
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allowing near-wild-type splicing. It remains unclear why the results are not consistent, 
















































Mitochondrial ribosomal protein of the small subunit; contains twin cysteine-x9-cysteine 
motifs; oxidized by Mia40p during import into mitochondria 
YKL003C MRP17 
Mitochondrial ribosomal protein of the small subunit; MRP17 exhibits genetic interactions 
with PET122, encoding a COX3-specific translational activator 
YOR158W PET123 
Mitochondrial ribosomal protein of the small subunit; PET123 exhibits genetic interactions 
with PET122, which encodes a COX3 mRNA-specific translational activator 
YKL155C RSM22 
Mitochondrial ribosomal protein of the small subunit; also predicted to be an S-
adenosylmethionine-dependent methyltransferase 
YNR036C YNR036C 
Mitochondrial protein; may interact with ribosomes based on co-purification experiments; 
similar to E. coli and human mitochondrial S12 ribosomal proteins 
YGL064C MRH4 
Mitochondrial ATP-dependent RNA helicase of the DEAD-box family; required for 
assembly of the large subunit of mitochondrial ribosomes; binds to the large subunit rRNA, 
21S_rRNA; localizes to the matrix face of the mitochondrial inner membrane and associates 
with the large subunit precursor and with mature ribosomes 
YPL005W AEP3 
Peripheral mitochondrial inner membrane protein; may facilitate use of unformylated tRNA-
Met in mitochondrial translation initiation; PPR protein (Lipinski, 2011) 
YMR064W AEP1 Translational activator for mitochondrial OLI1 gene; PPR protein (Lipinski, 2011) 
YLR067C PET309 
Specific translational activator for the COX1 mRNA; also influences stability of intron-
containing COX1 primary transcripts; localizes to the mitochondrial inner membrane; 
contains seven pentatricopeptide repeats (PPRs) 
YNR066W SOV1 transcriptional activator for Var1 (Herrmann et al. 2013) PPR protein (Lipinski, 2011) 
YDR350C ATP22 





Protein required for mitochondrial ribosome small subunit biogenesis; null mutant is 
defective in respiration and in maturation of 15S rRNA; protein is localized to the 
mitochondrial inner membrane; null mutant interacts synthetically with prohibitin (Phb1p) 
YJL023C PET130 
Protein required for respiratory growth; the authentic, non-tagged protein is detected in 
highly purified mitochondria in high-throughput studies 
YER087W YERO87W 
Protein with similarity to tRNA synthetases; non-tagged protein is detected in purified 
mitochondria; null mutant is viable and displays elevated frequency of mitochondrial 
genome loss 
YGR222W PET54 
Mitochondrial inner membrane protein; binds to the 5' UTR of the COX3 mRNA to activate 
its translation together with Pet122p and Pet494p; also binds to the COX1 Group I intron 
AI5 beta to facilitate exon ligation during splicing 
YLR382C NAM2 
Mitochondrial leucyl-tRNA synthetase; also has a direct role in splicing of several 
mitochondrial group I introns; indirectly required for mitochondrial genome maintenance 
YLR139C SLS1 
Mitochondrial membrane protein; coordinates expression of mitochondrially-encoded genes; 
may facilitate delivery of mRNA to membrane-bound translation machinery 
YPL029W SUV3 
ATP-dependent RNA helicase; component of the mitochondrial degradosome along with the 
RNase Dss1p; the degradosome associates with the ribosome and mediates RNA turnover; 
also required during splicing of the COX1 AI5_beta intron 
YHR120W MSH1 
DNA-binding protein of the mitochondria; involved in repair of mitochondrial DNA; has 
ATPase activity and binds to DNA mismatches; has homology to E. coli MutS; transcription 




Table 4.1(continued): Potential splicing factors identified by mass spectroscopy.  
 
Ribonucleoproteins were prepared from isolated mitochondria from + and - strains of 161-U7/ 
aI5 and 161-U7/bI1 and analyzed by mass spectrometry. Listed are those proteins which were 
enriched in the - strains. Systematic names, standard gene names and protein functions, when 
known, are given. The shaded area represents those proteins for which deletions in the - strains 







Figure 4.1: Northern hybridization analysis showing the effect of deletion of potential splicing 





Figure 4.1(continued): Northern hybridization analysis showing the effect of deletion of potential 
splicing factors identified by mass spectroscopy analysis in comparing single intron + to - 
strains.  
 
(A) Northern hybridizations of wild-type strain 161-U7/aI5 + and - and derivatives of the 
petite strain in which the indicated gene has been deleted. Cells from freshly streaked plates were 
resuspended in YPR at a starting O.D.600 = 0.2 and allowed to grow for 20 h. Total cellular RNA 
was isolated, run in a 1.5% RNA-grade agarose gel, blotted onto a nylon membrane, and 
hybridized with a 32P-labeled DNA oligonucleotide complementary to the COX1 terminal exon. 
(B) Wild-type strain 161-U7/bI1 + and - and derivatives of the petite strain in which the 
indicated gene has been deleted. Cells were cultured, RNA prepared and run as in A except the 
blot was hybridized with a 32P-labeled DNA oligonucleotide complementary to the COB terminal 





























Figure 4.2: Northern hybridization analyses showing the effect on aI5 and bI1 splicing in - 
strains with deletions of known translational activators.  
 
(A) Northern hybridizations of wild-type (WT) strain 161-U7/aI5 + and - and derivatives of 
the petite strain in which the indicated gene has been deleted. Cells were cultured, RNA prepared 
and run as described in Fig. 4.1. Northern hybridization of the COX1 exon (top panel) is as in Fig. 
4.1. To probe for intron aI5, the membrane was stripped and rehybridized with a 32-P-label DNA 
oligonucleotide complementary to aI5. (B) Wild-type (WT) strain 161-U7/bI1 + and - 
derivatives of the petite strain in which the indicated gene has been deleted. Cells were cultured, 
RNA prepared and run as in Fig.4.1B. To probe for intron bI1, the membrane was stripped and 
rehybridized with a 32-P-label DNA oligonucleotide complementary to the bI1 intron (bottom 




Figure 4.3: Northern hybridization analysis showing the effect on aI5 splicing in - strains with 
deletions of other translational activator and PPR proteins. 
 
Northern hybridization analysis of wild-type (WT) strain 161-U7/aI5g r- and derivatives of  that 
strain in which the indicated gene has been deleted. Cells were cultured, RNA prepared and run 
and hybridized as in Fig. 4.1A. Primary (Pri), Precursor (Pre), and mature mRNA (mRNA are 































Figure 4.4(continued): PCR analyses confirming gene replacement in 161-U7/aI5 - strains with 
mixed splicing phenotypes. 
 
(A) Relative positions of DNA primers (see Methods) used in B and C to test by PCR for gene 
replacement by a kanamycin resistance cassette. The boundaries of the transforming kanamycin 
cassette are indicated by red lines. Relative positions of primers used in testing for the presence of 
the gene (G) and kanamycin cassette (K) are shown. Forward primers (right-pointing arrows) 
were complementary to the region upstream of the cassette originally used for homologous 
recombination. Reverse primers (left-pointing arrows) were complementary to either the 5´ region 
within the gene or the kanamycin cassette. (B) Colony PCR analyses of freezer stocks. The 
deleted gene is indicated above sets of mutants with either wild-type (+) or defective (-) splicing 
phenotypes for each given isolate. Wild-type strains (WT) were used as controls. PCR reactions 
testing either for the presence of a kanamycin cassette (K) or the indicated gene (G) is indicated 
beneath each lane. White font indicates colonies are white; dark font indicates colonies are 
cream-colored when grown on YPD/G418 agar plates. (C) PCR analyses of isolated whole-cell 


























Figure 4.5: Northern hybridization analysis confirming - status of 161-U7/aI5 - strains.  
 
 (Top) Blot from Figure 4.1A (lanes 1-13) was stripped and rehybridized (bottom) with a 32P-
labeled DNA oligonucleotide complementary to the COX2 mRNA. Primary (Pri), Precursor (Pre), 
and mature mRNA (mRNA) are indicated to the right of the panels. 
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Figure 4.6: Northern hybridization analysis confirming - status of 161-U7/bI1 - strains.  
 
 (Top) Blot from Figure 4.1B (lanes 1-13) was stripped and rehybridized (bottom) with a 32P-
labeled DNA oligonucleotide complementary to the COX2 mRNA. Primary (Pri), Precursor (Pre), 
and mature mRNA (mRNA) are indicated to the right of the panels. 
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Chapter 5: Oxa1 plays a role in aI5 and bI1 splicing 
5.1 BACKGROUND  
5.1.1 Rationale  
The screen for mt intron splicing factors discussed in Chapters 3 and 4 identified 
Oxa1 as a protein potentially required for aI5 and bI1 splicing (Fig 3.12A, lanes 22-23; 
Fig. 3.12B, lanes 23-24; Fig. 4.3, lane 6). These interesting results prompted further 
exploration of the possibility that Oxa1 might function as a splicing factor for aI5 and 
bI1. The results of these investigations form the basis of this chapter. 
5.1.2 Structure and function of Oxa1 
A member of the highly-conserved Oxa1/YidC/Alb3 protein family, Oxa1 is 
found in the inner membranes of yeast mitochondria (Funes et al. 2011). All members of 
this family function as insertases, that is, proteins that assist in the insertion of 
hydrophobic proteins into membranes. In the case of Oxa1, the protein assists with the 
inner membrane insertion of the highly hydrophobic proteins encoded by the mt genome; 
however, nuclear-encoded proteins imported into the mitochondrion are also assisted by 
Oxa1 (Hildenbeutel et al. 2012). Some evidence suggests that translocation of the 
hydrophobic proteins is facilitated by the formation of a pore composed of Oxa1 dimers 
(Kohler et al. 2009; Krüger et al. 2012). 
Oxa1 has 5 transmembrane domains positioned within the mitochondrial inner 
membrane with an N-out, C-in orientation (Hell et al. 1997; Funes et al. 2011) 
(Fig.5.1A). These transmembrane domains comprise the hydrophobic core of the protein 
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and are so well conserved that the region may be functionally interchanged among Oxa1, 
YidC and Alb3 (Jiang et al. 2003; Funes et al. 2009).  Linking the first two 
transmembrane domains is a feature common to all insertases, the Loop 1 region that 
extends into the matrix which is thought to contribute to ribosome binding (Lemaire et al. 
2000). A second Oxa1 domain, less common among insertases, is the C-terminal domain 
(CTD) that also protrudes into the matrix and interacts with the mt ribosome and possibly 
with the nascent polypeptides to increase the efficiency of the insertion process (Jia et al. 
2003; Szyrach et al. 2003; Kohler et al. 2009). The yeast CTD is thought to form an 
amphipathic α-helix with one positively-charged and one hydrophobic surface 
characteristic of a coiled-coil structure that has been shown to be both required and 
sufficient for binding the mt ribosome to the mt inner membrane (Kohler et al. 2009).  
Previous studies in the multi-intron yeast strain W303 have shown that deletion of either 
of these domains individually does not prevent growth on glycerol, while deletion of both 
domains, does. (Lemaire et al. 2000).  
Crosslinking experiments indicate that Oxa1 dimers localize above the ribosome 
polypeptide exit tunnel allowing the direct insertion of nascent and highly hydrophobic 
mitochondrially-encoded proteins into the hydrophobic inner membrane (Jia et al. 2003; 
Szyrach et al. 2003; Kohler et al. 2009; Keil et al. 2012). (Fig. 5.1B). This raises the 
possibility that the splicing defect observed due to the loss of Oxa1 may be a result of an 
indirect effect on another yet-unidentified protein dependent on this function. However, 
other proteins have been shown to also participate in protein insertion within the 
mitochondrion, so that Oxa1 is not necessarily absolutely essential for this process 
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(Dimmer and Rapaport 2012). Except for Cox2, all mt translation products can integrate 
into the membrane in the absence of Oxa1, although with reduced efficiencies (Altamura 
et al. 1996; He and Fox 1997; Hamel et al. 1998; Lemaire et al. 2000).  
5.1.3 The processing of the 21S rRNA transcript 
The rRNA of the mitochondrial large subunit (LSU) is the 21S rRNA. The 
polycistronic 6.7-kb primary transcript of the 21S rRNA gene includes the non-coding 
genes of the mitochondrial tRNAs for threonine, cysteine and histidine (Turk et al. 2013) 
(Fig.5.2). Following  3´ processing, the resulting precursor is 4.4 kb which, with the 
excision of the 1.1-kb intron, matures to the final 3.3-kb rRNA (Merten et al. 1980). In 
some of the Northern hybridizations that follow, these RNAs were visualized by using a 
32
P-labeled DNA oligonucleotide complementary to the exon of the LSU/rRNA (small 
arrow below LSU in Fig. 5.2) 
5.2 RESULTS 
5.2.1 Splicing defects in oxa1 strains are observed in aI5 and bI1, but not  
During the general screen, Oxa1 was among many proteins knocked out in four 
different 
+ 
strains: 161-U7/aI5, 161-U7/bI1, 161-U7/I
0
and 161-U7/ (see Methods). 
The Northern hybridizations in Figure 5.3 compiles several deletion strains in which the 
blots were hybridized with 
32
P-labeled DNA oligonucleotides complementary to either 
the terminal exons of COX1, COB, or LSU/ 21s rRNA. In each blot, wild type is in lane 
1. The strong splicing defect produced by the deletion of the general RNA chaperone, 
Mss116, is clearly observed in lane 2 of all three hybridizations. Deletion of three 
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mitoribosomal proteins in lanes 3-5 follow, each exhibiting a defect less extreme than 
that of Mss116, for both aI5 and bI1 splicing, though no splicing defect is evident for . 
The gene YNL184C encodes an uncharacterized protein whose deletion causes splicing 
defect patterns (lanes 6) similar to those of the mitoribosomal proteins. GTF1 encodes a 
subunit of the trimeric GatFAB AmidoTransferase (AdT) complex (Barros et al. 2011). 
Its deletion in lanes 7 causes no splicing defect in any of the three introns. Similarly, 
deletion of KAP123, which encodes a cytoplasmic protein that facilitating nuclear import 
of ribosomal proteins prior to assembly into ribosomes (Rout et al. 1997), has no impact 
on the splicing of any of the introns (lanes 8). The oxa1 strains in lanes 9 exhibited 
strong splicing defects for the group II introns aI5 and bI1,though no defect is seen for 
the group I intron .  This result prompted two questions: (1) Is the defective splicing a 
result of Oxa1’s close association to the mitoribosomes? (2) Is Oxa1 a splicing factor 
specific to group II introns, or more particularly, to aI5 and bI1?  
5.2.2 Splicing defects are exacerbated in oxa1- strains grown in YPR 
To address the first question, OXA1was deleted in aI5 and bI1 single-intron 
petite (
-
) strains to reduce the background effect of the mitoribosomes These strains lack 
functional mitoribosomes and exhibit a diminished ability to splice both aI5 and bI1 
even with a wild-type nuclear genotype as observed in Chapter 4.   
The Northern hybridizations in Fig. 5.4 show the effect of deletion of OXA1 in 
single intron 
-
 strains compared to deletions in single intron 
+
 and intronless I
0
 strains. 
The intronless control shows little difference between wild type and oxa1 (Fig. 5.6A 
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and B, lanes 1-2), suggesting that Oxa1’s effect may be limited to strains with introns. In 
the 
+
 strains, the effect of deleting OXA1 is particularly apparent in the aI5 strain as 
compared to the bI1 (5.3 A and B, lanes 3-4). In the 
-
 strains, deleting OXA1 exacerbates 
the splicing defects in both aI5 and bI1strains when compared to 
- 
wild type, with 
virtually all of the RNA in precursor form and none as spliced mRNA (Fig. 5.4, A and B, 
lanes 6). This suggested that Oxa1 may be playing a role in splicing, even in the absence 
of functional mitoribosomes.  
5.2.3 Loss of Oxa1 impacts splicing in aI5 and bI1 more than in other tested mt 
introns 
The next question to be addressed was whether Oxa1 is required specifically for 
the splicing of group II introns aI5 and bI1. To test this, I first attempted to knock out 




 wild-type strain harboring all 12 group I and II introns in COX1 and 
COB. While OXA1 knock-outs were relatively easily obtained in single-intron strains 





wild-type strain resulted in only two transformants. In culture, these quickly became 
petite resulting in loss of mtRNA that consequently resulted in Northern hybridizations of 
poor quality. As an alternative, I chose to use the three strains, HRH421, HRH524 and 
HRH422, previously used in Chapter 3. For clarity, they will be briefly described again 
here. 
Strain HRH421 has only the group II intron, aI1. This intron encodes its own 
active maturase and requires RNA chaperone, Mss116 for proper splicing. Strain 
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HRH524 only has group II intron aI2. It also encodes its own active maturase and 
requires Mss116. Strain HRH422 has 3 group I introns: aI4, bI4 and bI5. Intron aI4 
encodes an inactive maturase but is aided instead by the active maturase encoded by bI4 
that assists in the splicing of itself and aI4 (Rho and Martinis 2000). Besides Mss116, 
splicing of both of these introns is aided by Nam2, a mt leucyl-tRNA synthetase 
(Labouesse 1990). Intron bI5 does not code for a maturase; its splicing is facilitated by 
Cbp2 as well as Mss116. 
In Figure 5.5 A, COX1 group II introns aI5 aI1, and aI2, as well as group I 
intron aI4 are compared. The intronless strain I
0
 is used as control (lanes 1-2). In marked 
contrast to aI5in lanes 4 and 6, introns aI1, aI2, and aI4 (lanes 8, 10, 12) show no 
dependence on Oxa1 for splicing. Similarly, COB group I introns bI4 and bI5 (in B, lane 
8) do not exhibit any evident splicing defect except with darker contrast, during which a 
faint band corresponding to the size of unspliced bI5 (also 2.9 kb) becomes visible. This 
faint band is distinctly different from the pronounced defect observed for bI1 in lanes 4 
and 6. Thus, Oxa1 did not have any marked effect on any of the group I introns tested, 
and among the group II introns, Oxa1 appears to be more important to those without 
maturases; i.e. aI5 and bI1.  It is interesting to note that despite the close relationship 
between Oxa1 and the mitoribosome, deletion of the insertase has little noticeable effect 
on the expression of the intron-encoded maturases of aI1 and aI2 as observed by their 
near-wild-type splicing. One possible explanation is the hydrophilic maturases are not 
reliant on Oxa1’s insertase function.  
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5.2.4 Oxa1 mutants suggest aI5and bI1 splicing is influenced by the protein’s 
insertase activity 
With much of Oxa1 buried within the mt inner membrane, the two domains that 
extend into the matrix would seem to be those likely involved in splicing. In 2004, 
Lemaire, et al. designed a series of Oxa1 mutants to test the functions of its various 
domains (Lemaire et al. 2004). Here, I reconstructed these mutants to investigate how 
each might contribute to intron splicing. Figure 5.6A illustrates the locations of amino 
acid residues (designated by asterisks) within the Oxa1 protein topology that were used in 
constructing mutants in Fig. 5.6B. The untagged and myc-tagged wild-type sequences are 
diagrammed in (i) and (ii), respectively. One mutant has a large portion of Loop 1 
removed (iii); one has most of the CTD removed (iv); and one has both regions removed 
(v). All were myc-tagged for possible subsequent Western blotting. Previous studies have 
shown that Oxa1 tolerates C-terminal tagging well (Reif et al. 2005; Jia et al. 2009; Stoldt 
et al. 2012). Each of the constructs was cloned into centromeric plasmid pRS416 and 
transformed into a strain in which the chromosomal copy of OXA1 had been replaced by 
a kanamycin resistance cassette. Selection required use of a uracil
-
 defined media; here I 
used Hartwell’s Complete (HC) with 2% glucose as carbon source. Cultures were grown 
in HC lacking uracil with 2% raffinose as carbon source to minimize the effect of glucose 
repression (see Methods). These complementation mutants were then tested by Northern 
hybridization for the effect they had on the splicing of aI5 and bI1. 
Following scanning with a phosphorimager, the Northern hybridizations in 
Figures 5.7 and 5.8 were analyzed using GelQuant software (BioChem Lab Solutions) to 
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determine the percentage of spliced mRNA. Ratios of mRNA to mRNA + precursor 
RNA (upper value) or to mRNA + precursor + primary transcript (lower value) are 
indicated as percent spliced mRNA under each lane in the blot. Intronless strain I
0 
served 
as negative control.  
5.2.4.1 Effect of loss of two Oxa1 domains on aI5splicing 
The effects on aI5 splicing are shown in Fig. 5.7A. Both of the oxa1/ aI5 + 
and 
-
 strains exhibited a severe splicing defect (lanes 9 and 16) that is rescued by 
complementation with wild type (lanes 10-11 and 17-18). Comparable splicing ability by 
the untagged and myc-tagged wild-type complements showed little interference by the 
myc tag: in the 
+
 strains (79% and 73%, respectively) and in the 
-
 strains (86% and 
84%, respectively). This corroborates previous work showing that C-terminal tagging is 
well tolerated by Oxa1 (Reif et al. 2005). Complementation by the  Loop 1 (L1-myc) 
had little effect on splicing in 
+ 
(86%, lane 12). In contrast, this mutant did not rescue 
the splicing defect in the aI5 
-
 strain to the extent it did in the 
+
 strain (70% spliced 
mRNA, lane 19), suggesting that the presence of the ribosome can somewhat compensate 
for the lack of Loop 1. Complementation with CTD Oxa1 mutant protein (CTD-myc) 




 strains (lanes 13 and 20), which exhibited 
similar splicing abilities at 84% and 83%, respectively. This indicates that the tail region 
is not critical for aI5 splicing. Complementing with the double-deletion mutant 





strains with only 57% and 51% splicing (lanes 14 and 21), respectively. Thus, though 
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neither the Loop 1 nor the CTD domains appeared critical to splicing on their own, loss 
of both domain did cause an aI5 splicing defect.  This defect, however, was not as severe 




 null mutant complements which exhibited only 26% and 
35% splicing (lanes 9 and 16), respectively. This suggests that the remaining core 
transmembrane insertase domain that contributes most significantly to the proper splicing 
of aI5.  
5.2.4.2 Effect of loss of two Oxa1 domains on bI1 splicing 
The effects on bI1 splicing by the Oxa1 complementation mutants are shown in 
Fig 5.8A. Two values for the percent splicing were determined: as the ratio of mRNA to 
Precursors 1, 2 and the mRNA (top value) and the second (lower value) as the ratio of 
mRNA to precursors 1, 2 (Pre-1 and Pre-2 combined), mRNA and the primary transcript 
(Pri). Interestingly, remnants of the COB primary transcript are only evident for the 
empty vector and wild-type complements (lanes 9-11), but not for the L and CTD 
mutant complements (lanes 12- 14 and 19-21). Therefore, in the results and discussion 
below, only the top value will be considered. Also evident are several unidentified RNAs 
(*), which run faster than the mRNA but slower than the bI1 intron that likely represent 
splicing intermediates containing the intron and exon.  These latter RNAs may represent 
different configurations of the excised lariat, and nonetheless were not considered in the 
determination of percent splicing. 




 wild types in lanes 8 and 15 shows a slight splicing 
defect in the 
- 
strain (82% as compared to 100% for 
+
). As in the previous set of 
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complementing proteins, the myc tag appears to have no adverse effect on splicing. This 
is clearly observed by comparing the splicing abilities of the 
+
 wild-type untagged and 
tagged complementing proteins, both with 94% splicing (lanes 10 and 11); and the 
-
 
untagged and tagged wild type with 79% and 80% splicing, respectively (lanes 17 and 
18). 
Interestingly, with only 32% splicing, the 
+
 null mutant (lane 9) exhibits a 
stronger splicing defect than the 
- 
strain (lane 16) with 58%. Complementation by the 
L1-myc mutants rescues both: 93% splicing for 
+
 (lane 12) and 84% for 
- 
(lane 19), 
suggesting that the Loop 1 domain is not essential for bI1 splicing. Similarly, 




 strains to regain 
near-wild-type splicing at 95% and 80%, respectively (lanes 13 and 20), also suggesting 
that this domain is not essential for splicing. Complementation with the double-deletion 
mutant complement (L1/CTD-myc) rescues splicing only to 63%, accompanied by a 
sharp drop in COB RNA (lane 14).  Unexpectedly, the 
-
 strain is not as severely affected 
as is the 
+
 strain. In this case, complementation with L1/CTD-myc (though not as 
restorative as complementation with either L1 or CTD individually) restores splicing 
to 76%. Complementation with L1/CTD-myc still maintains levels of splicing greater 
than those of the null mutants (compare lanes 14 to 9 and 21 to 16).  
To assess equal loading, both the aI5 and bI1 blots were stripped and 
rehybridized with a 
32
P-labeled DNA oligonucleotide complementary to the intronless 
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COX2 mRNA (Figs. 5.7B and 5.8B). There is no observable COX2 message for the 
petites, as expected (lanes 15-21).  
5.2.4.3 Loss of Oxa1 up-regulates 21S rRNA 
Because of Oxa1’s interaction with the large mitoribosomal subunit, and to test 
for the presence of a second portion of the mt genome, the membranes were re-stripped 
and rehybridized for the mitochondrially-encoded 21S rRNA of the large subunit using a 
32
P-labeled DNA oligonucleotide (Figs. 5.7C and 5.8C). Unexpectedly, the wild-type 
+ 
strains have very low levels of 21S rRNA (lanes 1 and 8), while the oxa1 strains which 
were complemented with the empty vectors have strong signals (lanes 2 and 9). It seems 
plausible that in the wild-type strains, the 21S rRNA is bound within the mitoribosomes, 
so that little free RNA remains. Without Oxa1, however, 21S rRNA appears to be 
upregulated, perhaps to signal the biogenesis of more mitoribosomes. However, a similar 
effect is not observed for the 15S rRNA of the small subunit (Figs. 5.7D and 5.8D) in 
which the levels are approximately equal. 
Neither the 21S nor the 15S rRNAs are seen in the aI5 and bI1 
-
 strains, 
confirming their lack of assembled mitoribosomes (lanes 15-21). 
5.2.5 Type of media appears to affect splicing 
One of the other unexpected results of these experiments was the large amount of 
mRNA visible in the
- 
wild-type and oxa1 mutant strains (Fig. 5.7A and Fig. 5.8A, 
lanes 15 and 16). This is in contrast to the more severe splicing defects observed 
previously when grown in similar conditions, but with YPR media (Fig. 5.4A and B, 
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lanes 6; and Fig. 5.5A and B, lanes 5 and 6). Since the complementing mutants in these 
experiments were expressed in plasmids that required minimal media lacking uracil for 
selection, it seemed possible that the strains required more time to exhibit a splicing 
defect. To test this idea, strains used in Fig. 5.7A, lanes 15 and 16, (oxa1/aI5+ and -) 
were cultured in HC/Ura
-
 media with 2% raffinose over a course of 60 h. Samples of each 
were taken at 20, 24, 36, and 60 h and total RNA prepared as before. Insufficient RNA 
was available in the time-zero sample, so cells were obtained instead by scraping them 
from the starting HC/Ura
-
/raffinose agar plates. Northern hybridization analyses in Fig. 
5.9 show that even at 60 h, there is no complete splice defect when grown in this media 
compared to the splicing defect usually observed at 20 h when grown in YPR. 
5.2.6 General RNA chaperone, Mss116 is not dependent on Oxa1 
Thus, for both aI5 and bI1, complementation with the double-deletion mutant 
L1/CTD-myc caused a defect that was less severe than the null, but more severe than 
either single deletion. This implies that the remainder of Oxa1, that is, the core domain 
that functions as an insertase, may be involved in the splicing of these introns. It is 
unclear whether this effect is direct, or whether an as-yet-unidentified protein dependent 
upon Oxa1 may be responsible. Previous studies have shown that besides mitochondrial-
encoded proteins, some nuclear-encoded mitochondrial inner-membrane proteins are also 
dependent upon Oxa1 for proper membrane insertion (He and Fox 1997; Hell et al. 1997; 
Szyrach et al. 2003; Bohnert et al. 2010).  
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It appeared unlikely that Mss116 would be this unidentified protein since wild-
type splicing was observed in Fig. 5.5 in several of the oxa1 mutants that harbor other 
introns. Nonetheless, it seemed prudent to confirm this hypothesis by Western blotting. 
Wild-type 161-U7aI5 and three of its derivatives were tested for the presence of 
Mss116: oxa1, mrp1, and img1. Cultures of each were grown with shaking at 30° C 
to O.D.600 = 1.0 in 50 ml of either YPD or YPR. Whole-cell protein was isolated as 
described in Methods. Proteins were separated on 4-12% bis-tris mini gels (Life 
Technologies) with one gel being stained using Coomassie Brilliant Blue and the second 
used for overnight transfer to PVDF membrane for Western blotting (see Methods).  
In Figure 5.10, the oxa1 strain (lanes 3-4) is flanked by the wild-type (WT) in 
lanes 1-2, and mitoribosomal protein deletion strains mrp1 and img1  in lanes 5-8. 
Wild type shows all the Mss116 protein in its fully-mature state at 72 kDa. Deletion of 
the two mitochondrial ribosomal proteins Mrp1 and Img1 (lanes 5-8) show significant 
amounts of precursor Mss116 (76 kDa), though the mature protein is in quantities 
comparable to wild type. The oxa1 strain in lanes 3 and 4, shows only minimal amounts 
of precursor evident in addition to the mature Mss116 in quantities comparable to wild-
type. This indicates that deletion of OXA1 has little impact on mitochondrial importation 
of Mss116. 
5.3 DISCUSSION 
 The yeast insertase Oxa1 appeared to be critical for aI5 and bI1 splicing during 
the general screen in Chapter 3 and when tested in a petite (
-
) strain in Chapter 4. It is 
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described in the SGD as required for genome maintenance, though this statement is only 
inferred from genetic and mutant interactions (website accessed March 2015).  Here, I 





 oxa1 strain did rapidly become 0, further suggesting the protein may play a role in 
splicing. 
 Deletion of OXA1 in 
-
 strains elicited a severe splice defect in both aI5 and bI1 
introns when grown in YPR media. This splicing defect was specific for these two introns 
when compared to group I and group II introns aI1, aI2, aI4, bI4 and bI5.  
 To test which specific domains within OXA1 might be most involved in splicing, 
the effect of the loss of the two domains that extend into the matrix (Loop 1 and the C-
terminal domain) were tested. This involved complementation with mutants expressed on 
a plasmid that required minimal media for selection. The two Oxa1 domains contributed 
somewhat to the splicing efficiency, but the main contributor was the core insertase 
domain. This result suggests that there are other yet-unidentified splicing factors that rely 
on Oxa1’s insertase function, very likely membrane-bound proteins. Testing confirmed 
that the general RNA chaperone Mss116 is not reliant on Oxa1.  
When grown in minimal HC media, there was no severe splicing defect in the 
oxa1 aI5 - strain as when it was cultured in YPR, suggesting that Oxa1 is not critical 
for splicing when the growth rate is slow. One possible explanation for this observation 
may be that during slow growth, the introns may fold into their catalytic conformations 
independently of Oxa1, with other proteins known to also have less efficient insertase                                     
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functions, like Oxa2, assisting in positioning splicing factors into the inner membrane. In 
rapidly-growing cells, Oxa1 may indirectly assist in splicing by positioning splicing 











 Figure 5.1:  The yeast mitochondrial insertase, Oxa1 
 
 
(A) A model of a monomer of Oxa1 depicting its N-out, C-in orientation with respect to the mt 
inner membrane (adapted from Bonnefoy, et al., 2009). Five transmembrane domains comprise 
the core of the protein. Two domains, Loop 1 and the C-terminal domain (CTD) extend into the 
mitochondrial matrix and are being tested here for their contribution to splicing. (B)  Both Loop 1 
and the CTD interact with the mt ribosome near its tunnel exit. The CTD forms an amphipathic 
-helix with one positively charged and one hydrophobic surface that has been found to help bind 









Figure 5.2:  Processing pathway of the 21s rRNA of the large subunit (LSU) 
 
Processing and splicing of the 21S rRNA/tRNAT/tRNAC/tRNAH primary transcript. The 
transcriptional start site of the 21S rRNA gene is indicated by a bent arrow,the 21S rRNA non-
coding exons are in black, and the  intron is in gray. A 6.7-kb primary transcript (Pri) is cleaved 
downstream of 21S rRNA at the dodecamer sequence (lollipop) to generate a 4.4-kb 21S rRNA 













Figure 5.3:  Northern hybridization analyses comparing the effect on splicing in 3 different + 
strains: aI5, bI1 and LSU ().  
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Figure 5.3 (continued):  Northern hybridization analyses comparing the effect on splicing in 3 
different + strains: aI5, bI1 and LSU ().  
  
(A) Northern hybridizations of wild-type strain 161-U7/aI5 + and derivatives of that strain in 
which the indicated gene has been deleted. Strains were grown in YPR to an O.D.600 of about 0.8. 
Total cellular RNA was isolated, run in a 1.5% RNA-grade agarose gel, blotted onto a nylon 
membrane, and hybridized with a 32P-labeled DNA oligonucleotide complementary to the COX1 
terminal exon. The primary, precursor, and mature mRNA transcripts are denoted as Pri, Pre, and 
mRNA, respectively. (B) Northern hybridizations of wild-type strain 161-U7/bI1 + and 
derivatives of that strain in which the indicated gene has been deleted. Strains were grown, RNA 
isolated and run as in (A). Blots were hybridized with a 32P-labeled DNA oligonucleotide 
complementary to the COB terminal exon. Primary (Pri), precursors 1 and 2 (Pre-1 and Pre-2), 
and mature mRNA (mRNA) are indicated to the right of the panel. (C) Northern hybridizations of 
wild-type strain 161-U7/+ and derivatives of that strain in which the indicated gene has been 
deleted. Strains were grown, RNA isolated and run as in (A). Blots were hybridized with a 32P-
labeled DNA oligonucleotide complementary to the LSU terminal exon. Precursor and mature 



















Figure 5.4: Northern hybridization analyses. Deletion of OXA1 exacerbates splicing defects in 






Figure 5.4(continued): Northern hybridization analyses. Deletion of OXA1 exacerbates splicing 
defects in single-intron petite strains grown in YPR. 
 
Northern hybridizations of wild-type strains 161-U7/I0 +, 161-U7/aI5 + or 161-U7/aI5 - and 
derivatives of those strains in which OXA1 has been deleted. Strains were grown, RNA isolated, 
run, blotted and hybridized as in Fig. 5.2A. Primary (Pri), precursor (Pre), and mature mRNA 
(mRNA) are indicated to the right of the panel. (B) Northern hybridizations of wild-type strains 
161-U7/I0 + or 161-U7/bI1 + and 161-U7/bI1 - and derivatives of those strains in which OXA1 
has been deleted. Strains were grown, RNA isolated, run, blotted as in Fig. 5.2A. Blots were 
hybridized with a 32P-labeled DNA oligonucleotide complementary to the COB terminal exon. 
Primary (Pri), precursors 1 and 2 (Pre-1 and Pre-2), and mature mRNA (mRNA) are indicated to 













































































































Figure 5.5 (continued): Northern hybridization analyses. Group II introns aI5 and bI1 are more 
dependent on Oxa1 for splicing than are other introns tested. 
 
Northern hybridizations of wild-type strains 161-U7/I0 +, 161-U7/aI5 +, 161-U7/aI5 - 161-
U7/aI1 +, 161-U7/aI2 + and 161-U7/aI4 + and derivatives of those strains in which OXA1 has 
been deleted. Strains were grown, RNA isolated, run, blotted and hybridized as in Fig. 5.2A. 
Precursor (Pre) and mature mRNA (mRNA) are indicated to the right of the panel. To better 
visualize the fainter bands, the image is duplicated with greater contrast to the right. To assess 
loading, the blot was stripped and rehybridized with a 32P-labeled DNA oligonucleotide probe 
complementary to COX2. (B) Northern hybridizations of wild-type strains 161-U7/I0 +, 161-
U7/bI1 +, 161-U7/bI1 -, 161-U7/bI4/bI5 +, and derivatives of those strains in which OXA1 has 
been deleted. Strains were grown, RNA isolated, run, blotted as in Fig. 5.2A. Blots were 
hybridized with a 32P-labeled DNA oligonucleotide complementary to the COB terminal exon. 
Precursor 2 (Pre-2), and mature mRNA (mRNA) are indicated to the right of the panel. To better 
visualize the fainter bands, the image is duplicated with greater contrast to the right.  To assess 
loading, the blot was stripped and rehybridized with a 32P-labeled DNA oligonucleotide probe 


















Figure 5.6: Wild-type yeast Oxa1 and Oxa1 mutant constructs. 
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Figure 5.6 (continued): Wild-type yeast Oxa1 and Oxa1 mutant constructs. (After Lemaire, et al. 
2004).  
 
(A) Locations of amino acid residues (designated by asterisks) within the Oxa1architecture used 
in constructing mutants in (B) below. (B) Complementation mutants engineered to test the effect 
on splicing of the deletion of Loop 1 and CTD individually and together. (i) Wild-type Oxa1with 
domains key to this study labeled below the diagram and their boundary residues numbered 
above. (ii) Wild-type Oxa1 with a C-terminal myc tag added after residue K402 (iii) 
Oxa1Loop1myc was constructed by deleting the portion of Loop 1 from A155 to K197. A C-
terminal myc tag follows K402. (iv) Oxa1CTDmyc was constructed by deleting the C-terminal 
domain from W320 to K402. The myc tag follows residue 319. (v) Oxa1Loop1CTDmyc was 
constructed by deleting both Loop 1 and CTD as in (iii) and (iv). Each was cloned into a 
centromeric plasmid pRS416 and transformed into a strain in which the chromosomal copy of 




















Figure 5.7: Northern hybridization analyses. Complementation of aI5 splicing defects by Oxa1 
mutants expressed on centromeric plasmid pRS416.  
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Figure 5.7(continued): Northern hybridization analyses. Complementation of aI5 splicing defects 
by Oxa1 mutants expressed on centromeric plasmid pRS416.  
 
Northern hybridizations of wild-type strains 161-U7/I0 +, 161-U7/aI5 + or 161-U7/aI5 - and 
derivatives of those strains in which OXA1 has been deleted and complemented by Oxa1 variants 
expressed from plasmid pRS416. Constructs are as described in Fig. 5.5B. Vector is empty 
pRS416; L1 is Loop 1. Starter cultures of O.D.600 = 0.2 were grown in Hartwell’s Complete liquid 
media with 2% raffinose but lacking uracil at 30°C for 20 hours. RNA was isolated, run, blotted 
and hybridized as in Fig. 5.2A. Precursor (Pre) and mature mRNA (mRNA) are indicated to the 
right of the panel.  Following scanning with a phosphorimager, the percentage of spliced mRNA 
was determined using GelQuant software (BioChem Lab Solutions). Ratios of mRNA to mRNA 
+ precursor RNA (upper value) or to mRNA + precursor + primary transcript (lower value) are 
indicated under each lane in the blot. To assess loading, the blot was stripped and rehybridized 
with a 32P-labeled DNA oligonucleotide probe complementary to COX2. To test for levels of 21S 
rRNA, the blot was stripped once again and rehybridized with a 32P-labeled DNA oligonucleotide 














Figure 5.8: Northern hybridization analyses. Complementation of bI1 splicing defects by Oxa1 
mutants expressed on centromeric plasmid pRS416.  
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Figure 5.8 (continued): Northern hybridization analyses. Complementation of bI1 splicing defects 
by Oxa1 mutants expressed on centromeric plasmid pRS416.  
 
Northern hybridizations of wild-type strains 161-U7/I0 +, 161-U7/bI1 + or 161-U7/bI1 - and 
derivatives of those strains in which OXA1 has been deleted and complemented by Oxa1 variants 
expressed from plasmid pRS416. Constructs are as described in Fig. 5.5B. Vector is empty 
pRS416; L1 is Loop 1. Cells were cultured as in Fig. 5.6. RNA was isolated, run, blotted and 
hybridized as in Fig. 5.2A. Primary, precursor 1, precursor 2, mature mRNA and intron bI1 are 
denoted as Pri, Pre-1, Pre-2, mRNA, and bI1 to the right of the panel. Unidentified RNAs are 
indicated by asterisks. Following scanning with a phosphorimager, the percentage of spliced 
mRNA was determined using GelQuant software (BioChem Lab Solutions). Ratios of mRNA to 
mRNA + precursor RNA (upper value) or to mRNA + precursor + primary transcript (lower 
value) are indicated under each lane in the blot. To assess loading, the blot was stripped and 
rehybridized with a 32P-labeled DNA oligonucleotide probe complementary to COX2. To test for 
levels of 21S rRNA, the blot was stripped once again and rehybridized with a 32P-labeled DNA 

















Figure 5.9: Northern hybridization analyses. Time course of 161-U7/aI5 + and 161-U7/aI5 - 
derivatives in which OXA1 has been deleted and complemented with empty vector 
pRS416. 
 
Strains are those in Fig. 5.6, lanes 9 and 16, grown in Hartwell’s Complete minimal media, 
lacking uracil with 2% raffinose for the number of hours indicated at the top of each lane on the 
blot with the exception of time zero. To obtain sufficient RNA for Northern hybridization, the 
time zero sample was scraped from HC/Ura-/raffinose agarose plates. RNA was isolated, run, 












Figure 5.10: SDS-PAGE and Western blot comparing the effect on Mss116 with the deletion of 
three different proteins  
 
The strains analyzed were wild-type 161-U7/aI5 + and derivatives of that strain in which genes 
for the insertase OXA1, or mitoribosomal proteins MRP1 and IMG1 were deleted. Strains were 
grown at 30° C in 50 ml of either Yeast Peptone Dextrose (YPD) or Yeast Peptone Raffinose 
(YPR) as indicated above each lane. TCA-precipitated proteins were separated on a 0.1% SDS/4-
12% polyacrylamide gel and  (A) stained with Coomassie Brilliant Blue or (B) transferred to a 
Sequi-Blot™ PVDF membrane (Bio-Rad) and probed with an antibody an Mss116 antibody. 
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Chapter 6: Mne1 is a component of the mitochondrial splicing 
apparatus responsible for processing group I intron aI5  
 
6.1 BACKGROUND 
Nuclear-encoded protein Mne1 had previously been reported to be a 
mitochondrial protein in a large-scale localization study (Huh et al. 2003). It was first 
identified as a possible splicing factor for the group I intron aI5 in strain BY4741 during 
the Phase I portion of the screenNyberg 2006 In 2008, deletion of MNE1 was found 
to cause cells to exhibit a drug sensitivity similar to that of cox mutants and to have a 
specific impairment in cytochrome C oxidase assembly (Hillenmeyer et al. 2008).  
Here, I further investigated the splicing abilities of this protein within a derivative 
of strain W303 received from the lab of Roland Lill (Kispal et al. 1999) in collaboration 
with the lab of Dennis Winge at the University of Utah Health Sciences Center (Watts et 
al. 2011). Strain W303 is a derivative of strain S288c with genotype MATa/MATα /leu2-
3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11. 
6.2 RESULTS  
Mne1 Functions in aI5 Intron Splicing 
Northern analyses were carried out with total RNA isolated from W303 wild-type 
and mne1Δ strains harboring a COX1 with seven confirmed mtDNA introns (Fig. 6.1). 
Strains were grown at 30 °C in 50 ml of YP with 2% raffinose to an O.D.600 = 0.8-1.0. 
Total RNA was run on a 1.2% agarose gel with RNA-grade 1× TAE buffer (40 mM Tris  
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acetate, 1 mM EDTA), pH 8, at RT and blotted overnight onto a nylon membrane. The 
32
P-labeled DNA oligonucleotides complementary to the COX1 terminal exon or to each 
intron used for the analyses are listed in Table 2.1.  
Hybridization with the COX1 exon 6 probe shows a 2.2-kb mature COX1 mRNA 
in the wild-type strain (Fig. 6.1B, lane 1). This band is greatly diminished in mne1Δ cells 
where, instead, two larger bands of about 3.8 and 6.3 kb are apparent (lane 2). Intron-
specific probes for the three COX1 group II introns show that splicing of the aI1, aI2, and 
aI5γ introns is not affected in the absence of Mne1 (lanes 4, 6, and 16). The spliced aI3, 
aI4, and aI5β introns are not visible in the Northern blots and appear to be unstable in 
mitochondria (1.4 kb signals seen in lanes 7-10, 13, and 14 are most likely cross-
hybridization to the 15S rRNA). Strong hybridization signals running just below the large 
ribosomal subunit band with the aI3 and aI4 intron probes are detected in the wild-type 
strain and suggest that these bands represent the splicing intermediates containing the 
single introns and exons. The same band is also visible with the exon probe in the wild-
type strain in lane 1. These aI3 and aI4 splicing intermediates are greatly reduced in 
the mne1Δ strain (lanes 8and 10). However, with both probes we see a signal for a 6.3-kb 
band also seen with the COX1 exon probe. This suggests that this band contains more 
than one unspliced intron. The aI5α probe shows little difference between the wild-type 
and mne1Δ cells with the exception of a slightly more intense band running below the 
small ribosomal subunit rRNA, which is possibly the excised aI5α intron (lane 12). The 
greatest difference in hybridization signals is seen with the aI5β probe (lane 14). The  
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strongest signal (at 3.8 kb) in the mne1Δ strain co-migrates with the large ribosomal 
subunit band and most likely represents a COX1 RNA that has all introns removed except 
aI5β. A second signal is detected for an RNA of about 6.3 kb, which co-migrates with the 
signals seen for the aI3 and aI4 intron probes. This suggests that the 6.3-kb band 
represents multiple RNA species that all contain the aI5β intron and also aI3 and/or aI4. 
6.3 DISCUSSION 
Mne1 is shown to be an important accessory factor in the splicing of COX1 
precursor RNA through the removal of the aI5intron. Splicing of the aI5 intron is 
known to require at least 5 other proteins including Mrs1, Mss18, Mss116, Pet54, and 
Suv3 (Seraphin et al. 1988; Valencik et al. 1989; Bousquet et al. 1990; Huang et al. 2005; 
Turk and Caprara 2010). In S. cerevisiae strain S288c, the aI5 intron is not in frame 
with the upstream exon, so that its intron-encoded maturase appears to require alternative 
splicing to place it in-frame (Turk et al. 2013). This alternative splicing requirement may 
offer one explanation for the need of multiple splicing factors for this intron in 














Fig. 6.1(continued): Northern hybridization analysis of COX1 introns in WT and mne1 cells in 
strain W303.  
 
(A) Schematic showing the molecular organization of the COX1 gene from the wild-type strain 
(top), with the size of each intron (in nt) given below its name. Group I introns are indicated by a 
blue line and group II introns by a red line. Splice variants containing either single or multiple 
introns aI3, aI4 and /or aI5 are shown below. The size (kb) of each variant is indicated to the 
right. (B) Northern hybridization analysis. Strains of wild-type W303 or derivatives in which 
MNE1 had been deleted were grown in YPR to an O.D.600 = 0.8-1.0. Total cellular RNA was 
isolated, run in a 1.2% RNA-grade agarose gel, blotted onto a nylon membrane, and hybridized 
with a 32P-labeled DNA oligonucleotide complementary to the COX1 terminal exon, or COX1 
introns aI1, aI2, aI3, aI4, aI5- and 21S rRNA exon 1 as detailed in Table 2.1. The numbers to 
the right of each Northern panel indicate the approximate size of the indicated transcripts in kb. 
The positions of the large and small ribosomal rRNAs are indicated as LSU and SSU, 









Chapter 7: General RNA Chaperone, Mss116 
7.1 BACKGROUND 
The S. cerevisiae DEAD-box protein Mss116 (Fig. 7.1) is involved in many 
processes within the yeast mitochondrion, among which is intron splicing where Mss116 
promotes the efficient splicing of all thirteen mt group I and group II introns (Huang et al. 
2005). Previous studies from the Lambowitz lab indicated that Mss116 functions as a 
general RNA chaperone that uses its ATP-dependent RNA-unwinding activity to disrupt 
stable RNA secondary and tertiary structures that are kinetic traps during RNA folding 
(Huang et al. 2005; Halls et al. 2007 ; Del Campo et al. 2009; Mallam et al. 2012).  Other 
findings from both the Lambowitz and Pyle laboratories indicated that Mss116 could also 
promote some splicing steps in an ATP-independent manner  (Solem et al. 2006; Halls et 
al. 2007 ) with the Pyle lab suggesting that such ATP-independent functions play a major 
role in the splicing of the group II intron aI5 (Solem et al. 2006). In this section, I used 
mutational analysis to investigate ATP-dependent and  -independent roles of Mss116 in 
group II intron splicing in vivo, as well as the impact on splicing of mutations in 
conserved helicase motifs involved in RNA binding and the coupling of ATP hydrolysis 
to RNA unwinding (Fig. 7.1B). I also investigated the minimal amount of Mss116 
required to promote group II intron splicing in vivo and used TAP-tagging to look for 
proteins that interact with Mss116 in vivo. My findings provide insight into the 
mechanism of action of Mss116 in promoting group II intron splicing in vivo.  
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7.2 RESULTS 
7.2.1 Temperature does not compensate for loss of Mss116 in aI5 splicing in vivo 
To test whether Mss116 was required for aI5 splicing in S. cerevisiae in vivo at 
temperatures outside of its optimal growth temperature of 30° C, I cultured strains at 25° 
C, 30° C and 37° C. The strains tested were 161-U7/aI5, 161-U7/I
0
, and derivatives of 
those strains in which MSS116 had been deleted. Each strain was grown in 50 ml of YPR 
at the indicated temperatures to O.D.600 = 0.8-1.0. Total RNA was isolated and run on a 
1.5% agarose gel as described in Methods. The Northern hybridization analysis in Fig. 
7.2 compares the abilities of wild-type and mss116 strains to promote the splicing of 
aI5 at 25°C, 30°C and 37°C (lanes 1-6). In the wild-type strain, splicing at all three 
temperatures is efficient with very little unspliced precursor remaining (lanes 1-3), 
although at 37°, there is a slight reduction in the amount of mRNA as compared to the 
other  temperatures.  Interestingly, there is no comparable reduction of mRNA at 37° in 
the intronless strain, I
0
 (lane 9). In contrast to wild type, the transcripts in all the 
mss116/aI5 strains remain as unspliced precursor at each of the three temperatures. 
This indicates that Mss116 is required at these temperatures as well as at 30° C (lanes 4-
6). Additionally, there is also a notable reduction in RNA at 37°. In the I
0
 control strains, 
the reduction in RNA at the elevated temperature is seen only in the mss116 strain in 
lane 12. Together, these data show that high temperatures do not compensate for the loss 
of Mss116’s splicing activity for aI5 in vivo.  
7.2.2 The splicing activity of Mss116 mutants correlates with ATP-dependent RNA 
unwinding activity  
For most of its functions, Mss116, like other DEAD-box proteins, uses ATP-
dependent RNA unwinding to promote RNA structural transitions. However, the Pyle 
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lab, using mutants K158R, K158A (motif I) and SAT/AAA (motif III) along with the mt 
group II intron aI5 as a substrate for their in vitro experiments, reported that ATP-
dependent helicase activity is not required for Mss116-stimulated splicing of aI5 and 
that Mss116 facilitates the folding of this intron primarily by stabilizing a folding 
intermediate (Solem et al. 2006; Karunatilaka et al. 2010). To address the apparent 
inconsistencies in the understanding of this mechanism, we conducted more in-depth 
studies (Potratz et al. 2011). 
Motif I, also known as the Walker A motif, forms a phosphate-binding loop (P-
loop) found in many nucleotide-binding proteins (Walker et al. 1982; Sarastea et al. 
1990).  The signature pattern of the motif is the tripeptide glycine, lysine and threonine 
(GKT) of which the lysine (K) residue is crucial for nucleotide-binding, forming a pocket 
that binds the - and -phosphates of the NTP (Hanson and Whiteheart 2005). Mutations 
in this region of other DEAD-box proteins reduce or eliminate ATPase activity (Pause, 
EMBO, 1992).  In Mss116, this critical lysine is K158 (Fig. 7.1B).  
Motif III, whose conserved amino acid sequence is S-A-T (Fig. 7.1A and B), lies 
at the interface of D1 and D2 in the protein’s closed conformation and is involved with 
communication between D1 and D2, possibly bridging ATP interactions to RNA binding 
(Story et al. 2001; Banroques et al. 2010).  
To investigate the function of motifs I and III in promoting the splicing of group 
II intron aI5 in vivo, I engineered the centromere (CEN) plasmid pRS416 to express 
wild-type Mss116 and mutants K158R, K158A, or SAT/AAA. These plasmids were then  
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transformed into a 161-U7 mss116Δ yeast strain harboring only mt intron aI5 and grown 
at 30 in Hartwell Complete media minus uracil (HC/Ura
-
) with 2% raffinose to O.D.600 = 
1.5 (see Methods).  Using this non-repressing fermentable carbon source allowed 
examination of splicing even in mutants with strongly defective Mss116.  
The Northern hybridization analysis in Fig. 7.3A compares the abilities of wild-
type and Mss116 mutant strains to promote splicing of intron aI5. The blot was 
hybridized with a 
32
P-labeled DNA oligonucleotide probe complementary to the COX1 
terminal exon.  As expected, the wild-type strain with a functional chromosomal copy of 
MSS116, spliced aI5γ efficiently, yielding a predominant band corresponding to mature 
COX1 mRNA (lane 1), while the predominant band that accumulated in the mss116Δ 
strain was unspliced precursor RNA (lane 2). Complementation of the splicing defect by 
expression of wild-type Mss116 from the CEN plasmid effectively restored aI5γ splicing 
to near wild-type levels (lane 3). In contrast, the K158A and K158R mutants were unable 
to complement splicing of aI5γ substantially above the low residual level in the mss116Δ 
strain (null phenotype; lanes 4 and 5). Complementation with the K158A mutant allowed 
for a very small increase in spliced mRNA that paralleled the small amount of residual 
ATPase activity described by the Pyle group (Solem et al. 2006). The SAT/AAA mutant 
gave an intermediate phenotype, with approximately equal amounts of spliced mature 
mRNA and unspliced precursor (lane 6). The mutant proteins were expressed at or near 
the level of wild-type Mss116 as verified by Western blot (Fig. 7. 2B). These results are 
in good agreement with previous experiments using strains with multiple COX1 and COB  
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introns showing that K158A and other motif I mutants gave a null phenotype, while the 
SAT/AAA mutant gave an intermediate phenotype for the splicing of all mitochondrial 
group I and group II introns examined (Huang et al. 2005; Bifano et al. 2010). 
 
 
Taken together, these experiments showed that Mss116 mutants K158A, K158R 
and SAT/AAA promote splicing in vivo to levels that correlate with their ATP-dependent 
RNA-unwinding activities. The K158 mutants had essentially no RNA-unwinding 
activity, while the motif III mutant retained partial RNA unwinding activity (Potratz et al. 
2011). These results indicated that, although DEAD-box proteins play multiple roles in 
RNA folding, the physiological function of Mss116 in aI5γ splicing includes a 
requirement for ATP-dependent local unfolding, allowing a nonfunctional RNA structure 
to convert into functional, catalytic RNA.  
7.2.3 Effect of mutations in motif III on mitochondrial intron splicing in vivo 
Our understanding of motif III was further refined by Northern and Western 
analyses of in vivo splicing activity of functional variants identified by high-throughput 
genetic selection and unigenic evolution method (Mohr et al. 2011). In this set of 





 harboring the twelve group I and group II introns from the 
COX1 and COB genes. Those variants able to grow on glycerol, a non-fermentable 
carbon source, were identified as having functional motif III mutants (Fig. 7.1B). These 
variants were then grown at 30 in HC/Ura
-
 media with 2% raffinose to an O.D.600 ≈ 1.5. 
Aliquots of the culture were reserved for whole cell TCA protein preparation for 
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immunoblots and the remainder was used for total cellular RNA isolation (see Methods). 
Northern blots of whole cell RNAs from the different strains were hybridized with 
32
P-
labeled DNA oligonucleotides complementary to either the COX1 or COB terminal exon. 
The membranes were then stripped and rehybridized with a probe complementary to the 
COX2 RNA to assess equal loading.  
The Northern blots in Fig. 7.4A show that the SAT mutants that support growth 
on glycerol also promote splicing of COX1 or COB introns, albeit to different degrees. In 
lane 1, the wild-type strain exhibits a splicing phenotype in which the predominant band 
is the mature mRNA, in both the COX1 and COB strains. In contrast to the splicing 
phenotype of COX1 in the single-intron aI5 strain seen in Northern hybridizations in 
previous chapters, multiple bands are evident in this multi-intron strain. In lane 2, the 
mss116strain exhibits a severe splicing defect of both COX1 and COB, with no evident 
spliced mature mRNA. Complementation with wild-type MSS116 in lanes 3, rescues the 
defects in splicing both introns, displaying splicing patterns similar to those observed in 
lane 1. The AAA mutant in lane 4, produced no observable mature mRNAs, as expected 
from its severely impaired glycerol-growth phenotype. A comparison of the splicing 
phenotypes of the SAT/AAA mutant in this multi-intron strain with that in the single 
intron strain in Fig. 7.3A, lane 6, clearly shows the more extreme splicing defect the 
mutation has on a strain with multiple introns. 
Unexpectedly, several of the novel motif III variants demonstrated near-wild-type 
efficiency in promoting splicing in both COX1 and COB intron (FAT, GGT, LCT, and  
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SST; lanes 6, 8, 11 and 12). DAC and GIG in lanes 5 and 9 displayed moderate splicing 
efficiency, with GST and GAV displaying progressively weaker splicing efficiencies 
(lanes 10 and 7, respectively). Interestingly, though the latter two variants displayed weak 
efficiencies in splicing COX1 introns, they both displayed moderate efficiencies in 
splicing introns within the COB gene. Western blots showed that all of the variant 
proteins were expressed from the CEN plasmid at levels comparable to that of the wild-
type protein (Fig.7.4B). 
The variability allowable in Mss116 motif III is greater than that observed in 
previous studies of other DEAD-box proteins, including Ded1 where similar codon 
randomization was done separately for the first and third positions (Banroques et al. 
2010). The fully or moderately functional Mss116 variants break the consensus sequence 
pattern of alcohol-small amino acid-alcohol at different sites along each of the three 
positions, with the moderately functional variant GIG violating this consensus at all three 
positions. Although the four strongest variants all share the final threonine, this amino 
acid at the third position is not itself sufficient for efficient splicing as seen by the weak 
splicing of the GST variant, nor is it essential as observed in the moderate splicing of the 
DAC variant. Interestingly, the almost fully functional FAT variant places a large 
phenylalanine side chain at a position where it would not easily fit in the crystal structure 
of Mss116 in its closed state.  
Our observations of permissible amino acid substitutions indicate that: (1) the 
putative H-bonds between the hydroxyls of S305 and T307 and residues in motifs II and 
VI in the crystal structure are not essential for splicing activity; (2) A306 and T307 can 
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be substituted with residues having similarly-sized nonpolar or uncharged polar side 
chains; and (3) S305 can tolerate substitutions with larger side chains (F, D, L, H, M, Q). 
The larger degree of variation observed for the Mss116 motif III mutants as compared to 
that observed in other work (Banroques et al. 2010) may be a result of the simultaneous 
randomization of the codons.  Alternatively, Mss116 may be less dependent upon motif 
III interactions than are other DEAD-box proteins due to its higher RNA-binding affinity 
(Rudolph et al. 2006; Mohr et al. 2008).  Nonetheless, the strong splicing defect observed 
in the AAA mutant, particularly in the multi-intron strain, argues that motif III is required 
for Mss116 splicing activity.  
7.2.4.   Effect of mutations in the Mss116 RNA-binding tract on splicing of 
mitochondrial introns in vivo 
The crystal structure of Mss116 identified several amino acid residues along the 
helicase core and the CTE that contacted U10 RNA suggesting these residues may serve 
a potentially critical function (Del Campo and Lambowitz 2009). Although the helicase 
core contacted residues U3-U10, U9 and U10, it displayed only weak electron densities, 
indicating mobility in those positions. Contacts with U3-U8 were made mainly through 
residues in the conserved motifs and were part of an RNA-binding tract spanning core 
domains 1 and 2, similar to that seen in other DEAD-box protein structures (Del Campo 
and Lambowitz 2009). However, structures of Mss116 and other DEAD-box proteins 
provide only a static picture of these contacts with little insight into their relative 
contributions to RNA binding or intron splicing. Here, I investigated variants in the 
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RNA-binding motifs Ic, IV and the recently identified Post II (at D280, downstream of 
motif II) (Fig. 7.1B) (Mohr et al. 2011). 
In the unigenic evolution analysis, seven of the residues identified as contacting 
U10 RNA in the crystal structure were invariant (R190, T242, R245, D248, D280, R415, 
T433), while one (K384) showed only the conservative substitution to R. These residues 
were further assessed by randomizing the codons for each and then selecting for 
functional mutants by growth on glycerol. The analysis showed that a number of amino 
acid residues whose side chains make ionic or H-bond contacts with the RNA are 
conserved, while residues that make main-chain contacts could often be replaced by non-
synonymous residues that could make the same contacts. I tested the effect on splicing in 
six of these mutants: T242P, R245A, D248V, D280I, D280S, and K384G (Fig. 7.5A).  
The splicing abilities for five of these mutants (lanes 4, 6, 7, 8 and 9) were similar to that 
of the wild-type strain (lane 1) and correlated well with glycerol growth which was also 
similar to wild type (not shown). The one striking exception was R245A which grew only 
weakly on glycerol and exhibited a severe splicing defect (lane 5); strongly suggesting 
that the aliphatic, positively charged side chain of arginine plays a key role is mt intron 
splicing. 
The correlated Western blot in Fig. 7.5B reveals near wild-type levels of protein 
expression for all the variants with the exception of mutant D248V (lane 6) which 
exhibited about a 3-fold reduction in expression level as compared to wild-type, yet 
maintained near wild-type splicing ability.  
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These findings show that in all functional variants, an -helix is predicted to be 
maintained despite the amino acid sequence changes. 
7.2.5. Analysis of N-terminal and C-terminal truncations in vivo 
Flanking D1 and D2 are the upstream N-terminal extension (NTE) and the 
downstream -helical C-terminal extension (CTE) and the unstructured, basic C-tail (Fig. 
7.1A). In crystal studies of Mss116, the C-tail was not visible, an indication of the 
flexibility of that domain (Del Campo and Lambowitz 2009). However, by using a 
different method, small angle X-ray scattering (SAXS), visualization of flexible regions 
and thus the full-length Mss116 protein was possible. Data collected with SAXS by 
others in our lab had indicated that the NTE projects outward and away from the RNA-
binding D1 and that the C-tail may act as a tether to bind nonspecifically to different 
portions of large RNAs, perhaps enabling the helicase core to sample nearby regions for 
RNA unwinding (Mallam et al. 2011).   
The CTE is known to be necessary for Mss116 activity, since mutations within 
the region destabilize and inactivate the protein (Del Campo and Lambowitz 2009). The 
cause for this was made clear when our lab obtained X-ray crystal structures of truncated 
Mss116 (ΔC-tail), illustrating that the CTE interacts extensively with D2. A wedge helix 
within the CTE, together with another in motif Ic, caused RNA crimping that is thought 
to help induce strand separation (Del Campo and Lambowitz 2009).  
Previous studies in our lab of a CTE mutant (569) showed its splicing ability to 
be suboptimal (Mohr et al. 2008). Here, I re-examined this mutant and investigated the 
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impact on splicing with the deletion of the NTE, of the C-tail (Δ598), and of both 
domains simultaneously using the constructs diagrammed in Fig. 7.6. 









the CEN plasmid vector pRS416 alone or expressing either the wild-type Mss116 or the 
N- or C- terminal truncation mutants. Cultures were grown as described in section 7.2.2. 
The Northern hybridizations in Figure 7.7A show multiple bands indicative of the 





transformed with CEN plasmid vector pRS416 showing wild-type splicing. In lane 2 is 
the mss116/1+2+ strain also transformed with the empty vector where no mature mRNA 
was evident in either the COX1 or COB transcript. Complementation with wild-type 
Mss116 expressed from pRS416 rescued the splicing defects in both COX1 and COB, 
although a prominent band of incompletely spliced transcript just smaller than the 
primary transcript is evident for COB (lane 3). Complementation with either the NTE 
mutant (lane 4), the C-tail mutant (lane 5) or the mutant with deletion of both domains 
(lane 6) each rescued the splicing defects in both COX1 and COB, as predicted from prior 
in vitro studies showing that splicing is primarily dependent upon domains D1 and D2 
(Mallam et al. 2012). In lane 7, complementation with the 569 mutant rescued splicing, 
but only partially as the amounts of both COX1 and COB mature mRNAs were reduced 
as compared to wild type. To confirm uniform loading, each blot was stripped and 
rehybridized with a 
32
P-labeled DNA oligonucleotide complementary to COX2. In all 
cases, splicing was sufficient to support growth on glycerol (data not shown).  
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In the Western blot in Fig. 7.7B, the truncated mutant Mss116 proteins are the 
expected sizes. Interestingly, despite the similar levels of splicing ability, the levels of 
Mss116 varied widely. This is especially evident in comparing the single truncation 
mutant NTE (lane 4) or C-tail (lane 5) to the double mutant NTE + C-tail (lane 6). 
The loss of the NTE region reduces the protein signal to 25% wild type, whereas the C-
tail protein level is comparable to that of wild type (1.1-fold difference). The combination 
of both of these truncations, however, results in a severely reduced level of Mss116 (8% 
wild type; lane 6).  
To assess loading, the lower portion of the blot was probed with porin antibody, 
which confirmed that similar levels of total protein had been loaded.  The reduction in 
signals may be a result of increased protein degradation of the more severely mutated, 
and perhaps more unstable, proteins. Alternatively, the truncations my reflect loss of 
epitope recognition sites for the Mss116 polyclonal antibody. This possibility will be 
addressed below. 
7.2.6. Determining the efficiency of anti-Mss116 antibody recognition of wild-type 
and truncated mutant Mss116 proteins 
The apparent low levels of Mss116 seen in Figs. 7.5, lane 6 and 7.7, lane 6, 
suggested that very little Mss116 was required to support wild-type levels of splicing of 
the COX1 and COB introns. While loss of epitope recognition sites for the D248V 
mutant would not be expected, the same is not true for the double truncation mutant 
NTE + C-tail discussed in the previous section.  
In Fig. 7.8A, the Western blot shows samples of the full-length and truncated 
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proteins each at concentrations of 2, 3, 4, and 5 nM. Image acquisition was with a 
FluorChemHD2 camera (Cell Biosciences) and densitometry was performed with 
GelQuant software (BioChemLabSolutions.com) to obtain signal values for each band 
and their corresponding local backgrounds. Background values were subtracted from the 
corresponding band values to obtain the corrected signal value at each concentration. 
The ratio of the signal for the wild-type protein compared to that of the double-
truncation mutant was calculated at each concentration. A mean ratio of 2.2 was 
determined as the average efficiency of Mss116 antibody recognition of wild-type to 
mutant Mss116 epitopes. 
In the Western blot in Fig. 7.7B, the NTE + C-tail signal is 8% wild type, 
indicating an apparent 12.5-fold decrease in protein level compared to wild type. 
Correcting for loss of epitope recognition sites in the truncation mutant, I calculate that 
the actual decrease in protein level in the mutant is 12.5/2.2 = 5.7-fold, or approximately 
six-fold lower than wild type. Thus, Mss116 is capable of promoting splicing at levels at 
least 6 times lower than those normally found in wild-type cells. 
7.2.7 Modifying the in vivo expression of Mss116  
The results in the section above suggested that reduced levels of Mss116 are 
sufficient for near wild-type splicing. To investigate the minimum amount of wild-type 
Mss116 required for splicing, I attempted to reduce levels of Mss116 expression using 
two different methods. 
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7.2.7.1 Modulating Mss116 expression using a family of TEF promoters 
The first method involved cloning the MSS116 ORF behind a family of yeast 
Translation Elongation Factor (TEF) promoters which had been engineered to vary in 
strength for the expression of exogenous proteins in yeasts  and  were provided to us by 
the lab of Dr. Hal Alper (Alper et al. 2005). The plasmids were transformed into a 161-
U7-mss116/1+2+ strain and grown in YPR at 30° C to O.D.600 = 1.  Approximately 60 
µg of total TCA-precipated protein were separated by SDS-PAGE, transferred to a PVDF 
membrane and immunoblotted. The weakest promoter of the set, TEF2 (Fig. 7.9 lane 4), 
however, gave expression levels that were considerably higher than those of the native 
MSS116 promoter (lane 3), so a second method was devised. 
7.2.7.2 Modulating Mss116 expression by mutating the MSS116 promoter 
In this second method, portions of the MSS116 putative promoter were deleted 
within plasmid pHRH197 to regulate Mss116 expression levels. Previous work had 
shown that the region 710 bp upstream of the Mss116 ATG was able to drive expression 
in this plasmid (Huang et al. 2005).  This -710 sequence was analyzed by the online 
software Promoter Scan (http://www-bimas.cit.nih.gov/molbio/proscan/) to search for 
key promoter elements. A predicted TATA box (at -501, relative to the ATG) and 
transcriptional start site (TSS) (at -472,  relative to the ATG) were located in the region 
flanked by two ClaI restriction sites (Fig. 7.10A).  
To delete the region flanked by the two ClaI sites (-704 and -356), plasmid 
pHRH197 was digested with ClaI and religated by standard methods.  This mutant was 
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then used as the template for the remaining deletion constructs which were engineered by 
stitch PCR to add different promoter segments using primers listed in Table 2.1. 
Sequence-verified plasmids were cloned into digested pHRH197 with selection on 
LB/Amp
R








mss116Δ strain using the yeast transformation protocol described in Methods. Cultures 
were grown at 30 in  30 ml HC/ Ura
- 
media, with 2% raffinose as carbon source to 
O.D.600 =  1.0.  
  The Western blot in Fig. 7.11B shows the variation in Mss116 expression levels 
achieved by the MSS116 promoter mutations.  Lane 1 show the level of expression from 
the wild-type genomic copy of MSS116, while lane 2 shows lack of Mss116 expression in 
the mss116 transformed with an empty vector, pHRH197. Complementation of the  
mss116 strain with Mss116 expressed from the CEN plasmid with the full 710 bp 5´ 
UTR restores expression to wild-type levels (lane 3). Unexpectedly, deletion of the 
putative TATA box and TSS regions (-704/-356) in lane 4 did not cause a significant 
decrease in expression. Similarly, deletion of the -704/-314 region permitted wild-type 
expression (lane 5).  Significant reductions in expression levels were seen with the 
deletions of -307/ -61 and -704/ -61 regions in lanes 6 and 7, respectively. As expected, 
deletion of the entire promoter region, -704 to -1 entirely eliminated Mss116 expression 
(lane 8).  
Interestingly, but not unexpectedly, based on observations in preceding sections, 
the splicing abilities of Mss116 with reduced expression remained similar to wild type for 
both COX1 and COB transcripts (Fig. 7.11A, lanes 6 and 7). The mutant promoter in lane 
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6, -307/-61, provided the lowest level of expression that gave wild-type levels of 
aI5and bI1 splicing and will be used in estimating the minimum amount of Mss116 
required for splicing.  
7.2.8 Estimating the minimum amounts of Mss116 needed for mt intron splicing 
To estimate the amounts of Mss116 in the wild-type and the most reduced 
samples (-307/-61) (Fig. 7.11B, lanes 3 and 6), protein preparations from known 
volumes of each were analyzed by Western blot alongside a series of known 
concentrations of purified Mss116 (Fig. 7.12A). The concentration of the wild-type 
sample was diluted by 50% to prevent oversaturation of signal. The standards were 
diluted Mss116 that had been overexpressed in E. coli and purified to homogeneity. The 
stock concentration was determined by Bradford assay and confirmed by Qubit® 2.0 
Fluorometer (Life Technologies). Using GelQuant.NET software 
(BiochemLabSolutions.com) to measure signal intensities, concentrations of the wild-
type and mutant samples were calculated by simple linear regression derived from the 
standard curve (Fig. 7.12B).  Independent trials gave a mean value of 1.7 nM  ( = 0.1) 
for the promoter mutant sample, and 2.4 nM for the 50% wild-type sample. Cell 
number/ml was estimated using a hemocytometer and associated O.D.600 values. From 
this, estimates for the number of cells loaded for each sample were obtained. The protein 
concentrations obtained from the standard curve were then converted from nM to 
pmol/l, and then multiplied by the volume loaded in l. The resulting value in pmol was 
converted to moles and multiplied by Avogadro’s constant to obtain an estimate of the 
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number of Mss116 molecules loaded. Using this method and correcting for the 50% wild-
type sample used, the estimated value for wild-type Mss116 was calculated to be 
approximately 96,000 molecules per cell. 
The Saccharomyces Genome Database reports the estimated amounts of wild-type 
Mss116 to be 10,300 molecules/cell, a figure derived from work in the lab of Dr. 
Jonathan Weissman  (Ghaemmaghami et al. 2003). There are several possible 
explanations for the almost ten-fold disparity between my value and that of 
Ghaemmaghami, et al. with the most likely causes being the use of different strains, 
methods and carbon sources.   
In the previous study, the values were obtained by TAP-tagging the open reading 
frame and expressing it from its natural chromosomal location in yeast strain BY4741. 
Extracts containing TAP-fusion proteins were then analyzed by Western blot using an 
anti-CBP antibody. Here, I used an untagged molecule expressed from a CEN plasmid in 
strain 161-U7. The protein expression was measured using a polyclonal antibody specific 
for Mss116.  
The type of carbon source used is another variable that could explain the 
discrepancy in values. It is well documented that the use of glucose as a carbon source 
suppresses mitochondrial gene expression, sometimes referred to as the “Crabtree effect” 
(Crabtree 1928; Thomson et al. 2005). In contrast to the glucose used in rich media by 
Ghaemmaghami, et al., I used raffinose, a carbon source that does not cause this 
suppression. It is plausible that the differences in these values reflect the differences in 
Mss116 expression with and without glucose suppression. 
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  From my estimate of  96,000 molecules per cell for wild-type Mss116, we can 
now return to Figs. 7.5, 7.7, and 7.11 to extrapolate the reduced values of the mutants 
observed in which significant  reduction in Mss116 signal was accompanied by near-
wild-type splicing. The full length D248V mutant seen in Fig. 7.5, lane 6 had about a 3.5-
fold reduction in Mss116 signal compared to wild type, or about 27,000 molecules per 
cell.  In Fig. 7.7, lane 6, the Mss116 NTE+ C-tail truncation mutant showed a 6-fold 
reduction compared to wild-type which translates to approximately 16,000 molecules per 
cell, whereas in Fig. 7.11, lane 6, the 6.7-fold reduction translates to about 14, 000 
molecules per cell.   
In  S. cerevisiae, mtDNA  has been estimated  to be about 15% of the total DNA 
content of the cell, or about 25-50 copies of 75-kb mt genomes per haploid cell 
(Williamson 1976; Williamson 2002). Taking the estimated number of Mss116 
molecules per cell at 96,000 and the range of 25- 50 mt genomes per cell, this translates 
to between 1900 and 3800 molecules of Mss116 per mt genome. Using the SGD value of 
10,300 molecules per cell would be equivalent to about 200-400 molecules of Mss116 
per mt genome. Thus, with or without glucose suppression, Mss116 appears to be very 
abundant so that even at reduced levels, there are sufficient molecules present to produce 
a wild-type splicing phenotype. 
7.2.9. Other proteins associated with Mss116 
It is now well understood that Mss116 interacts with RNAs as substrates in 
fulfilling its many functions. What is not known, however, is with which other proteins 
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Mss116 may interact, especially during intron splicing. Toward that end, this part of the 
study was designed to identify those proteins that associate with Mss116. 
Tandem Affinity Purification (TAP-tag) has become a standard method of pulling 
down protein complexes associated with a TAP-tagged protein of interest (Rigaut et al. 





strain had shown that it is associated with multiple mitoribosomal proteins of 
both the large and small ribosomal subunits (Huang 2004); however, a strain lacking 
introns was not tested. This result raised the question: How would the population of 
proteins be altered in an intronless strain where Mss116 is not required for splicing? 
7.2.9.1 Identifying proteins associated with TAP-tagged Mss116 in multi-intron and 
intronless strains 
To address the question above, wild-type Mss116 was TAP-tagged at the C-
terminus as diagrammed in Fig. 7.13 and cloned into CEN plasmid pRS416. Plasmids 
expressing TAP-tagged and untagged Mss116 (pHRH197, (Huang 2004)) were then 
transformed into strains 161-U7mss116/1+2+, which harbors the twelve group I and 
group II mt introns of COX1 and COB, and into 161-U7 mss116 /I0, an isogenic, 
intronless strain. Mitochondria were isolated from each strain grown in 1 l cultures of 
HC/Ura
-
 media with 2% raffinose at 30° C to O.D.600 ≈ 3 as detailed in Methods. The 
TAP protocol was followed as described in Methods with the following exception: the 
calmodulin beads were washed in either the standard 200 mM KCl or the less stringent 
170 mM KCl wash buffer prior to elution. The beads were boiled in 30 µl loading dye for 
2 min to release the bound proteins. Half of each boiled sample was then separated in a 4-
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12% polyacrylamide SDS gel (Fig. 7.14). The other half was run for approximately 1 cm 
in an identical gel, with the single band being excised for mass spectroscopy analysis at 
the University of Texas at Austin Protein Facility.  
The protein gel in Fig. 7.14A shows proteins associated with the tagged (lane 1) 
and untagged Mss116 (lane 2) in the I
0
 strain with the 200 mM salt wash.  Lanes 3 and 4 




 strain.  
Table 7.1 lists the proteins identified by mass spectroscopy with the 200 mM salt 
wash. The spectral count for each protein was normalized to that of the total sample. No 
proteins were detected in the untagged samples, although bands of 51 and 28 kDa were 
evident in the gel for the untagged I
0
 strain (Fig. 7.14, lane 2). These bands may be 
residual TEV protease or contaminating E. coli proteins from the TEV protease isolation 
that would not be identified in an S. cerevisiae database. The proteins were listed in 




 strain over the 
I
0
 strain (right-hand column).  The list of proteins is comprised of 15 proteins other than 
Mss116 and was very similar for both strains. The data are shown graphically in Fig. 










strain (red) over the I
0
 strain (green) for each protein.  
Other than mitoribosomal proteins, two other proteins (highlighted in yellow in 
Table 7.14 and Fig. 7.15) were also pulled down with Mss116: the cytoplasmic helicase 
Ded1 (Senissar et al. 2014) and the COB processing protein and bI5 splicing factor, Cbp2 






 strain than in the I
0
 strain and may be a contaminant associated with the 
mitochondrial outer membrane, it is known to be essential for translation initiation on 
cytoplasmic ribosomes in S. cerevisiae (Iost et al. 1999). However, upregulation of Ded1 
due to retrograde signaling for the import of other mt proteins and the possibility that 
some proportion of Ded1 functions within mitochondria cannot be disregarded. Cbp2 was 
found to be slightly more abundant in the I
0




, but it is unclear if this 
difference is significant. 
To identify proteins that might be more tenuously associated with Mss116 as 
possible components of a less stable complex, the final salt wash concentration in the 
TAP protocol was reduced from the standard 200 mM to 170 mM (Fig. 7.14B).  With this 
change, many more proteins were identified (Table 7.2). As in Table 7.1, the proteins 




 strain over 
those for the I
0





 strain to the left of the X-axis. Although most of the proteins were again 
mitoribosomal proteins from the large subunit, several other non-ribosomal proteins were 
identified (yellow highlight). The heights of the bars relative to each other reflect the fold 




 strain (red) over the I
0
 strain (green). The protein with the greatest fold 
change over I
0
 was an uncharacterized protein, Yer077C that when tested in Phase I was 





 strain were Mgm101, Mrm1, Aim23, and Oms1. Mgm101 is a protein required 
for mtDNA damage repair and for mt genome maintenance (Chen et al. 1993). 
Mrm1/Pet56 methylates a conserved nucleotide in mt 21S rRNA (Sirum-Connolly and 
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Mason 1993) and its deletion was found in Chapter 3 to cause splicing defects in both 
aI5 and bI1. Aim23 is a mt translation initiation factor (Kuzmenko et al. 2014). Oms1 is 
a multicopy repressor of defects caused by mutations in Oxa1 (Lemaire et al. 2004). As 
in the more stringent 200 mM salt wash, Cbp2 was again found to be associated with the 
tagged Mss116; however, under these less stringent wash conditions, it was more 




 than in the I
0
. In addition to mitoribosomal proteins from the large 
subunit, proteins from the small subunit were also found in the less stringent wash. 
Table 7.3 is a compilation of the proteins identified in the experiments under both 
sets of conditions, along with the proteins identified in a previous study in which the final 
salt wash was 200 mM KCl (Huang 2004). Here, the proteins are ordered by their 
molecular weights, with “Y” (Yes) signifying the identification of that protein in the 
indicated experiment. With few exceptions, the proteins are mitoribosomal proteins, and 
where there is agreement in all three sets, the mitoribosomal proteins are often those 
located near the ribosomal tunnel exit (Mrpl3, Mrpl4, Mrpl22, and Mrpl40), a region of 
the mitoribosome known to be enriched with mitochondria-specific proteins and rRNA 
(Amunts et al. 2014). Other mitoribosomal proteins found in all sets were Yml6, and 
Mrpl15.  
Considered together, the data above show that Mss116 appears to associate 
primarily with mitoribosomal proteins with relatively few differences observed between 
an intronless strain and one containing 12 mt introns.  
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7.2.9.2 Identifying proteins associated with TAP-tagged Mss116 in single-intron petite 
strains 
Because of the large number of mitoribosomal proteins being identified as 
associated with the tagged Mss116 in the 
+
 strains, this next set of experiments was 
conducted in single-intron petite strains which lack functional mitoribosomes to reduce 
their background effect. The strains were tested previously (Figs. 5.7 and 5.8) and lack 
21S and 15S rRNAs. Plasmids expressing TAP-tagged and untagged wild-type Mss116 




 strains of 161-U7mss116/aI5 and 161-U7mss116/bI1. 
Cultures were grown, mitochondria isolated and treated as described in 7.2.8a. 
The resulting proteins were separated in a 4-12% SDS polyacrylamide gel and 
stained with Coomassie Brilliant Blue (Fig. 7.17).  In lanes 1-4 are the proteins associated 
with the TAP-tagged Mss116 in the four tested strains. Mss116 is clearly evident. In 
lanes 5-8 are the protein bands that represent the background in these strains, most of 
which are seen in both the tagged and untagged strains.  
7.2.9.2a Identifying proteins associated with Mss116 in aI5 strains 
Table 7.4 lists the proteins identified by mass spectroscopy in TAP-tagged and 




strains. The proteins are in decreasing order 
of the fold change observed for the corrected 
+
 over the corrected 
-
 strains. Corrected 
values were determined by subtracting the background untagged spectral count from the 
tagged value for each protein. Thus ordered, the proteins that are at the top of the list 
(fold change greater than 1) are those that were more abundant in the 
+
 strain than the 
-
 
strain, possibly highlighting those proteins that allow efficient splicing in the former 
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strain that are lacking in the latter. Conversely, the proteins at the bottom of the list (fold 
change = 0; not found in 
+
) are those proteins that may be enriched in the 
- 
strains over 
the mitoribosomal background. Non-ribosomal proteins are highlighted in yellow at both 
ends of the list.  
Unexpectedly, the values for Mss116 were much higher in the single intron 




 or intronless strains. Though 
the reason for this is unclear, the Mss116 values dwarf those of the remaining proteins so 
that they are excluded from the graph in Fig. 7.18.  
The graph is arranged with proteins enriched in the aI5
+
 strain (blue) to the left 
on the X-axis, and those enriched in the 
-
 strain (red) to the right with each portion of 
the graph enlarged in Figures 7.19 and 7.20 for clarity. Mitoribosomal proteins of the 
large subunit are predominantly represented in the 
+
 strain that are absent from the 
-
 
although several non-mitoribosomal proteins are also identified (yellow highlight).  
Among these are Yme2, a protein that assists in maintaining mt nucleoid structure and 
number; Pet127, a protein with a role in 5´-end processing of mtRNAs (Haffter and Fox 
1992); Yhm2, a protein that associates with mt nucleoids and plays a role in replication 
and segregation of the mt genome (Thorsness and Fox 1993); Mrm1/Pet56, a protein that 
methylates a critical nucleotide in mt 21S rRNA (Sirum-Connolly and Mason 1993) and 
whose deletion was found in Chapter 3 to cause splicing defects in both aI5 and bI1; and 
several proteins associated with the electron transport chain: Yhb1, Mir1, Pet9, Nde1 
(Luttik et al. 1998; Reinders et al. 2007; Azuma et al. 2008; Tkach et al. 2012). 
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Among the proteins enriched in the aI5
-
 strain were many cytoplasmic 
ribosomal proteins from both large and small subunits. Others included Ded1, a putative 
cytoplasmic DEAD-box protein also identified above; Tim44, a protein involved in 
protein import to the mitochondrion; aI5 splicing factors Mne1 and Suv3; bI5 splicing 
factor Cbp2; Aep3, a PPR protein involved in mt translation initiation; Rmd9, a PPR 
protein that may play a role in delivering mtRNAs to the mitoribosomes, and whose 
overexpression can compensate for the loss of Oxa1; and PPR protein and translational 
activator Pet309. 
The presence of Cbp2 and Pet309 echoes the results from the Dieckmann lab in 
which these two proteins, together with Cbp1, were associated in a high-molecular 
weight complex that linked transcription to translation (Krause et al. 2004). Interestingly, 
here Cbp2 and Pet309 are associated with Mss116, with splicing factors for aI5, and 
with PPR proteins Rmd9, Suv3, and Aep3 which are known to interact with RNAs. More 
recently, these proteins were found together complexed with mitoribosomal proteins 
(Kehrein et al. 2015). 
7.2.9.2b Identifying proteins associated with Mss116 in the bI1 strains 




 161-U7/bI1 strains, listed in 




. Unlike the situation in the aI5 strains, 
where Mss116 was found at levels more than double in aI5 
-
 than those in aI5 
+
, in 
bI1, the situation was reversed, with the bI1
+
 strain having more than double the amount 
of Mss116 compared to the bI1
-
. Nonetheless, the levels of Mss116 in the bI1 strains 
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were also very high, dwarfing the levels of the remaining proteins. For that reason, 
Mss116 is not graphed in Fig. 7.21. On the left side of the X-axis are those proteins that 
were enriched in the bI1 
+
 strain (blue), and on the right, those enriched in the bI1 
-
 
strain (red). Each portion of the graph is enlarged for clarity in Figures 7.22 and 7.23. 
As was the case with the aI5 strains, the predominant proteins in the bI1 
+
 that 
are lacking in the bI1 
-
 are the mitoribosomal proteins of the large subunit, most of 
which are identical to those identified in the aI5 
+
 strain. With the varied levels of 
Mss116, the implication is that there is no direct relationship between the levels of 
Mss116 and these mitoribosomal proteins. 
Several other proteins identified in the aI5 
+
 strain were also identified in the 
bI1 
+ 
strain: Mrm1, Ybh1, Mir1, and Nde1. Additional non-ribosomal mitochondrial 
proteins enriched in the bI1 
+
 strain but not in the aI5 
+
 that may be involved 
specifically in bI1 splicing were: Mrx4/Ypl168W, an uncharacterized protein that 
associates with the mitoribosome (Kehrein et al. 2015); Rrg9, a protein of unknown 
function whose deletion causes loss of mtDNA (Merz and Westermann 2009); Fmp52, a 
protein of unknown function that localizes to the mt outer membrane (Dardalhon et al. 
2007); Yil077C, a putative protein of unknown function detected in highly purified 
mitochondria (Reinders et al. 2006) , and Mgr1, a subunit of the mt protease complex that 
degrades misfolded mt proteins (Dunn et al. 2006).  
Many small subunit mitoribosomal proteins were enriched in the bI1 
-
 strain, in 
contrast to the aI5
-
 strain, as was PPR protein and aI4 and bI4 splicing factor, Ccm1. 
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Other non-ribosomal proteins enriched in the bI1 
-
 strain were Cyt1 and Qcr2, both 
associated with the electron transport chain (Dorsman and Grivell 1990; Schneider and 
Guarente 1991); Ilv5, a protein with a role in maintaining mtDNA (Macierzanka et al. 
2008); and Pdb1, a component of the pyruvate dehydrogenase complex (Miran et al. 
1993).  
Few of the proteins enriched in the aI5
-
 strains were also enriched in the bI1 
-
strain, suggesting the possibility that each petite may signal the cell for the import of 
specific proteins.  
In both petite strains, many of the enriched proteins were involved in respiration 
and could be contaminants or may serve dual functions to also play a role in splicing.  




following RNase treatment 
 The large number of mitoribosomal proteins that appeared to be associated with 
Mss116 raised the question as to whether the helicase was interacting with the 
mitoribosomal proteins themselves or perhaps this observation was an artifact of the 
helicase’s association with the ribosomal RNA. To test this possibility, the 161-U7 
mss116/1+2+ strain containing a plasmid expressing TAP-tagged Mss116 was cultured 
and the mitochondria isolated as described in section 7.2.8a. In this set of experiments, 
however, the mitochondrial experimental sample was treated with 60 µl RNase A 
(Thermo Scientific) to a final concentration of 0.2 mg/ml and the control sample with 60 
µl of solubilization buffer immediately following the standard solubilization step (see 
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Methods). Both were incubated at 30° C for 10 min before proceeding with the remainder 
of the TAP protocol. 
 Samples were separated on a 4-12% gradient gel and stained with Coomassie 
Brilliant Blue (Fig. 7.20). In lane 1, the sample without the RNase treatment, Mss116 
remains clearly apparent. The RNase-treated sample in lane 2, however, has lost almost 
all of its Mss116, suggesting that Mss116 may be interacting with and stabilized by 
rRNA. The level of mitoribosomal proteins is also diminished compared to the untreated 
sample. The 23- kDa band is not degraded, however, an indication that contaminating 
proteases are not responsible for the loss of Mss116. The results are consistent with the 
possibility that Mss116 may be interacting with the rRNAs and not the mitoribosomal 
proteins. 
7.3 Discussion  
The general RNA chaperone Mss116 functions in splicing the mitochondrial 
group I and group II introns in S. cerevisiae. This study provided greater insight into the 
mechanics of this role, provided estimates of the protein’s abundance, and identified 
proteins that are associated with the helicase. 
Permissible amino acid substitutions throughout Mss116 aided our understanding 
of the protein’s mechanism of action: substitutions indicated that the RNA bend induced 
by the helicase core depends on ionic and hydrogen-bonding interactions with the bound 
RNA.  The functionally important regions included those containing conserved sequence 
motifs involved in ATP and RNA binding or interdomain interactions, as well as 
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previously unidentified regions that may function in protein-protein interactions. Also 
identified were two conserved regions-one the previously noted post II region in the 
helicase core, and the other in the CTE-that may help displace or sequester the opposite 
RNA strand during RNA unwinding. The in vivo splicing analysis of the Mss116 
SAT/AAA mutant in the single intron strain provided strong evidence that splicing ability 
is directly related to ATPase function.  
Estimates for the amount of Mss116 were determined. The protein appears to be 
very abundant with an estimated 96,000 molecules per cell or between 1900 and 3800 
molecules of Mss116 per mt genome. With such a plentiful protein, reduction to 15% of 






Pull-down experiments indicated that many proteins appear to interact with TAP-
tagged Mss116. Chief among these were mitoribosomal proteins; however, RNase 
treatment disrupted many of these interactions, suggesting that Mss116 is primarily 
associated with the rRNAs. One intriguing explanation for these results may have 
Mss116 interacting with rRNAs as a means to monitor the status of the mitoribosome, 











Figure 7.1: Key features of wild-type Mss116 and the mutants investigated in this study.  
 
(A) Diagram of Mss116 showing domain architecture as described in Fig. 1.5. Motifs colored 
orange interact with ATP; those colored green interact with ssRNA. Motif III, in black, does not 
contact either ATP or RNA, but is involved with bridging domains 1 and 2. (B) Mss116 mutants 
investigated in this study. The wild-type sequence for each motif is indicated at the top between 












Figure 7.2: Northern hybridization analysis comparing the abilities of wild-type strains and 
derivatives of those strains in which MSS116 has been deleted to promote splicing 
of group II intron aI5 at 3 different temperatures. 
 
The strains analyzed were wild-type (WT) 161-U7/aI5, 161-U7/I0 and derivatives of those 
strains in which MSS116 has been deleted. Strains were grown in 30 ml YPR at 25°C, 30°C, and 
37°C to O.D.600 ≈ 1.0. Total cellular RNA was isolated for each sample and 1.0 µg run in a 1.5% 
RNA-grade agarose gel, blotted onto a nylon membrane, and hybridized with a 32P-labeled DNA 
oligonucleotide complementary to the COX1 terminal exon (small arrow below COX1 in Fig. 










Figure 7.3: Northern hybridization analysis and correlated Western blot analyses comparing the 
abilities of wild-type and K158 and SAT/AAA mutant Mss116 proteins to promote 
the splicing of group II intron aI5γ. 
 
 184 
Figure 7.3(continued): Northern hybridization analysis and correlated Western blot analyses 
comparing the abilities of wild-type and K158 and SAT/AAA mutant Mss116 proteins to 
promote the splicing of group II intron aI5γ. 
 
 (A) Northern hybridization analysis. The strains analyzed were wild-type (WT) 161-U7/aI5 and 
mss116Δ/aI5 containing the CEN plasmid vector pRS416 or CEN plasmids expressing wild-type 
Mss116 or the indicated mutants. Strains were grown in HC/Ura-/raffinose liquid media (see 
Methods) to O.D.600 = about 1.0. Total cellular RNA was isolated, 1.0 µg run in a 1.5% RNA-
grade agarose gel, blotted onto a nylon membrane, and hybridized with a 32P-labeled DNA 
oligonucleotide complementary to the COX1 terminal exon (the small arrow below COX1 in Fig. 
3.1 A). Lane 1, wild-type 161-U7/aI5 (WT) transformed with CEN plasmid pRS416 (empty 
vector); lane 2, mss116Δ/aI5γ transformed with CEN plasmid pRS416 (empty vector); lanes 3–6, 
mss116Δ/aI5 transformed with CEN plasmids expressing Mss116 mutants K158A, K158R, and 
SAT/AAA (B) Western blot. The blot shows TCA-precipitated proteins (~60 g) from the same 
strains as in A, separated in a 0.1% SDS 4–20% polyacrylamide gradient gel, transferred to a 
Sequi-Blot™ PVDF membrane (Bio-Rad) and probed with an anti-Mss116 antibody. (C) The 
Western blot was stripped and stained with AuroDye Forte (GE Healthcare) to confirm equal 
loading. The numbers to the left of the gel in (B) and (C) indicate the positions of size markers 
















Figure 7.4: Northern hybridization analysis and correlated Western blot analyses comparing the 
abilities of wild-type and motif III mutant Mss116 proteins to promote mt intron 
splicing in strain 161-U7 mss116/1+2+. 
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Figure 7.4 (continued): Northern hybridization analysis and correlated Western blot analyses 
comparing the abilities of wild-type and motif III mutant Mss116 proteins to promote mt intron 
splicing in strain 161-U7 mss116/1+2+. 
 
The strains analyzed were wild-type (WT) 161-U7/1+2+ and mss116Δ/1+2+ containing the CEN 
plasmid vector pRS416 or CEN plasmids expressing wild-type Mss116 or the indicated motif III 
mutants. Strains were cultured as in Fig. 7.2. (A) Northern hybridization analysis. The blots show 
whole-cell RNAs from the indicated strains separated in a 1.5% agarose gel, blotted onto a nylon 
membrane, and hybridized with 32P-labeled oligonucleotide probes complementary to the COX1 
or COB terminal exon. The blots were then stripped and rehybridized with a probe for the 
intronless COX2 gene to assess equal loading. (B) Western blot. The blot shows TCA-
precipitated proteins from the same cultures as in A, separated in a 0.1% SDS/4–12% 
polyacrylamide gradient gel, transferred to a Sequi-Blot™ PVDF membrane (Bio-Rad), and 























Figure 7.5: Northern hybridization analysis and correlated Western blot analyses comparing the 
abilities of wild-type and Mss116 RNA-binding tract mutant proteins derivatives to 
promote mt intron splicing in strain 161-U7 mss116/1+2+. 
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Figure 7.5(continued): Northern hybridization analysis and correlated Western blot analyses 
comparing the abilities of wild-type and Mss116 RNA-binding tract mutant proteins derivatives 
to promote mt intron splicing in strain 161-U7 mss116/1+2+. 
 
The strains analyzed were wild-type 161-U7/1+2+ (WT) and mss116Δ/1+2+ containing the CEN 
plasmid vector pRS416 or CEN plasmids expressing WT Mss116 or the indicated mutant. Strains 
were cultured as in Fig. 7.2. (A) Northern hybridization analysis. Whole-cell RNAs from the 
indicated strains were separated in a 1.5% agarose gel, blotted onto a nylon membrane and 
hybridized with 32P-labeled probes for COX1, COB and COX2, as described in the legend of 
Figure 7.3. (B) Western blot. TCA-precipitated proteins from the same strains were separated in a 
0.1% SDS/4–12% polyacrylamide gradient gel, transferred to a Sequi-Blot™ PVDF membrane 
(Bio-Rad) and probed with anti-Mss116 antibody. After imaging, the membrane was stripped of 























Figure 7.6: Schematic of  Mss116 N-and C-terminal truncation mutants.  
 
Wild-type Mss116 and truncation mutants. The protein is identified to the left of the schematic, 
and the size (kDa) of the mature protein is indicated to the right. (The cleaved mitochondrial 
target sequence, Mt, is not included in the size estimate of the mature protein.). Amino acid 
















Figure 7.7: Northern hybridization and correlated Western blot analyses comparing the abilities 
of wild-type and Mss116 truncation mutants to promote mt intron splicing in strain 
161-U7 mss1161+2+.  
 191 
 
Figure 7.7 (continued): Northern hybridization and correlated Western blot analyses comparing 
the abilities of wild-type and Mss116 truncation mutants to promote mt intron splicing in strain 
161-U7 mss1161+2+.  
 
The strains analyzed were wild-type 161-U7/1+2+ and mss116Δ/1+2+ containing the CEN plasmid 
vector pRS416 or CEN plasmids expressing WT Mss116 or the indicated N- or C- terminal 
truncation mutants. Strains were cultured as described in Fig. 7.2. (A) Northern hybridization 
analysis. Whole-cell RNAs from the indicated strains were separated in a 1.5% agarose gel, 
blotted onto a nylon membrane, and hybridized with 32P-labeled probes for COX1, COB and 
COX2, as described in the legend of Figure 7.3. (B) Western blot. TCA-precipitated proteins from 
the same cultures as in (A) were separated in a 0.1% SDS/4–12% polyacrylamide gradient gel 
and transferred to a Sequi-Blot™ PVDF membrane (Bio-Rad). The membrane was cut along the 
50 kDa marker, and the upper portion of the membrane probed with anti-Mss116 antibody and 





























Figure 7.8: Estimating the efficiency of anti-Mss116 antibody recognition of wild-type and 
truncated Mss116 proteins. 
 
(A) Western blot.. Known concentrations (nM) of purified full-length and truncated Mss116 
(NTE + C-tail) proteins shown in Fig. 7.6 were separated in a 0.1% SDS/4–12% 
polyacrylamide gradient gel, transferred to a Sequi-Blot™ PVDF membrane (Bio-Rad), and 
probed with an anti-Mss116 antibody. Image acquisition was with a FluorChemHD2 camera 
(Cell Biosciences) and densitometry was performed with GelQuant.NET software 
(BioChemLabSolutions.com). (B) Western blot from Fig. 7.7B with the level of expression of 
Mss116 NTE + C-tail relative to that of the wild-type protein without (% WT and fold change 
compared to WT) and with correction for the efficiency of antibody recognition (fold change 






Figure 7.9: Western blot showing modulation of Mss116 protein expression by TEF promoter 
mutations.  
 
The strains analyzed were WT 161-U7/1+2+ and mss116Δ/1+2+ containing the plasmid vector 
p416 or the indicated pRS416-TEF-Mss116 plasmids, in order of increasing promoter strength 
(Alper et al. 2005). TCA-precipitated proteins were separated in a 0.1% SDS/4–12% 
polyacrylamide gradient gel, transferred to a Sequi-Blot™ PVDF membrane (Bio-Rad), and 














Figure 7.10: Constructs used for modulating Mss116 expression by MSS116 promoter mutations. 
 
(A) Wild-type MSS116 promoter. Landmark restriction sites and their distances in bp from the 
ATG initiation codon are indicated in parentheses. The white arrowheads mark putative TATA 
box and transcriptional start site (TSS) as predicted by Promoter Scan software. (B) Promoter 
mutants used to alter the level of Mss116 expression. Deleted regions of the promoter are given to 
the left in bp from the ATG. Presence or absence of protein expression by each mutated promoter 




Figure 7.11: Northern hybridization analysis and correlated Western blot analyses comparing the 
ability of Mss116 expressed from a plasmid at various levels to promote mt intron 
splicing in strain 161-U7mss116/1+2+. 
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Figure 7.11(continued): Northern hybridization analysis and correlated Western blot analyses 
comparing the ability of Mss116 expressed from a plasmid at various levels to promote mt intron 
splicing in strain 161-U7mss116/1+2+. 
 
The strains analyzed were wild-type 161-U7/1+2+ (WT) and mss116Δ/1+2+ containing the CEN 
plasmid vector pRS416 or CEN plasmids expressing wild-type Mss116 with the WT promoter or 
the indicated promoter mutations as diagrammed in Fig. 7.10. Strains were cultured as in Fig. 7.3. 
(A) Northern hybridization analysis. Whole-cell RNAs from the indicated strains were separated 
in a 1.5% agarose gel, blotted onto a nylon membrane, and hybridized with 32P-labeled probes 
complementary to the COX1 or COB terminal exon. (B) Western blots. TCA-precipitated proteins 
from the same cultures as in (A) were separated in a 0.1% SDS/4–12% polyacrylamide gradient 
gel and transferred to a Sequi-Blot™ PVDF membrane (Bio-Rad). The membrane was cut along 
the 50 kDa marker, and the upper portion of the membrane was probed with anti-Mss116 
antibody and the lower portion with anti-porin antibody for use as loading control. After imaging, 




























Figure 7.12: Quantification of Western blots to estimate levels of Mss116 expression in strains 
with wild-type and mutant promoters. 
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Figure 7.12(continued): Quantification of Western blots to estimate levels of Mss116 expression 
in strains with wild-type and mutant promoters. 
 
 
(A) Western blot. Wild-type (WT) and mutant promoter mutant  -307/-61 strains were run 
alongside known concentrations (nM) of purified Mss116 in a 0.1% SDS/4–12% polyacrylamide 
gradient gel and transferred to a Sequi-Blot™ PVDF membrane (Bio-Rad). The membrane was 
cut along the 50 kDa marker, and the upper portion of the membrane was probed with anti-
Mss116 antibody and the lower portion with anti-porin antibody for use as loading control. After 
imaging, the upper blot was stripped of antibodies and stained with Colloidal Gold Stain (Bio-
Rad) to assess loading. The location of the Mss116 band is indicated to the right. (B) Linear 
regression of Western blot in (A) used in determining the formula for calculating the 
concentrations of the tested proteins. Image acquisition was with a FluorChemHD2 camera (Cell 





















Figure 7.13: TAP-tagged Mss116 construct.  
 
Schematic of wild-type Mss116 protein with a C-terminal in-frame TAP tag expressed in CEN 
plasmid pRS416. Features of Mss116 are as described in Fig. 7.6. The Tandem Affinity 
Purification (TAP) tag consists of two affinity modules, Protein A and Calmodulin Binding 
Protein (CBP) separated by a Tobacco Etch Virus (TEV) protease-cleavable sequence (Puig et al. 
























Figure 7.14: SDS polyacrylamide gel showing proteins associated with TAP-tagged and untagged 
Mss116 in strains 161-U7mss116/1+2+ and 161-U7 mss116/I using a standard 
200 mM KCl final salt wash. 
 
(A). Strains used were 161-U7mss116/1+2+ (1+2+) and 161-U7 mss116/I (I0) expressing TAP-
tagged (+) or untagged (-) Mss116 from CEN plasmid vector pRS416. Strains were cultured in 1 l 
of HC/Ura- media with 2% raffinose at 30°C to O.D.600 = 3. Isolated mitochondria were subjected 
to the TAP protocol as described in Methods using the standard final bead wash of 200 mM KCl. 
Beads were boiled for 2 min in loading dye to release bound proteins. Half of the sample was 
separated in a 4-12% polyacrylamide gel and stained with Coomassie Brilliant Blue. (B) Strains 
wee cultured, mitochondria isolated and subjected to the TAP protocol as in A except for using a 
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ATP-dependent RNA helicase DED1  GN=DED1  DED1 66 2 10 0 0 5 
54S ribosomal protein L1, mitochondrial  GN=MRPL1  RM01 31 2 9 0 0 4.5 
54S ribosomal protein RML2, mitochondrial  
GN=RML2  
RML2 44 3 7 0 0 2.3 
54S ribosomal protein L3, mitochondrial  GN=MRPL3  RM03 44 7 14 0 0 2 
54S ribosomal protein L15, mitochondrial  
GN=MRPL15  
RM15 28 0 2 0 0 2 
54S ribosomal protein YmL6, mitochondrial  
GN=YML6  
RL4P 32 7 13 0 0 1.86 
54S ribosomal protein L11, mitochondrial  
GN=MRPL11  
RM11 29 6 7 0 0 1.17 
54S ribosomal protein L8, mitochondrial  GN=MRPL8  RM08 27 2 2 0 0 1 
ATP-dependent RNA helicase MSS116, 
mitochondrial  GN=MSS116  
MS116 76 132 120 0 0 0.91 
54S ribosomal protein L40, mitochondrial  
GN=MRPL40  
RM40 34 11 9 0 0 0.82 
54S ribosomal protein L35, mitochondrial  
GN=MRPL35  
RM35 43 4 3 0 0 0.75 
54S ribosomal protein L41, mitochondrial  
GN=MRP20  
RM41 31 4 2 0 0 0.5 
COB pre-mRNA-processing protein 2, splicing 
factor  GN=CBP2  
CBP2 74 4 1 0 0 0.25 
54S ribosomal protein L4, mitochondrial  GN=MRPL4  RM04 37 12 2 0 0 0.17 
54S ribosomal protein L22, mitochondrial  
GN=MRPL22  
RM22 35 5 0 0 0 0 
54S ribosomal protein L9, mitochondrial  GN=MRPL9  RM09 30 3 0 0 0 0 
 
 
Table 7.1: Proteins associated with TAP-tagged Mss116 in strains 161-U7mss116/1+2+ 













Table 7.1(continued): Proteins associated with TAP-tagged Mss116 in strains 161-U7 
mss116/1+2+ and 161-U7 mss116/I using final bead wash of 200 mM KCl. 
 
Strains are as in 7.14A. Samples were run approximately 1 cm in a 4-12% polyacrylamide gel and 
stained with Coomassie Brilliant Blue. The single band for each sample was excised and sent to 
the University of Texas at Austin Protein Facility where it was processed and subjected to mass 
spectroscopic analysis. (Details in Methods). Proteins were identified by comparison to the 
UniProt database for S. cerevisiae.  Spectral counts for each protein were normalized to the count 
for the total sample. Untagged values were subtracted from the TAP-tagged value to obtain a 
background-corrected value. The ratio of corrected 1+2+ to I0 values was calculated to estimate 
enrichment in the intron-containing strain over the intronless strain (1+2+ fold change over I0).  
Proteins are listed in decreasing order of the fold change. Mss116 and known splicing factor 
Cbp2 are in bold. Non-ribosomal proteins are highlighted in yellow. The UniProt Accession 
identification number (UniProt Accession #) and the molecular weight in kDa (MW) are 






















Figure 7.15: Proteins associated with Mss116 in strains 161-U7mss116/1+2+ and 161-U7 
mss116/I using final bead wash of 200 mM KCl. 
 
Graphical representation of the data in Table 7.1. The height of the bars relative to each other 
represents the fold change of the corrected, normalized spectral count of the 1+2+ strain (red) over 
the I0 strain (green). The proteins are listed in order of decreasing 1+2+ to I0 fold change. Non-
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Uncharacterized protein YER077C GN=YER077C  YEQ7 80 1 16 0 0 16 
37S ribosomal protein NAM9, mitochondrial GN=NAM9  NAM9 56 1 13 0 0 13 
54S ribosomal protein L8, mitochondrial GN=MRPL8  RM08 27 0 12 0 0 12 
Mitochondrial genome maintenance protein MGM101 
GN=MGM101  
MG101 30 1 8 0 0 8 
rRNA methyltransferase, mitochondrial GN=MRM1  MRM1 46 2 12 0 0 6 
Altered inheritance of mitochondria protein 23, 
mitochondrial GN=AIM23  
AIM23 41 0 6 0 0 6 
40S ribosomal protein S9-B GN=RPS9B  RS9B 22 1 5 0 0 5 
40S ribosomal protein S24-A GN=RPS24A  RS24A 15 0 5 0 0 5 
Ribosomal protein VAR1, mitochondrial GN=VAR1  RMAR 47 2 9 0 0 4.5 
COB pre-mRNA processing protein 2, splicing factor 
GN=CBP2 
CBP2 74 0 4 0 0 4 
Methyltransferase OMS1, mitochondrial GN=OMS1  OMS1 56 8 23 2 0 3.83 
37S ribosomal protein PET123, mitochondrial GN=PET123  RTPT 36 3 11 0 0 3.67 
37S ribosomal protein S23, mitochondrial GN=RSM23  RT23 51 8 26 0 0 3.25 
37S ribosomal protein S17, mitochondrial GN=MRPS17  RT17 28 4 12 0 0 3 
37S ribosomal protein S5, mitochondrial GN=MRPS5  RT05 35 3 9 0 0 3 
54S ribosomal protein L16, mitochondrial GN=MRPL16  RM16 27 2 6 0 0 3 
37S ribosomal protein S16, mitochondrial GN=MRPS16  RT16 14 3 8 0 0 2.67 
37S ribosomal protein S9, mitochondrial GN=MRPS9  RT09 32 2 5 0 0 2.5 
54S ribosomal protein L35, mitochondrial GN=MRPL35  RM35 43 18 38 0 0 2.1 
54S ribosomal protein L49, mitochondrial GN=MRPL49  RN49 18 5 10 0 0 2 
37S ribosomal protein MRP1, mitochondrial GN=MRP1  RT01 37 5 10 0 0 2 
37S ribosomal protein S24, mitochondrial GN=RSM24  RT24 37 4 8 0 0 2 
54S ribosomal protein MRP49, mitochondrial GN=MRP49  RM49 16 2 4 0 0 2 
54S ribosomal protein L9, mitochondrial GN=MRPL9  RM09 30 14 27 0 0 1.93 
60S ribosomal protein L4-A GN=RPL4A  RL4A  39 6 11 0 0 1.83 
54S ribosomal protein L36, mitochondrial GN=MRPL36  RM36 20 4 7 0 0 1.75 
60S ribosomal protein L8-B GN=RPL8B  RL8B 28 4 7 0 0 1.75 
37S ribosomal protein S35, mitochondrial GN=MRPS35  RT35 40 5 8 0 0 1.6 
 
Table 7.2: Proteins associated with TAP-tagged Mss116 in strains 161-U7mss116/1+2+ and 






Table 7.2 (continued) 
Protein      

























ATP-dependent RNA helicase MSS116, mitochondrial 
GN=MSS116  
MS116 76 19 30 0 0 1.58 
Biotin synthase, mitochondrial GN=BIO2  BIOB 42 5 6 1 0 1.5 
37S ribosomal protein RSM28, mitochondrial GN=RSM28  RSM28 41 8 12 0 0 1.5 
54S ribosomal protein L23, mitochondrial GN=MRPL23  RM23 18 8 12 0 0 1.5 
54S ribosomal protein L7, mitochondrial GN=MRPL7  RM07 33 6 9 0 0 1.5 
40S ribosomal protein S4-A GN=RPS4A  RS4A 29 2 3 0 0 1.5 
54S ribosomal protein L2, mitochondrial GN=MRP7  RM02 43 19 28 0 0 1.47 
54S ribosomal protein L41, mitochondrial GN=MRP20  RM41 31 13 19 0 0 1.46 
54S ribosomal protein L24, mitochondrial GN=MRPL24  RM24 30 20 29 0 0 1.45 
54S ribosomal protein L3, mitochondrial GN=MRPL3  RM03 44 42 59 0 0 1.4 
54S ribosomal protein L25, mitochondrial GN=MRPL25  RM25 19 8 11 0 0 1.38 
54S ribosomal protein L13, mitochondrial GN=MRPL13  RM13 30 14 19 0 0 1.36 
54S ribosomal protein L20, mitochondrial GN=MRPL20  RM20 22 15 20 0 0 1.33 
54S ribosomal protein L28, mitochondrial GN=MRPL28  RM28 17 12 16 0 0 1.33 
54S ribosomal protein L1, mitochondrial GN=MRPL1  RM01 31 22 29 0 0 1.32 
54S ribosomal protein L22, mitochondrial GN=MRPL22  RM22 35 24 32 0 0 1.3 
54S ribosomal protein YmL6, mitochondrial GN=YML6  RL4P 32 20 26 0 0 1.3 
37S ribosomal protein MRP51, mitochondrial GN=MRP51  RT51 39 7 9 0 0 1.29 
54S ribosomal protein L33, mitochondrial GN=MRPL33  RM33 10 7 9 0 0 1.29 
40S ribosomal protein S8-B GN=RPS8B  RS8B 22 7 9 0 0 1.29 
54S ribosomal protein L40, mitochondrial GN=MRPL40  RM40 34 26 32 1 0 1.28 
54S ribosomal protein L17, mitochondrial GN=MRPL17  RM17 32 13 15 0 0 1.15 
54S ribosomal protein RML2, mitochondrial GN=RML2  RML2 44 21 23 0 0 1.09 
54S ribosomal protein L4, mitochondrial GN=MRPL4  RM04 37 22 23 0 0 1.05 
54S ribosomal protein IMG2, mitochondrial GN=IMG2  IMG2 16 9 9 0 0 1 
54S ribosomal protein L15, mitochondrial GN=MRPL15  RM15 28 9 9 0 0 1 
54S ribosomal protein L27, mitochondrial GN=MRPL27  RM27 16 7 7 0 0 1 
37S ribosomal protein S7, mitochondrial GN=RSM7  RT07 28 6 6 0 0 1 
37S ribosomal protein S12, mitochondrial GN=MRPS12  RT12 17 4 4 0 0 1 
37S ribosomal protein MRP4, mitochondrial GN=MRP4  RT04 44 4 4 0 0 1 
40S ribosomal protein S6-A GN=RPS6A  RS6A 27 3 3 0 0 1 
54S ribosomal protein L51, mitochondrial GN=MRPL51  RM51 16 13 12 0 0 0.92 
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ADP,ATP carrier protein 2 GN=PET9  ADT2 34 9 5 0 0 0.56 
54S ribosomal protein L11, mitochondrial GN=MRPL11  RM11 29 5 1 0 0 0.2 
Mitochondrial DNA replication protein YHM2 GN=YHM2  YHM2 34 3 0 0 0 0 
 
 
Table 7.2(continued): Proteins associated with TAP-tagged Mss116 in strains 161-
U7mss116/1+2+ and 161-U7 mss116/I using final bead wash of 170 mM KCl. 
 
Strains are as in 7.14B. Samples were treated and analyzed as in Table 7.1. Proteins are listed in 
decreasing order of the 1+2+ to I0 fold change. Mss116 and known splicing factor Cbp2 are in 
bold. Non-ribosomal proteins are highlighted in yellow. The UniProt Accession identification 










































































































































161-U7 mss116/I using final bead wash of 170 mM 
KCl. 
Graphical representation of the data in Table 7.2. The height of the bars relative to each other 
represents the fold change of the corrected, normalized spectral count of the 1+2+ strain (red) over 
the I0 strain (green). The proteins are listed in order of decreasing 1+2+ to I0 fold change with 
proteins to the left on the X-axis more enriched in the 1+2+ strain. Non-ribosomal proteins are 





































Uncharacterized protein YER077C  GN=YER077C 80  Y  
ATP-dependent RNA helicase MSS116, mitochondrial  GN=MSS116  76 Y Y Y 
COB pre-mRNA-processing protein 2, splicing factor  GN=CBP2  74 Y Y  
ATP-dependent RNA helicase DED1 GN=DED1 66 Y   
tRNA (guanine(26)-N(2))-dimethyltransferase, mitochondrial  GN=TRM1  64  Y  
Methyltransferase OMS1, mitochondrial  GN=OMS1  56  Y  
37S ribosomal protein NAM9, mitochondrial  GN=NAM9  56  Y  
37S ribosomal protein S23, mitochondrial  GN=RSM23  51  Y Y 
Ribosomal protein VAR1, mitochondrial  GN=VAR1  47  Y  
rRNA methyltransferase, mitochondrial  GN=MRM1  46  Y  
54S ribosomal protein L3, mitochondrial  GN=MRPL3 , tunnel exit 44 Y Y Y 
54S ribosomal protein RML2, mitochondrial  GN=RML2  44 Y Y  
37S ribosomal protein MRP4, mitochondrial  GN=MRP4  44  Y Y 
54S ribosomal protein L35, mitochondrial  GN=MRPL35  43 Y Y  
54S ribosomal protein L2, mitochondrial  GN=MRP7  43  Y  
Biotin synthase, mitochondrial  GN=BIO2  42  Y  
37S ribosomal protein RSM28, mitochondrial  GN=RSM28  41  Y  
Altered inheritance of mitochondria protein 23, mitochondrial  GN=AIM23  41  Y  
37S ribosomal protein S35, mitochondrial  GN=MRPS35  40  Y  
37S ribosomal protein MRP51, mitochondrial  GN=MRP51  39  Y Y 
60S ribosomal protein L4-A  GN=RPL4A  39  Y  
54S ribosomal protein L4, mitochondrial  GN=MRPL4 , tunnel exit 37 Y Y Y 
37S ribosomal protein MRP1, mitochondrial  GN=MRP1  37  Y  
37S ribosomal protein S24, mitochondrial  GN=RSM24  37  Y  
54S ribosomal protein L10, mitochondrial  GN=MRPL10  36  Y  
37S ribosomal protein PET123, mitochondrial  GN=PET123  36  Y  
54S ribosomal protein L22, mitochondrial  GN=MRPL22 , tunnel exit 35 Y Y Y 
37S ribosomal protein S5, mitochondrial  GN=MRPS5  35  Y  
54S ribosomal protein L40, mitochondrial  GN=MRPL40 , tunnel exit 34 Y Y Y 
ADP,ATP carrier protein 2  GN=PET9  34  Y Y 
ATP synthase subunit gamma, mitochondrial  GN=ATP3  34  Y  
Mitochondrial DNA replication protein YHM2  GN=YHM2  34  Y  
54S ribosomal protein L7, mitochondrial  GN=MRPL7  33  Y  
37S ribosomal protein S28, mitochondrial GN= MRPS28 33   Y 
54S ribosomal protein YmL6, mitochondrial  GN=YML6  32 Y Y Y 
54S ribosomal protein L17, mitochondrial  GN=MRPL17  32  Y  
37S ribosomal protein S9, mitochondrial  GN=MRPS9  32  Y Y 
54S ribosomal protein L41, mitochondrial  GN=MRP20,  tunnel exit  31 Y Y  
54S ribosomal protein L1, mitochondrial  GN=MRPL1  31 Y Y  
37 S ribosomal protein Rsm25, mitochondrial GN=RSM25 31   Y 
54S ribosomal protein L24, mitochondrial  GN=MRPL24  30  Y  
54S ribosomal protein L9, mitochondrial  GN=MRPL9  30 Y Y  
54S ribosomal protein L13, mitochondrial  GN=MRPL13, tunnel exit 30  Y Y 
Mitochondrial genome maintenance protein MGM101  GN=MGM101  30  Y  
37S ribosomal protein Rsm26, mitochondrial GN=RSM26 30   Y 
40S ribosomal protein S4-A  GN=RPS4A  29  Y  
54S ribosomal protein L11, mitochondrial  GN=MRPL11  29 Y Y  
54S ribosomal protein L15, mitochondrial  GN=MRPL15  28 Y Y Y 
Table 7.3: Compilation of those proteins associated with Mss116 in 3 different experiments. 
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60S ribosomal protein L8-B  GN=RPL8B  28  Y  
37S ribosomal protein S7, mitochondrial  GN=RSM7  28  Y  
37S ribosomal protein S17, mitochondrial  GN=MRPS17  28  Y  
54S ribosomal protein L16, mitochondrial  GN=MRPL16  27  Y  
54S ribosomal protein L8, mitochondrial  GN=MRPL8  27 Y Y  
40S ribosomal protein S6-A  GN=RPS6A  27  Y  
54S ribosomal protein L20, mitochondrial  GN=MRPL20  22  Y Y 
40S ribosomal protein S8-B  GN=RPS8B  22  Y  
40S ribosomal protein S9-B  GN=RPS9B  22  Y  
54S ribosomal protein L36, mitochondrial  GN=MRPL36  20  Y  
54S ribosomal protein IMG1, mitochondrial  GN=IMG1  19  Y Y 
54S ribosomal protein L25, mitochondrial  GN=MRPL25  19  Y  
54S ribosomal protein L49, mitochondrial  GN=MRPL49  18  Y  
54S ribosomal protein L23, mitochondrial  GN=MRPL23  18  Y  
54S ribosomal protein L28, mitochondrial  GN=MRPL28  17  Y  
37S ribosomal protein S12, mitochondrial  GN=MRPS12  17  Y  
54S ribosomal protein IMG2, mitochondrial  GN=IMG2  16  Y  
54S ribosomal protein L51, mitochondrial  GN=MRPL51  16  Y Y 
54S ribosomal protein L27, mitochondrial  GN=MRPL27,  tunnel exit  16  Y  
54S ribosomal protein MRP49, mitochondrial  GN=MRP49  16  Y  
40S ribosomal protein S24-A  GN=RPS24A  15  Y  
37S ribosomal protein S16, mitochondrial  GN=MRPS16  14  Y  
54S ribosomal protein L33, mitochondrial  GN=MRPL33  10  Y  
 
 
Table 7.3(continued): Compilation of those proteins associated with Mss116 in 3 different 
experiments  
 
Proteins identified as being associated with TAP-tagged  Mss116 from Tables 7.1 (200 mM) and 
7.2 (170 mM) alongside results previously reported (Huang 2004). Proteins are listed in 
descending order of their molecular weights in kDa (MW). Mss116 and known splicing factor 














Figure 7.17: SDS polyacrylamide gel showing proteins associated with TAP-tagged and untagged 
Mss116 in + and- strains of 161-U7mss116/aI5 and 161-U7mss116/bI1. 
 
The + and- strains of 161-U7mss116/aI5 and 161-U7mss116/bI1 expressing TAP-tagged 
and untagged Mss116 from CEN plasmid vector pRS416 were cultured as in Fig. 7.14.  
Mitochondria were isolated and subjected to the TAP protocol as in 7.14A. Mss116 and other 
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54S ribosomal protein L3, mitochondrial GN=MRPL3  RM03 44 65 0 0 0 65 
54S ribosomal protein L10, mitochondrial GN=MRPL10  RM10 36 44 0 0 0 44 
54S ribosomal protein L40, mitochondrial GN=MRPL40  RM40 34 36 1 0 0 36 
54S ribosomal protein RML2, mitochondrial GN=RML2  RML2 44 35 0 0 0 35 
54S ribosomal protein IMG1, mitochondrial GN=IMG1  IMG1 19 33 0 0 0 33 
54S ribosomal protein YmL6, mitochondrial GN=YML6  RL4P 32 31 0 0 0 31 
54S ribosomal protein L24, mitochondrial GN=MRPL24  RM24 30 28 0 0 0 28 
54S ribosomal protein L13, mitochondrial GN=MRPL13  RM13 30 27 0 0 0 27 
54S ribosomal protein L4, mitochondrial GN=MRPL4  RM04 37 26 0 0 0 26 
54S ribosomal protein L41, mitochondrial GN=MRP20  RM41 31 23 0 0 0 23 
54S ribosomal protein L8, mitochondrial GN=MRPL8  RM08 27 22 0 0 0 22 
54S ribosomal protein L23, mitochondrial GN=MRPL23  RM23 18 21 0 0 0 21 
54S ribosomal protein L49, mitochondrial GN=MRPL49  RN49 18 20 0 0 0 20 
54S ribosomal protein L20, mitochondrial GN=MRPL20  RM20 22 19 0 0 0 19 
54S ribosomal protein L31, mitochondrial GN=MRPL31  RM31 16 16 0 0 0 16 
54S ribosomal protein L51, mitochondrial GN=MRPL51  RM51 16 16 0 0 0 16 
54S ribosomal protein L9, mitochondrial GN=MRPL9  RM09 30 15 0 0 0 15 
54S ribosomal protein L27, mitochondrial GN=MRPL27  RM27 16 15 0 1 0 15 
54S ribosomal protein L15, mitochondrial GN=MRPL15  RM15 28 14 0 0 0 14 
54S ribosomal protein L33, mitochondrial GN=MRPL33  RM33 10 12 0 0 0 12 
Mitochondrial escape protein 2 GN=YME2  YME2 97 10 1 0 0 10 
54S ribosomal protein L25, mitochondrial GN=MRPL25  RM25 19 14 2 0 0 7 
54S ribosomal protein L1, mitochondrial GN=MRPL1  RM01 31 27 4 0 0 6.75 
54S ribosomal protein L22, mitochondrial GN=MRPL22  RM22 35 20 3 0 0 6.67 
37S ribosomal protein S23, mitochondrial GN=RSM23  RT23 51 6 0 1 0 6 
54S ribosomal protein L16, mitochondrial GN=MRPL16  RM16 27 6 0 0 0 6 
Flavohemoprotein GN=YHB1   FHP 45 6 0 0 0 6 
54S ribosomal protein MRP49, mitochondrial 
GN=MRP49  
RM49 16 6 1 0 0 6 
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54S ribosomal protein IMG2, mitochondrial GN=IMG2  IMG2 16 11 2 0 0 5.5 
54S ribosomal protein L11, mitochondrial GN=MRPL11  RM11 29 5 0 0 0 5 
Mitochondrial DNA replication protein YHM2 
GN=YHM2  
YHM2 34 5 0 0 0 5 
Mitochondrial phosphate carrier protein GN=MIR1  MPCP 33 8 2 0 0 4 
Uncharacterized protein YPL168W GN=YPL168W  YP168 49 3 0 0 0 3 
37S ribosomal protein S7, mitochondrial GN=RSM7  RT07 28 3 0 0 0 3 
37S ribosomal protein MRP51, mitochondrial 
GN=MRP51  
RT51 39 3 0 0 0 3 
37S ribosomal protein S24, mitochondrial GN=RSM24  RT24 37 3 0 0 0 3 
ADP,ATP carrier protein 2 GN=PET9  ADT2 34 14 4 2 0 3 
37S ribosomal protein MRP1, mitochondrial GN=MRP1  RT01 37 8 3 0 0 2.67 
54S ribosomal protein L12, mitochondrial GN=MNP1  MNP1 21 5 2 0 0 2.5 
External NADH-ubiquinone oxidoreductase 1, 
mitochondrial GN=NDE1  
NDH1 63 4 2 0 0 2 
Threonine dehydratase, mitochondrial GN=ILV1  THDH 64 5 3 1 1 2 
Protein FMP52, mitochondrial GN=FMP52  FMP52 25 7 3 2 0 1.67 
54S ribosomal protein L32, mitochondrial GN=MRPL32  RM32 21 9 6 0 0 1.5 
Putative mitochondrial translation system component 
PET127 GN=PET127  
PT127 93 11 8 0 0 1.38 
54S ribosomal protein L36, mitochondrial GN=MRPL36  RM36 20 14 11 0 0 1.27 
rRNA methyltransferase, mitochondrial GN=MRM1  MRM1 46 5 4 0 0 1.25 
Uncharacterized mitochondrial membrane protein FMP10 
GN=FMP10  
FMP10 28 6 5 0 0 1.2 
Protein MLP2 GN=MLP2  MLP2 195 1 0 0 3 1 
Mitochondrial inner membrane i-AAA protease 
supercomplex subunit MGR1 GN=MGR1  
MGR1 47 3 3 0 0 1 
54S ribosomal protein L2, mitochondrial GN=MRP7  RM02 43 51 54 0 0 0.94 
54S ribosomal protein L35, mitochondrial GN=MRPL35  RM35 43 42 49 0 0 0.86 
54S ribosomal protein L28, mitochondrial GN=MRPL28  RM28 17 12 14 0 0 0.86 
54S ribosomal protein L7, mitochondrial GN=MRPL7  RM07 33 10 13 0 0 0.77 
40S ribosomal protein S6-A GN=RPS6A  RS6A 27 3 4 0 0 0.75 
54S ribosomal protein L17, mitochondrial GN=MRPL17  RM17 32 19 27 0 0 0.7 
Sphingolipid long chain base-responsive protein PIL1 
GN=PIL1  
PIL1 38 14 20 0 0 0.7 
60S ribosomal protein L19-A GN=RPL19A  RL19A 22 4 6 0 0 0.67 
Methyltransferase OMS1, mitochondrial GN=OMS1  OMS1 56 26 41 1 0 0.61 
Acetolactate synthase catalytic subunit, mitochondrial 
GN=ILV2  
ILVB 75 3 5 0 0 0.6 
Phosphatidate phosphatase APP1 GN=APP1  APP1 66 17 32 1 0 0.5 
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ATP-dependent RNA helicase MSS116, mitochondrial 
GN=MSS116  
MS116 76 438 964 22 2 0.45 
40S ribosomal protein S5 GN=RPS5  RS5 25 2 5 0 0 0.4 
60S ribosomal protein L18-A GN=RPL18A  RL18A 21 3 8 0 0 0.38 
Prohibitin-1 GN=PHB1  PHB1 31 4 12 0 0 0.33 
60S ribosomal protein L13-B GN=RPL13B  RL13B 23 4 13 0 0 0.31 
60S ribosomal protein L3 GN=RPL3  RL3 44 5 18 0 0 0.28 
60S ribosomal protein L20-A GN=RPL20A  RL20A 20 3 13 0 0 0.23 
60S ribosomal protein L8-B GN=RPL8B  RL8B 28 3 13 0 0 0.23 
Uncharacterized protein YER077C GN=YER077C  YEQ7 80 4 19 0 0 0.21 
60S ribosomal protein L27-A GN=RPL27A  RL27A  16 2 10 0 0 0.2 
ATPase expression protein 3 GN=AEP3  AEP3 70 1 5 0 0 0.2 
ATP-dependent RNA helicase DBP2 GN=DBP2  DBP2 61 2 11 0 0 0.18 
60S ribosomal protein L28 GN=RPL28  RL28 17 2 11 0 0 0.18 
Cytochrome c1, heme protein, mitochondrial GN=CYT1  CY1 34 2 11 0 0 0.18 
Heat shock protein 78, mitochondrial GN=HSP78  HSP78 91 4 17 1 0 0.18 
Heat shock protein 60, mitochondrial GN=HSP60  HSP60 61 4 24 0 1 0.17 
60S ribosomal protein L16-A GN=RPL16A  RL16A 22 1 6 0 0 0.17 
Protein CBP3, mitochondrial GN=CBP3  CBP3 39 4 13 2 0 0.15 
COB pre-mRNA-processing protein 2, splicing factor 
GN=CBP2  
CBP2 74 6 36 1 1 0.14 
60S ribosomal protein L2-A GN=RPL2A  RL2A 27 1 7 0 0 0.14 
40S ribosomal protein S13 GN=RPS13  RS13 17 1 7 0 0 0.14 
40S ribosomal protein S8-A GN=RPS8A  RS8A 22 1 7 0 0 0.14 
60S ribosomal protein L7-A GN=RPL7A  RL7A 28 2 15 0 0 0.13 
60S ribosomal protein L4-A GN=RPL4A  RL4A 39 4 31 0 0 0.13 
ATP synthase subunit alpha, mitochondrial GN=ATP1  ATPA 59 4 32 0 0 0.13 
Splicing factor MNE1 GN=MNE1  MNE1 77 1 8 0 0 0.13 
60S ribosomal protein L15-A GN=RPL15A  RL15A 24 1 9 0 0 .11 
Aconitate hydratase, mitochondrial GN=ACO1  ACON 85 1 9 0 0 0.11 
60S ribosomal protein L25 GN=RPL25  RL25 16 1 10 0 0 0.10 
40S ribosomal protein S4-A GN=RPS4A  RS4A 29 1 13 0 0 0.08 
Heat shock protein SSC1, mitochondrial GN=SSC1  HSP77 71 2 32 0 1 0.06 
60S ribosomal protein L21-A GN=RPL21A  RL21A 18 1 16 0 0 0.06 
ATP synthase subunit beta, mitochondrial GN=ATP2  ATPB 55 1 26 0 0 0.04 
Mitochondrial import inner membrane translocase subunit 
TIM44 GN=TIM44  
TIM44 49 0 4 0 0 0 
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40S ribosomal protein S3 GN=RPS3  RS3 27 0 4 0 0 0 
Cytochrome B pre-mRNA-processing protein 6 
GN=CBP6 
CBP6 19 0 5 0 0 0 
ATP-dependent RNA helicase, splicing factor SUV3, 
Mt GN=SUV3 
SUV3 84 0 5 0 0 0 
37S ribosomal protein S28, mitochondrial GN=MRPS28 RT28 33 0 5 0 0 0 
40S ribosomal protein S0-A GN=RPS0A RSSA1 28 0 5 0 0 0 
Elongation factor Tu, mitochondrial GN=TUF1 EFTU 48 0 6 0 0 0 
Potassium-activated aldehyde dehydrogenase, 
mitochondrial GN=ALD4 
ALDH4 57 0 6 0 0 0 
60S ribosomal protein L17-A GN=RPL17A RL17A 21 0 6 0 0 0 
60S ribosomal protein L36-B GN=RPL36B RL36B 11 0 7 0 0 0 
Pentatricopeptide repeat-containing protein PET309, 
mitochondrial GN=PET309 
PT309 113 0 7 0 1 0 
60S ribosomal protein L12-A GN=RPL12A RL12A 18 0 7 0 0 0 
60S ribosomal protein L33-B GN=RPL33B RL33B 12 0 7 0 0 0 
40S ribosomal protein S11-A GN=RPS11A RS11A 18 0 7 0 0 0 
Altered inheritance of mitochondria protein 36, 
mitochondrial GN=AIM36 
AIM36 29 0 7 0 0 0 
40S ribosomal protein S19-A GN=RPS19A RS19A 16 0 7 0 0 0 
40S ribosomal protein S7-B GN=RPS7B RS7B 22 0 7 0 0 0 
40S ribosomal protein S17-A GN=RPS17A RS17A 16 0 7 0 0 0 
Dihydrolipoyllysine-residue acetyltransferase 
component of pyruvate dehydrogenase complex, 
mitochondrial GN=LAT1 
ODP2 52 0 8 0 0 0 
40S ribosomal protein S2 GN=RPS2 RS2 27 0 8 0 0 0 
40S ribosomal protein S9-B GN=RPS9B RS9B 22 0 8 0 0 0 
Nucleolar protein 3 GN=NPL3 NOP3 45 0 8 0 0 0 
60S ribosomal protein L6-B GN=RPL6B RL6B 20 0 9 0 1 0 
60S ribosomal protein L14-B GN=RPL14B RL14B 15 0 9 1 0 0 
ATP-dependent RNA helicase DED1 GN=DED1 DED1 66 0 9 1 0 0 
60S ribosomal protein L1-A GN=RPL1A RL1A 24 0 9 0 0 0 
60S acidic ribosomal protein P0 GN=RPP0 RLA0 34 0 10 0 0 0 
37S ribosomal protein S22, mitochondrial GN=RSM22 RT22 72 0 10 0 0 0 
40S ribosomal protein S24-A GN=RPS24A RS24A 15 0 10 0 0 0 
Biotin synthase, mitochondrial GN=BIO2 BIOB 42 0 11 0 0 0 
60S ribosomal protein L35-A GN=RPL35A RL35A 14 0 14 0 0 0 




Table 7.4 (continued): Proteins associated with Mss116 in + and- strains of 161-
U7mss116/aI5.  
 
Strains are as in Fig. 7.17 (lanes 1, 2, 5 and 6) and were analyzed as in Table 7.1. Untagged 
values were subtracted from the TAP-tagged value to obtain a background-corrected value for 
each protein. The ratio of corrected + to - values was calculated to estimate enrichment in wild-
type strain over the petite strain (+ fold change over -).  Proteins are listed in decreasing order of 
the fold change. Proteins at the bottom of the list are those found only in -. Non-ribosomal 
proteins are highlighted in yellow. Mss116 and known splicing factors are in bold. The UniProt 
Accession identification number (UniProt Accession #) and the molecular weight in kDa (MW) 















































































                                                                                              
































Fig. 7.18 (continued): Proteins associated with Mss116 in + and- strains of  
161-U7mss116/aI5. 
 
Graphical analysis of data in Table 7.4. The height of the bars relative to each other represents the 
fold change of the correct, normalized spectral count of the aI5+ strain (blue) over the aI5- 
strain (red). The proteins are listed in order of decreasing aI5+ to aI5- fold change with 
proteins to the left on the X-axis more enriched in the aI5+ strain and those to the right more 
enriched in the aI5- strain. Each section of the graph is enlarged in subsequent Figures 7.19 












Fig. 7.19: Proteins that were associated with TAP-tagged Mss116 enriched in a 161-
U7mss116/aI5 + strain  
 
Enlarged view of the + enriched portion of the graph in Fig. 7.18. Non-ribosomal proteins are 





























Fig. 7.20: Proteins that were associated with TAP-tagged Mss116 enriched in a 161-
U7mss116/aI5 - strain 
 
Enlarged view of the - enriched portion of the graph in Fig. 7.18. Non-ribosomal proteins are 
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54S ribosomal protein L3, mitochondrial  GN=MRPL3  RM03 44 61 0 0 0 61 
54S ribosomal protein L10, mitochondrial  GN=MRPL10  RM10 36 48 0 0 0 48 
54S ribosomal protein L24, mitochondrial  GN=MRPL24  RM24 30 42 0 0 0 42 
54S ribosomal protein L4, mitochondrial  GN=MRPL4  RM04 37 38 0 0 0 38 
54S ribosomal protein L40, mitochondrial  GN=MRPL40  RM40 34 46 0 0 0 34 
54S ribosomal protein RML2, mitochondrial  GN=RML2  RML2 44 34 0 0 0 34 
54S ribosomal protein IMG1, mitochondrial  GN=IMG1  IMG1 19 34 0 0 0 34 
54S ribosomal protein L8, mitochondrial  GN=MRPL8  RM08 27 28 0 1 0 28 
54S ribosomal protein YmL6, mitochondrial  GN=YML6  RL4P 32 26 0 0 0 26 
54S ribosomal protein L13, mitochondrial  GN=MRPL13  RM13 30 25 0 0 0 25 
54S ribosomal protein L20, mitochondrial  GN=MRPL20  RM20 22 24 0 0 1 24 
54S ribosomal protein L22, mitochondrial  GN=MRPL22  RM22 35 20 0 1 0 20 
54S ribosomal protein L9, mitochondrial  GN=MRPL9  RM09 30 19 0 1 0 19 
54S ribosomal protein L15, mitochondrial  GN=MRPL15  RM15 28 19 0 0 0 19 
54S ribosomal protein L23, mitochondrial  GN=MRPL23  RM23 18 18 0 0 0 18 
54S ribosomal protein L49, mitochondrial  GN=MRPL49  RN49 18 18 0 0 0 18 
Mitochondrial escape protein 2  GN=YME2  YME2 97 16 0 0 0 16 
54S ribosomal protein L51, mitochondrial  GN=MRPL51  RM51 16 16 0 0 0 16 
54S ribosomal protein L25, mitochondrial  GN=MRPL25  RM25 19 15 0 0 0 15 
54S ribosomal protein L41, mitochondrial  GN=MRP20  RM41 31 15 0 0 0 15 
54S ribosomal protein L11, mitochondrial  GN=MRPL11  RM11 29 15 0 0 0 15 
37S ribosomal protein RSM28, mitochondrial  
GN=RSM28  
RSM28 41 14 0 0 0 14 
54S ribosomal protein L16, mitochondrial  GN=MRPL16  RM16 27 13 0 0 0 13 
54S ribosomal protein L31, mitochondrial  GN=MRPL31  RM31 16 13 0 0 0 13 
54S ribosomal protein L1, mitochondrial  GN=MRPL1  RM01 31 25 2 0 0 12.5 
54S ribosomal protein IMG2, mitochondrial  GN=IMG2  IMG2 16 21 2 0 0 10.5 
54S ribosomal protein L33, mitochondrial  GN=MRPL33  RM33 10 9 0 0 0 9 
54S ribosomal protein L27, mitochondrial  GN=MRPL27  RM27 16 8 0 0 1 8 
CDP-diacylglycerol--glycerol-3-phosphate 3-
phosphatidyltransferase  GN=PGS1  
PGPS1 59 8 0 0 0 8 
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54S ribosomal protein MRP49, mitochondrial  
GN=MRP49  
RM49 16 8 0 0 0 8 
Uncharacterized protein YPL168W  GN=YPL168W  YP168 49 8 0 0 0 8 
Mitochondrial phosphate carrier protein  GN=MIR1  MPCP 33 10 1 2 0 8 
60S ribosomal protein L20-A  GN=RPL20A  RL20A 20 8 1 0 0 8 
Flavohemoprotein  GN=YHB1  FHP 45 6 0 0 1 6 
Required for respiratory growth protein 9, mitochondrial  
GN=RRG9  
RRG9 25 6 0 0 0 6 
60S ribosomal protein L13-A  GN=RPL13A  RL13A  23 6 1 0 0 6 
54S ribosomal protein L12, mitochondrial  GN=MNP1  MNP1 21 11 2 0 0 5.5 
Histone H4  GN=HHF1  H4 11 5 0 1 0 5 
Ribosomal protein VAR1, mitochondrial  GN=VAR1  RMAR 47 5 0 0 0 5 
Mitochondrial homologous recombination protein 1  
GN=MHR1  
MHR1 27 5 1 0 0 5 
60S ribosomal protein L8-B  GN=RPL8B  RL8B 28 5 1 0 0 5 
54S ribosomal protein L36, mitochondrial  GN=MRPL36  RM36 20 11 2 2 0 4.5 
Protein FMP52, mitochondrial  GN=FMP52  FMP52 25 10 2 1 0 4.5 
Uncharacterized protein YIL077C  GN=YIL077C  YIH7 37 4 0 0 0 4 
Mitochondrial inner membrane i-AAA protease 
supercomplex subunit MGR1  GN=MGR1  
MGR1 47 9 2 1 0 4 
60S ribosomal protein L18-A  GN=RPL18A  RL18A 21 4 1 0 0 4 
rRNA methyltransferase, mitochondrial  GN=MRM1  MRM1 46 9 3 0 0 3 
External NADH-ubiquinone oxidoreductase 1, 
mitochondrial  GN=NDE1  
NDH1 63 6 2 0 0 3 
54S ribosomal protein L35, mitochondrial  GN=MRPL35  RM35 43 50 19 0 0 2.63 
ATP-dependent RNA helicase MSS116, mitochondrial  
GN=MSS116  
MS116 76 811 315 8 10 2.63 
60S ribosomal protein L19-A  GN=RPL19A  RL19A 22 5 2 0 0 2.5 
54S ribosomal protein L17, mitochondrial  GN=MRPL17  RM17 32 22 10 0 0 2.2 
54S ribosomal protein L32, mitochondrial  GN=MRPL32  RM32 21 8 5 0 1 2 
Sphingolipid long chain base-responsive protein PIL1  
GN=PIL1  
PIL1 38 22 12 0 0 1.83 
Uncharacterized protein YER077C  GN=YER077C  YEQ7 80 11 6 0 0 1.83 
Phosphatidate phosphatase APP1  GN=APP1  APP1 66 36 20 1 0 1.75 
54S ribosomal protein L7, mitochondrial  GN=MRPL7  RM07 33 12 7 0 0 1.71 
Uncharacterized mitochondrial membrane protein FMP10  
GN=FMP10  
FMP10 28 5 5 0 2 1.67 
54S ribosomal protein L2, mitochondrial  GN=MRP7  RM02 43 51 36 0 0 1.41 
Methyltransferase OMS1, mitochondrial  GN=OMS1  OMS1 56 44 32 0 0 1.38 
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Protein CBP3, mitochondrial  GN=CBP3  CBP3 39 9 9 0 2 1.29 
54S ribosomal protein L28, mitochondrial  GN=MRPL28  RM28 17 15 12 0 0 1.25 
Acetolactate synthase catalytic subunit, mitochondrial  
GN=ILV2  
ILVB 75 6 5 1 1 1.25 
60S ribosomal protein L7-B  GN=RPL7B  RL7B 28 5 6 0 0 0.83 
60S ribosomal protein L4-A  GN=RPL4A  RL4A 39 15 19 0 0 0.79 
Aconitate hydratase, mitochondrial  GN=ACO1  ACON 85 3 4 0 0 0.75 
Prohibitin-1  GN=PHB1  PHB1 31 9 9 4 2 0.71 
37S ribosomal protein S23, mitochondrial  GN=RSM23  RT23 51 9 12 1 0 0.67 
Heat shock protein 78, mitochondrial  GN=HSP78  HSP78 91 6 11 0 1 0.6 
37S ribosomal protein S22, mitochondrial  GN=RSM22  RT22 72 9 14 1 0 0.57 
40S ribosomal protein S5  GN=RPS5  RS5 25 4 7 0 0 0.57 
COB pre-mRNA-processing protein 2, splicing factor  
GN=CBP2  
CBP2 74 12 15 5 2 0.54 
37S ribosomal protein S7, mitochondrial  GN=RSM7  RT07 28 8 14 1 0 0.5 
37S ribosomal protein MRP1, mitochondrial  GN=MRP1  RT01 37 12 25 0 0 0.48 
37S ribosomal protein MRP4, mitochondrial  GN=MRP4  RT04 44 6 13 0 0 0.46 
37S ribosomal protein S25, mitochondrial  GN=RSM25  RT25 31 2 6 0 1 0.4 
37S ribosomal protein NAM9, mitochondrial  
GN=NAM9  
NAM9 56 4 11 0 0 0.36 
Altered inheritance of mitochondria protein 36, 
mitochondrial  GN=AIM36  
AIM36 29 2 5 1 2 0.33 
37S ribosomal protein MRP51, mitochondrial  
GN=MRP51  
RT51 39 5 15 0 0 0.33 
60S ribosomal protein L28  GN=RPL28  RL28 17 3 9 0 0 0.33 
37S ribosomal protein S9, mitochondrial  GN=MRPS9  RT09 32 3 10 0 0 0.33 
Heat shock protein SSC1, mitochondrial  GN=SSC1  HSP77 71 17 46 5 2 0.27 
40S ribosomal protein S17-A  GN=RPS17A  RS17A 16 1 5 0 0 0.2 
37S ribosomal protein S8, mitochondrial  GN=MRPS8  RT08 17 2 12 0 0 0.17 
37S ribosomal protein PET123, mitochondrial  
GN=PET123  
RTPT 36 2 13 0 0 0.15 
60S ribosomal protein L21-A  GN=RPL21A  RL21A 18 1 7 0 0 0.14 
37S ribosomal protein MRP17, mitochondrial  
GN=MRP17  
RT06 15 1 8 0 0 0.13 
37S ribosomal protein MRP13, mitochondrial  
GN=MRP13  
RT13 39 1 8 0 0 0.13 
ATP synthase subunit beta, mitochondrial  GN=ATP2  ATPB 55 5 48 0 0 0.10 
ATP synthase subunit alpha, mitochondrial  GN=ATP1  ATPA 59 7 53 3 5 0.08 
37S ribosomal protein S16, mitochondrial  GN=MRPS16  RT16 14 1 15 0 0 0.07 
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37S ribosomal protein S35, mitochondrial  GN=MRPS35  RT35 40 1 16 0 1 0.07 
Heat shock protein 60, mitochondrial  GN=HSP60  HSP60 61 2 28 1 1 0.04 
Cytochrome c1, heme protein, mitochondrial  GN=CYT1  CY1 34 7 9 7 5 0 
Mitochondrial group I intron splicing factor CCM1  
GN=CCM1  
CCM1 101 0 4 0 0 0 
40S ribosomal protein S3  GN=RPS3  RS3 27 0 4 0 0 0 
Ketol-acid reductoisomerase, mitochondrial  GN=ILV5  ILV5 44 0 5 0 0 0 
Mitochondrial peculiar membrane protein 1  GN=MPM1  MPM1 28 0 5 0 0 0 
Cytochrome b-c1 complex subunit 2, mitochondrial  
GN=QCR2  
QCR2 40 1 6 1 0 0 
60S ribosomal protein L35-A  GN=RPL35A  RL35A 14 0 6 0 0 0 
37S ribosomal protein MRP21, mitochondrial  
GN=MRP21  
RT21 20 0 6 0 0 0 
Biotin synthase, mitochondrial  GN=BIO2  BIOB 42 1 7 2 0 0 
        
Pyruvate dehydrogenase E1 component subunit beta, 
 mitochondrial  GN=PDB1  
ODPB 40 0 8 0 0 0 
37S ribosomal protein S28, mitochondrial  GN=MRPS28  RT28 33 0 26 0 0 0 
Inhibitory regulator protein IRA2  GN=IRA2  IRA2 352 0 2 4 1 0 
Prohibitin-2  GN=PHB2  PHB2 34 2 4 4 1 0 
 
 
Table 7.5 (continued): Proteins associated with Mss116 in + and- strains of 161-
U7mss116/bI1. 
 
Strains are as in Fig. 7.17, lanes 3, 4, 7 and 8 and were analyzed as in Table 7.1. Untagged values 
were subtracted from the TAP-tagged value to obtain a background-corrected value for each 
protein. The ratio of corrected bI1+ to bI1- values was calculated to estimate enrichment in 
wild-type strain over the petite strain (+ fold change over -).  Proteins are listed in decreasing 
order of the fold change. Proteins at the bottom of the list are those found only in -. Non-
ribosomal proteins are highlighted in yellow. Mss116 and known splicing factors are in bold. The 
UniProt Accession identification number (UniProt Accession #) and the molecular weight in kDa 























































































Figure 7.21 (continued): Proteins associated with Mss116 in + and- strains of 161-
U7mss116/bI1. 
 
Graphical analysis of data in Table 7.5. The heights of the bars relative to each other represent the 
fold change of the correct, normalized spectral count of the bI1+ strain (blue) over the bI1- 
strain (red). The proteins are listed in order of decreasing bI1+ to bI1- fold change with 
proteins to the left on the X-axis more enriched in the bI1+ strain and those to the right more 
enriched in the bI1- strain. Enlargements of the graph are in Figures 7.22 and 7.23. Due to the 











































Figure 7.22: Proteins that were associated with TAP-tagged Mss116 enriched in a 161-U7 
mss116/bI1 + strain  
 
Enlarged view of the - enriched portion of the graph in Fig. 7.21. Non-ribosomal proteins are 










Figure 7.23: Proteins that were associated with TAP-tagged Mss116 enriched in a 161-U7 
mss116/bI1 + strain  
Enlarged view of the - enriched portion of the graph in Fig. 7.21. Non-ribosomal proteins are 





























Figure 7.24: SDS polyacrylamide gel showing proteins associated with TAP-tagged Mss116 with 
and without RNase treatment. 
 
The strain tested was 161-U7mss116/1+2+ with TAP-tagged Mss116 expressed from plasmid 
vector pRS416. Cells were cultured and mitochondria were isolated as in Fig. 7.14. Mitochondrial 
pellets were solubilized as described in Methods with the following exception: to the 
experimental sample was added 60 µl RNase A and to the control sample 60 µl additional 
solubilization buffer. Each was incubated at 30°C for 10 min prior to proceeding with the 
remainder of the TAP protocol. Samples were separated on a 4-12% gradient gel and stained with 








It has long been recognized that yeast mitochondrial intron splicing and 
functionality of the mitoribosomes are linked (Rodeheffer and Shadel 2003). The most 
common view has been that without functional mitoribosomes, intron-encoded maturases 
cannot be translated, thereby blocking splicing (Pel and Grivell 1993).   
Here, I provided evidence that non-functional mitoribosomes and proteins 
involved in translation also negatively impact the in vivo splicing of introns that lack 
intron-encoded maturases. Interestingly, this splicing defect was sometimes 
circumvented: in the absence of functional mitoribosomes and certain proteins (primarily 
translational activators and/or PPR proteins), splicing was observed to proceed to 
completion, exhibiting a wild-type phenotype, presumably via second-site suppressor 
mutations. Further studies are necessary to ascertain the nature of these mutations. 
Three of the translational activators for components of the cytochrome c oxidase 
holoenzyme (Pet 309 for COX1, Pet111 for COX2, and Pet122 and Pet494 for COX3) 
have previously been shown to be membrane-bound (McMullin and Fox 1993; Manthey 
et al. 1998; Green-Willms et al. 2001; Naithani et al. 2003), leading to the notion that the 
translational activator proteins could be topographically organized on the surface of the 
inner membrane so that synthesis of proteins Cox1, Cox2, and Cox3 would be co-
localized to facilitate assembly of the core of the holoenzyme (Naithani et al. 2003; 
Gruschke and Ott 2010).  Translational activators for COB and COX1 mRNAs, Cbp1 and 
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Pet309 respectively, had also been shown to be associated in a high-molecular weight 
complex thought to link transcription to translation (Krause et al. 2004).  
The results presented here expand on this model, showing that Pet309 and 
translational activators for other mRNAs, Aep1, Sov1, and Atp22, strongly impact the 
splicing of aI5, possibly reflecting that a higher order of organization among these 
proteins is involved in aI5splicing.  
Some of the membrane-bound translational activators may be inserted into the 
inner membrane with the assistance of the insertase, Oxa1, whose deletion results in 
strong splicing defects in aI5and bI1. 
One interpretation of these data suggests the presence of a system at the mt inner 
membrane that monitors the status of the mitoribosome, possibly through the general 
RNA chaperone, Mss116, and is linked to the splicing apparatus. This putative splicing 
system may lend support to the previously proposed “translational integrator complex” 
thought to link transcription to translation (Bryan et al. 2002; Krause et al. 2004; Shadel 
2004) and  is further supported by recent work in which the mitoribosomes are found to 
be interacting with proteins involved with mRNA metabolism and maturation (Kehrein et 
al. 2015).  
The data presented here also point to distinctively different auxiliary protein 
requirements for the splicing of group I introns, group II introns encoding their own 
maturases, and group II introns aI5 and bI1 that do not encode their own maturases.  
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Further study is required to establish the identity of the putative second-site 
suppressor mutations discussed in Chapter 4. These studies may be complemented by 
microscopy to confirm the absence of mitoribosomes in the petite strains. 
More components of the putative splicing complex may be identified by repeating 
the Mss116 TAP tag pull-down experiments in Chapter 7 using low salt concentration 




















APPENDIX A:   
Following are the original Northern hybridizations used in the screen of the 
+ 
strains in Chapter 3.  All the hybridizations were performed by the author with the 
exception of those performed by technician Kathryn Turner, and are labeled KT.  The 
descriptions or functions of the tested proteins, if known, were taken from the 














































































































































































APPENDIX B:  
 
Listed below are the oligonucleotides (named ORF 5a and ORF 3a, forward and reverse 
primers, respectively) used to amplify the kanamycin cassette from the commercial strain 
BY4741 (Open Biosystems) for knocking out the genes in the 161-U7 strains used in Chapter 3.  
To confirm the gene replacement, a second set of oligonucleotides were used (named ORF 5b and 
ORF 3b, forward and reverse primers, respectively) situated outside of the original cassette. 
 
IMG1 5a AGAAGAAGAAGAAGAATCGAGTCTT 
IMG2 5a CTATAAGCAGTATAGCTCCAGCAAG 
MRP1 5a GTGAATCTCAAGGAGTAATCTTGC 
MRP10 5a TATATGATGACAGGTTCGTTCTCC 
MRP17 5a AGGATGATTTCTGATTAGGAGGAG 
MRP20 5a GTACATACATTTCTTGTGGAGAACG  
MRPL11 5a AGGGCTTAGTAGAGATTCATACAG  
MRPL13 5a TTATTCTTCGTTCTTTATCGCTGC 
IMG1 3a GATGTCTAGCACTTGAGTATACCT 
 IMG2 3a GTAAGCAACTTCTTTTCGATGGC 
MRP1 3a CAATGAAGATGAGGAAGACGTTTA 
MRP10 3a GAATTAAGTACGGTTTAACGGAGG 
MRP17 3a TAATGGTGTCTATGTTAAGTGAGG  
MRP20 3a GTTTAGAGATTATGTAGTTTGCTCC 
MRPL11 3a TTATCCTATGGGAACTGCTGAATC  
MRPL13 3a ATTATTCCCTTACTGCTTCTTGAG  
IMG1 5b TATATCTGTATGTGAGTGGTCAATG   
IMG2 5b AAGACAAGTAACATACATGCACATA   
MRP1 5b GTAATCTTTCCCATATTCAGGCTC  
MRP10 5b ATTGATCCGTGTTTATTTCCCTTC 
MRP17 5b TTCTTTCCAAATACCCACTCAAAC 
MRP20 5b TAGAGAATAAATCGACGAAGTGAG  
MRPL11 5b CATCTCAAGCCATCTTCAATACAC 
MRPL13 5b CTATTAGTTTATCGTTGGTGTTTGC  
IMG1 3b CTGTTGGAATTCGAAGTGAATTGTT 
IMG2 3b AACGATAAAGCCTACACACCTTTAA 
MRP1 3b GGAGAGATGATACAGATGATTCTGA 
MRP10 3b TGAGAAAGGACTCCAATAATCCAG 
MRP17 3b CCCTTCGTTATTTGATGGATCTAC 
MRP20 3b CAACATAAGAAGGCAATTTGGTCC  
MRPL11 3b TCTTTACATGCTTCAACTCCTTAC 
MRPL13 3b TTTCGTTTCTTCACATGGATCTTG 
 
MRPL16 5a CTAGGCTTTGTATCCAGTTGAATC  
MRPL27 5a TCAAGAGCTTCCTTACCATATAAC  
 274 
YDR114C 5a CCCTTGATTTCCATCTTCTTTGAC 
MRPL16 3a TTTCACGTCGTCATGTGTTTCTTC 
MRPL27 3a GTTATCGGTGAATCTTTGGGTTTG  
YDR114C 3a TAAGCAACCTACGCTAACAAATAC 
MRPL16 5b TACCCAAGTCCAAATCTGTTTCAC 
MRPL27 5b GGAAATGCAACAATGGATAAGATG  
YDR114C 5b AGGTACGGTGAGTGATGATATAAG 
MRPL 37 5b CGCAAACTTTAATAGCAACACAAC  
MRPL16 3b GTACTTCTTTCTTTGATAGCCACC  
MRPL27 3b TGGTATTTGGTTTGCTGATAAGTG  
YDR114C 3b TCTTTATCTTCGTTAGCTGGCATC 
 
MRPL6 5a ATTATTGGTTGTGATTATGCCTGG  
MRPL7 5a AGTAATAGACAGGACCGGAAATAG 
RML2 5a ATTGAAAGAGAAAGGGAACGTATG  
MRPL6 3a GGTTTCTAGTCTAAATGGTGTTCC  
MRPL7 3a GAGTTGAGTTGTGAGTTGTGTAAG 
RML2 3a TACAACCTCAAATCATATCGGTCC 
MRPL6 5b TTGACTGCATCTTGTATAGTTTCC  
MRPL7 5b CCTTAATGACTTACCCATACTCTTC  
RML2 5b AGAGCCTAATTCTTTGATAGTTCC  
MRPL6 3b AGTTCGAGAAATTGGAAGGTACAG  
MRPL7 3b TGCTAAGAAGACCAATAAACTTGC 
RML2 3b TGAAGTGATTAAAGTGACGAACAG 
 
YNL184C 5a CACTTGGTTGAAGATGGATTATCG 
YNL184C 3a CCTTCCATCTCCAATAAACTATGC  
YNL184C 5b TAATGTTAATATCGGGCCACAAAG  
YNL184C 3b TCAGTAGAAAGAAGAAGGAAGGTC  
 
DIA4 5a TCGTCAACTACAACCATTTATTGC 
MSD1 5a TCATGGTTGGAGTATTGCTATTTG 
MSE1 5a GGTGAAACTTCTAACTACTCATTCG  
MSM1 5a CACACTTACTTCCTTGTATAGTGC  
MST1 5a TATCACGCTTGGAGACCATTTATC  
MSU1 5a ATATCAATGCAAACCCGAATAAGC  
DIA4 3a AAACTGAAAGGTGTTACGGAAATC  
MSD1 3a GTAAACGTAGACTTTGGGAGATTG 
MSE1 3a AGTATAGTTTCGGTTTCGTTCGAG 
MSM1 3a ACAGGAAATGTAACATGGGAATATC 
MST1 3a GAGGAACCTCAAGACAAAGTAAAG 
MSU1 3a TTATAGTGGAGAAGAGAACCATCG 
DIA4 5b AAGCATCAATAGCCACCAAATAAG 
MSD1 5b GATTAGCAGATATTTGTAGCGGAG  
MSE1 5b GAAAGACTTGGAGACCATTAAAGC 
MSM1 5b ATATCTATGGTGTCGCTTTGTTTG 
MST1 5b ACTAACTACTTTGGACGTGACCTC 
 275 
MSU1 5b ACATTAACCAAAGCACTATCAGAG 
DIA4 3b TCTGATGCTTTATCTTTCTTCGTG 
MSD1 3b TGACAAGTAACGGCTGTGATAATG  
MSE1 3b GCCTTCCACTCTTCTAATTTCATC  
MSM1 3b AACAACTTCATGTTTGATTCCGAC 
MST1 3b CTGATGACAAGACAACTACTGAAG 
MSU1 3b TAGCCTTTCTCATAACTTCCCTTTC 
 
NAM2 5a GAATCAAAGAAACCGAAGAAAGTC    
PET56 5a TCATCTTTGCCTTCGTTTATCTTG 
SUV3 5a AAACCAGAATAACAGTAAGAGCAC 
MRH4 5a AGTATCTCTTTATTCTCTGGCCTG 
YOR199W 5a TGTAACTTCTTACGTTCTTGTTGG 
YOR200W 5a ATGAAACTGAACGAAGAAATGACC  
RPO41 5a TGATTATCAACAATACGCTGCTTC   
NAM1 5a TTATATTACTGCTCAACTTCCATGC 
SLS1 5a TAGCTCTTCTTCCACTTCTGTTTC 
AEP3 5a AATGATAACACTAACACAGGCTTC  
MTF1 5a TTTGAATGGTAACACTGTCTCTTG  
NAM2 3a AGAGTCTCTCAAAGTATAGCGTTC  
PET56 3a  GAACGAAGAAATGACCAGAATGAG 
SUV3 3a AGGATAGAGAACCCTGGAATGAAC 
MRH4 3a GATTACACTATGTCCTTGTTGCTG  
YOR199W 3a ACGATTTGAACGGATTATGTAACG  
YOR200W 3a ATAGTCGATGAACTGAAGGTTACG  
RPO41 3a TGCAAACGATAAACGCTAAGTATG  
NAM1 3a TGAATTTGAAATCTGCCGAACAAG  
SLS1 3a CGAAAGACAAAGAAGGTTAAATGC 
AEP3 3a AGTCGAAGAAGAGGAAGTTGAATG  
MTF1 3a ATTTAGCTTTGACGGTTCGTAGAG  
NAM2 5b AGTCAGTGAAAGTAGCTCATCATC 
PET56 5b CCTATACCTGTGTGGACGTTAATC  
SUV3 5b GAAGTGCAATCATCGTTAAAGGAG 
MRH4 5b GGGTGGACCAATGAGTATAAATTC  
YOR199W 5b CTCATTGATTCTTTGCTTGGCTTC 
YOR200W 5b TGCTTAATAGAGTCGTGAATGTTG 
RPO41 5b GCTTCCAAAGAAAGAAGATTACAAC  
NAM1 5b TTAAACAAGCCGAACAAGAACAAG 
SLS1 5b ATGTACTTTGGAAGGATGGAACTC  
AEP3 5b CTGCTTTACTTTCATTGTTTGGTG 
MTF1 5b TTCTAGGGCATATACTTCTTCCTC  
NAM2 3b CAATACCCGTCAACAAACAAATTC  
PET56 3b TGCTTAATAGAGTCGTGAATGTTG  
SUV3 3b TGTAGTATGGTGCGTTAGTCATAG  
MRH4 3b AACATCAAAGTGGCAGAACTAAAG 
YOR199W 3b ATAGTCGATGAACTGAAGGTTACG 
YOR200W 3b GTGTTATGACTTCCCTGACTAATG  
 276 
RPO41 3b CAAACAATAGACAGGTTTCACTGC  
NAM1 3b GTATAAGGAAAGGCAATATCGCTC 
SLS1 3b TTAACAGCAGTAGGACTAAAGAGC 
AEP3 3b CAATTAGGAACATTGAAGCCTCTG  
MTF1 3b CAAAGCAGCAGAATTATTCAAAGC 
 
AEP1 5a CAGATAGTCTGATTGCTCCAGAAG  
MEF2 5a CAGAGATCCGAACAAATGATAGTC 
MTG1 5a GTCCGTGGAACAAACAATCAATAG  
PET309 5a ACCTTATACTCCCTCGTAAACTTC 
SOV1 5a GAGATTCTATATCATGGGCACAGG 
TUF1 5a TCTATTATACTGACAACCCTGTTACC  
OCT1 5a AAAGCGAAATGGATCAGAGAATAC 
OXA1 5a ATGACGTGTTCCGTTCTTATGTTC 
AEP1 3a GTATATCAATCTTCCTTGCAGCAG  
MEF2 3a GCCACGAGGAACAAGAATATAAAG  
MTG1 3a GAGTTAATGGGTGGTGTATCAATC 
PET309 3a GTTTGCTAACTTACGGTGAAACTG 
SOV1 3a ACGTTAAACCAATCTCATCCTTTC  
TUF1 3a AATACGCCGGAAAGTAAACAAATC 
OCT1 3a GGGAAAGTGTTCTTTATATCGTAGG  
OXA1 3a TCATGCTATGGTGAACGACTTTAC  
AEP1 5b CTCACCTGAGATGTTATTGTTCAC    
MEF2 5b ACATCATGTATTACCAGCCTCTTC 
MTG1 5b AGATCACTCTACGAGACAATAGAC 
PET309 5b ATCTCCTTCTTCTCGTCTAGTTTC  
SOV1 5b AAATACTACTGGTTACTGTGCTCC 
TUF1 5b CGTCCACGAATGAAGATTCTAAAG  
OCT1 5b ATTGGTAAATCCAAACCTGACATC  
OXA1 5b GACCATTCGTTCTTTATCACTAGG  
AEP1 3b TTTCCACTATAAGTTGTCCACCAC  
MEF2 3b ATTTGCTTTCTACGTGTGATAGAC  
MTG1 3b AGGCATTGGAAGTTGACTATATTG 
PET309 3b GATGATGCTGTGATTGATGTGAAC 
SOV1 3b GACAAAGAGACTTAGAGAGCAATC  
TUF1 3b ATTCAAACTCTTCGTCATCCATAC 
OCT1 3b AATTAAGGGATTTGGATCTTGTGC 
OXA1 3b GACGTTTGTGAAAGAGAGAATACC  
 
PIM1 5a TAATGTATGGGTGCTTTGTAAAGG  
YDL104C 5a ACAAGTTTGGGTGCTTAGAAGTAG 
SSQ1 5a GATAATGATAAGTTGTGGGAGAGC  
MET7 5a ATTGGAACTGATAGAAGGTTGTTG    
MGM1 5a ATGGATCTAGTGTACTCTTTGAGG 
MGM101 5a AGCAGCAAACGCTAATAAGGTAAC  
PIM1 3a TTTACTTTCTGGTTTCGTTTCTCG  
YDL104C 3a AACATCACTTCACCATTCTTAGAC  
 277 
SSQ1 3a GGGTTTCCCTCTGAATAATGTTTAC 
MET7 3a CAGCAATGCCTAACAAATCAAATC  
MGM1 3a CAGATGTGTCTCTGCATACTGTAG 
MGM101 3a AAAGGGTAAGGGTATCAAGTTGTC  
PIM1 5b AGCAGGACTAAGCTAGATAGTAAC 
YDL104C 5b TTGGATCAGTGGTGTGAGAATATG  
SSQ1 5b GATTACGCGATATGTTTCCATACG  
MET7 5b GTAATTTACCTGATGGCGTCGAAC 
MGM1 5b AATCCGATCATACATACCCATCTC  
MGM101 5b ACCCAATCTCATCAAACTTAAAGG  
PIM1 3b  GGCAACATTTCTCAATAGCCTATC  
YDL104C 3b CTCAACGAAGAAGGAATAATGACC 
SSQ1 3b TTGGTATTATCAGTCTCTCCACTC  
MET7 3b TGACAGTAATAAGCAAACAGAAGC 
MGM1 3b AAGGTACTGCATTGTCAAGATTAG 
MGM101 3b GGTAAGGTCAAGAAGGTTCAATTAG 
 
MMM1 5a AAGAACCGTCAACATCCAATAAAG 
ADH3 5a ACATTTGAGGAATCGTATCGAAAC  
ATP22 5a TGTAACGAACGTATGAATGAAAGC 
INH1 5a CTTTCTTTGAATTTGTTCGTGGTTG  
ISA2 5a CGACTGTACTGTTTGTTCAAATTCC  
MMM1 3a GAAGGACCAATTCTGTCAAGAAAG 
ADH3 3a GAGAGTAATATCGAAGTGTGCAAG  
ATP22 3a ATCATTAAATCTAGGCTTGCCATC  
INH1 3a CACACTGTTCCTATCTTTCTATGC 
ISA2 3a TATATGAGATGGAAGGAAGTTCTCG 
MMM1 5b TCGTATTCATCACTTGTCTTGTTC    
ADH3 5b CGTCAGTGCAGGATATAAATGTAG  
ATP22 5b AAATATCTCTGTGCTCGATGTACC  
INH1 5b GGATGACCAAATCAAGGAAGTTAC 
ISA2 5b AATTTGCATCCCGTTCATAGATGG 
MMM1 3b TATTCTCAGTGTTGGGCTGTATTG 
ADH3 3b GATTCCATACACTACGTGCTAGTC 
ATP22 3b TATCAACAATGGAATCCCAACAAG  
INH1 3b TGAAATACTAAACAGCGCAGAAAG  
ISA2 3b AATAATTGAATGTGGTGGTGATGG 
 
YLR091W 5a TAAATACTGAAGATGACAGCAACC  
CAF17 5a  TAAGTTGTAAGTTTGCCTCAACAG  
FMP38 5a CCCATCTCCACTTATTCTATTGTTG 
YLR091W 3a TAACCTTCCCTGGACATATCTTAG 
CAF17 3a ATTATGGGTATATGGGTGTTGTTG 
FMP38 3a TTTATTGACTCGCCTTATACTCTAC  
YLR091W 5b TGTCAAAGAAGGAAATCATCACAG  
CAF17 5b TTCTTATCTCAACCATTTGCTGTC  
FMP38 5b GTTTCTTTCAGCATCTTCACCTTC  
 278 
YLR091W 3b TAGGAGTAAGCACCAATAAACGAG  
CAF17 3b GGTAGAAAGAAACAAGGCTTTACG 
FMP38 3b CTGTGTTGTTTGTTTCTCTCTAGC 
 
YGR150C 5a CCTTGTCGCACATTATCTTACTTC  
GLO3 5a AGTACCTAGATGTTACGAATGCTG 
LCB5 5a TTCAACTGTACTTCTTTGCACAAC 
YGR150C 3a GCTACCTACTATATCGACCACTAC 
GLO3 3a TGCAAGTGTTTCTAACGAATATGG  
LCB5 3a TTGATATTTCTACAGCAGAGGAGC 
YGR150C 5b GTCATCCCTCCTTTAATACGAAAC  
GLO3 5b TGCTCTAACTCTATCAATCATTTGC  
LCB5 5b CTTTATGAGAGGAGTAAGCACGAC  
YGR150C 3b CCCTTTATTATTTGGTTTGGCAATC 
GLO3 3b AATACATAAACAGCCACCTACTTTC 
LCB5 3b ATTACAGTTATGGGATACAGCAGG 
 
PKH2 5a TATATTCACATTTCTGAGGCAGAG  
RNR1 5a CTTATTGGGTGTTGAATAGAGGAC 
GON1 5a TAACGGCAACTCCAAATAAAGAAC 
NRP1 5a GAAGACGATGAAGACAGTGAGTAG 
PKH2 3a CTCAAGGTTTCACTGTCGAAATAG 
RNR1 3a TTGAAATAAAGGATGGAAGGAGTG 
GON1 3a TTGTTCTGCTGTAGTTAGACGTAG 
NRP1 3a GTCGAAGAATTTATCACTCACAGG  
PKH2 5b AGACTATTGCTTCTGATCCTTCTG  
RNR1 5b TTTCTATGGCCTTTGTTTACTATCG 
GON1 5b AACCAAAGAACTGGAAACTCAGAC  
NRP1 5b TAAAGATGGAAGCAAGACGGTATG 
PKH2 3b GAATTGTATTTGGAAAGGTTGCAG 
RNR1 3b GTCTCTATACATTTCCCAGTTTGC 
GON1 3b TCAGGAGAATGTCTTTGAAACCAG 
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